No. 91-8 (CURRENT MLmGHHES EN MEDE©ENE m OCT 0 4 199] Treatment of Panic Disorder with and without Agoraphobia iii-15:24:14 National Library of Medicine January 1985 through July 1991 1448 Citations .8. DEPARTMENT OF HEALTH & HIIMAN SERVICES Public Health Service 0 National Institutes of Health flUBLlC HEALTH LIBRARY flERKElIY 5; LIBRARY - unwaum op ' ‘ CALIFOlNIA ' \. CBM 91-8 Treatment of Panic Disorder with and Without Agoraphobia January 1985 through July 1991 1448 Citations Prepared by Karen Pan-ias, ML.S., National Library of Medicine Barry E. Wolfe, Ph.D., National Institute of Mental Health US. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service National Institutes of Health National Library of Medicine Reference Section 8600 Rockville Pike Bethesda, Maryland 20894 SERIES NOTE Current Bibliographies in Medicine (CBM) is a continuation in part of the National Library of Medicine’s Literature Search Series, which ceased in 1987 with No. 87-15. In 1989 it also subsumed the Specialized Bibliography Series. Each bibliography in the new series covers a distinct subject area of biomedicine and is intended to fulfill a current awareness function. Citations are usually derived from searching a variety of online databases. NLM databases utilized include MEDLINE", AVLINE", BIOETHICSLINE°, . CANCERLI'I", CATLINE", HEALTH, POPLINE” and TOXLINE'. The only criterion for the inclusion of a particular published work is its relevance to the topic being presented; the format, ownership, or location of the material is not considered. Comments and suggestions on this series may be addressed to: Karen Patrias, Editor Current Bibliographies in Medicine Reference Section National Library of Medicine Bethesda, MD 20894 301/496-6097 Ordering Information: Current Bibliographies in Medicine is sold by the Superintendent of Documents, US. Government Printing Office, Washington, DC. 20402. To order the entire CBM series for the calendar year 1991 (20 bibliographies), send $52.00 ($65.00 foreign) to the Superintendent of Documents citing GPO List ID: CBM91. For your convenience an order blank is given inside the back cover. Orders for individual bibliographies in the series ($3.00, $3.75 foreign) should be sent to the Superintendent of Documents citing the titleI CBM numberI and the GPO List ID given above. Use of funds for printing this periodical has been approved by the Director of the Office of Management and Budget through September 30, 1991. ii TREATMENT OF PANIC DISORDER WITH AND WITHOUT AGORAPHOBIAV; . Panic disorder in all of its various manifestations (e.g., with and without agoraphobia) is increasingly recognized as a serious and prevalent mental disorder. It has been estimated that over 10 million people in the United States may suffer from some form of panic disorder in any six month period. Because panic disorder is so often mistaken for a large number of physical and emotional disorders, it has become a significant public health issue to develop procedures for accurate diagnosis and effective treatment. Emergency room and primary care physicians, in particular, are in need of the best information available regarding the diagnosis and treatment of panic disorder, because they are usually the first to see such patients who believe themselves to be suffering from some cardiovascular crisis. Data are now available on the diagnosis and treatment of panic disorder, but controversy exists about the interpretation of these data and their implications for patient management. This bibliography was prepared in support of the National Institutes of Health Consensus Development Conference titled Treatment of Panic Disorder held in Bethesda, Maryland on September 25-27, 1991. The citations cover various aspects of panic disorder, including the epidemiology, etiology, diagnosis and classification, psychological and pharmacological methods of treatments as well as their mechanisms of actions. The bibliography relies primarily on journal articles, conference proceedings, and books and book chapters. Only English language materials have been included. There are a few case reports to illustrate various approaches to the treatment of panic disorder with and without agoraphobia. Letters and abstracts have been excluded. Finally, there is a special section on studies of agoraphobia which do not specifically discuss panic disorder. With the exception of the pharmacological treatment section, a citation appears under only one category. iii SEARCH STRATEGY A variety of online databases are usually searched in preparing bibliographies in the CBM series. To assist you in updating or otherwise manipulating the material in this search, the strategy used for the NLM’s MEDLINB database is given below. Please note that the search strategies presented here differ from individual demand searches in that they are generally broadly formulated and irrelevant citations edited out prior to printing. SS 1 = *PANIC OR PANIC (TF) OR PANIC/DRUG EFFECTS OR *AGORAPHOBIA SS 2 = (TW) PANIC SS 3 = TS (AB) :PANIC DISORDER: SS 4 = ANXIETY DISORDERS OR PI-IOBIC DISORDERS OR MENTAL DISORDERS OR AGORAPHOBIA SS 5 = 2 AND, EXP TRANQUILIZING AGENTS $86: 2 AND EXP ANTIDEPRESSIVE AGENTS SS 7 = 2 AND EXP MONOAMINE OXIDASE INHIBITORS SS 8 = 2 AND EXP F4 SS 9 = EXP CLINICAL TRIALS OR COMBINED MODALITY THERAPY OR COMORBIDITY SSIO= (TW) ACUTE AND PANIC AND INVENTORY 8811: 2 AND 4 OR 2 AND 9 $812:lOR3ORSOR6OR7OR8ORIOORll 8813: 12 AND NOT LETTER (TF) 8814: 13 AND NOT FOR (LA) GRATEFUL MED” To make online searching easier and more efficient, the Library offers GRATEFUL MED, microcomputer-based software that provides a user-friendly interface to most NLM databases. This software was specifically developed for health professionals and features multiple choice menus and "fill in the blank" screens for easy search preparation. GRATEFUL MED runs on an IBM PC (or IBM- compatible) with DOS 2.0 or a Macintosh, and requires a Hayes (or Hayes-compatible) modern. It may be purchased from the National Technical Information Service in Springfield, Virginia, for $29.95 (plus $3.00 per order for shipping). For your convenience, an order blank has been enclosed at the back of this bibliography. iv SAMPLE CITATIONS Citations in this bibliographic series are formatted according to the rules established for Index Medicus°. Sample journal and monograph citations appear below. For journal articles written in a foreign language, the English translation of the title is placed in brackets; for monographs, the title is given in the original language. In both cases the language of publication is shown by a three letter abbreviation appearing at the end of the citation. Note also that a colon (2) may appear within an author’s name or article title. The NLM computer system automatically inserts this symbol in the place of a diacritical mark. Journal Article: Authors Article Title /' \ _ Lydiard RB, Ballenger JC. Antidepressants in panic disorder and agoraphobia. J Affective Disord 1987 Sep-Oct;l3(2):153-68. / / \ \ Abbreviated Journal Date Volume Issue Pages Title Monograph: Authors Title / \ Barlow DH, Cemy JA. Psychological treatment of panic. New York: Guilford Press; c1988. 227 p. / / ./ \ Place of Publisher Date Total No. Publication of Pages TABLE OF CONTENTS page DIAGNOSIS AND CLASSIFICATION l EPIDEMIOLOGY 19 ETIOLOGY AND MAINTENANCE 20 PRIMARY CARE, FAMILY PRACTICE, AND SERVICES 27 TREATMENTS: Pharmacological - Tricyclic Antidepressants 29 - Alprazolam 35 - Other Benzodiazepines 40 - Monoamine Oxidase Inhibitors 45 - Other Pharmacological Treatments 48 - Reviews 51 Psychosocial - Cognitive/Behavioral Therapies 52 - Other Psychotherapies 54 - Reviews 55 Combined Treatments 55 Mechanism of Action of Treatments 56 AGORAPHOBIA 58 REVIEWS 66 BOOKS AND BOOK CHAPTERS 67 AUDIOVISUALS 76 vii DIAGNOSIS AND CLASSIFICATION Albus M, Maier W. Shera D. Bech P. Consistencies and discrepancies in self- and observer-rated anxiety scales. A comparison between the self- and observer-rated Marks-Sheehan scales. Eur Arch Psychiatry Clin Neurosci l990;240(2):96-102. Alnaes R. Torgersen S. DSM-III personality disorders among patients with major depression. anxiety disorders. and mixed conditions. J Nerv Ment Dis 1990 Nov;178(11):693-8. Alnaes R. Torgersen S. Major depression in combination with panic and non-panic anxiety: Childhood memories and precipitating events. I Anxiety Disord l990;4(3):191-9. Alnaes R. Torgersen S. MCMI personality disorders among patients with major depression with and without anxiety disorders. J Pers Disord 1990; 4(2):141-9. Anastasiades P. Clark DM. Salkovskis PM, Middleton H. Hackman A, Gelder MG. Johnston DW. Psychophysiological responses in panic and stress. I Psychophysiology l990;4(4):331-8. Argyle N, Deltito J. Allerup P. Maier W, Albus M. Nutzinger D, Rasmussen S. Ayuso JL. Bech P. The Panic-Associated Symptom Scale: measuring the severity of panic disorder. Acta Psychialr Scand 1991 Jan;83(1):20-6. Argyle N, Roth M. The definition of panic attacks, Part I. Psychiatr Dev 1989 Autumn;7(3):175-86. Argyle N, Roth M. The phenomenological study of 90 patients with panic disorder. Part II. Psychiatr Dev 1989 Autumn;7(3):187-209. Aronson TA. A follow-up of two panic disorder- agoraphobic study populations. The role of recruitment biases. J Nerv Ment Dis 1987 Oct; 175(10):595-8. Aronson TA. Is panic disorder a distinct diagnostic entity? A critical review of the borders of a syndrome. J Nerv Ment Dis 1987 Oct;175(10): 584-94. Aronson TA. Carasiti I, McBane D. Whitaker-Amitia P. Biological correlates of lactate sensitivity in panic disorder. Biol Psychiatry 1989 Sep;26(5): 463-77. Aronson TA. Logue CM. Phenomenology of panic attacks: a descriptive study of panic disorder patients’ self-reports. J Clin Psychiatry 1988 Jan;49(1):8-13. 1 Austin LS. Lydiard RB, Fossey MD, Zealberg JJ, Laraia MT. Ballenger JC. Panic and phobic disorders in patients with obsessive compulsive disorder. J Clin Psychiatry 1990 Nov;51(11):456—8. Ayuso Mateos IL, Bayon Perez C. Santo-Domingo Carrasco J. Olivares D. Atypical chest pain and panic disorder. Psychother Psychosom 1989; 52(1-3):92-5. Balon R. Ortiz A, Pohl R, Yeragani VK. Heart rate and blood pressure during placebo-associated panic attacks. Psychosom Med 1988 Jul-Aug;50(4):434-8. Balon R. Pohl R, Yeragani V. Rainey J. Oxenkrug GF. Platelet serotonin levels in panic disorder. Acta Psychiatr Scand 1987 Mar;75(3):315-7. Balon R, Pohl R. Yeragani VK. Rainey M Jr. Berchou R. Follow-up study of control subjects with lactate- and isoproterenol-induced panic attacks. Am J Psychiatry 1988 Feb;145(2):238-41. Balon R, Pohl R. Yeragani VK. Rainey JM. Weinberg P. Lactate- and isoproterenol-induced panic attacks in panic disorder patients and controls. Psychiatry Res 1988 Feb;23(2):153-60. Balon R. Rainey IM, Pohl R. Yeragani VK. Oxenkrug GF, McCauley RB. Platelet monoamine oxidase activity in panic disorder. Psychiatry Res 1987 Sep;22(1):37-41. Balon R. Yeragani VK. Pohl R. Phenomenological comparison of dextrose, lactate. and isoproterenol associated panic attacks. Psychiatry Res 1988 Oct; 26(1):43-50. Balon R. Yeragani VK. Pohl R. Muench J. Berchou R. Somatic and psychological symptoms during isoproterenol-induced panic attacks. Psychiatry Res 1990 May;32(2):103-12. Barlow DH. Vermilyea J. Blanchard EB, et al. The phenomenon of panic. J Abnorrn Psychol 1985; 94(3):320-8. Barreto E. Amado H. Identifying panic disorders. New Dir Ment Health Serv 1986 Winter;(32):31-44. Basha I, Mukerji V, Langevin P. Kushner M, Alpert M, Beitrnan BD. Atypical angina in patients with coronary artery disease suggests panic disorder. Int J Psychiatry Med 1989;19(4):341-6. Bass C. Chambers JB. Kiff P, Cooper D. Gardner WN. Panic anxiety and hyperventilation in patients with chest pain: a controlled study. Q J Med 1988 Dec; 69(260):949-59. 2 Bass C. Gardner WN. Respiratory and psychiatric abnormalities in chronic symptomatic hyperventilation. Br Med J [Clin Res] 1985 May 11;290(6479):l387-90. Bass C, Lelliott P. Marks I. Fear talk versus voluntary hyperventilation in agoraphobics and normals: a controlled study. Psychol Med 1989 Aug;19(3): 669-76. Baumbacher GD. Signal anxiety and panic attacks. Psychother Theory Res Pract Train 1989;26(1): 75 -80. Beck JG. Berisford MA. Taegtmeyer H. Bennett A. Panic symptoms in chest pain without coronary artery disease: A comparison with panic disorder. Behav Ther 1990;2‘l(2):241-52. Beck JG. Scott SK. Frequent and infrequent panic: a comparison of cognitive and autonomic reactivity. J Anxiety Disord l987;l(l):47-58. Beck JG: Taegtrneyer H. Berisford MA, Bennett A. Chest pain without coronary artery disease: An exploratory comparison with panic disorder. J Psychopathol Behav Assess 1989;l 1(3):209-20. Beitman BD, Basha I, Flaker G. DeRosear L. Mukerji V. Lamberti J. Non-fearful panic disorder. panic attacks without fear. Behav Res Ther 1987;25(6): 487-92. Beitman BD, Basha I, Flaker G, DeRosear L. Mukerji V. Lamberti JW. Major depression in cardiology chest pain patients without coronary artery disease and with panic disorder. J Affective Disord 1987 Jul-Aug;13(l):51-9. Beitman BD, Basha I. Flaker G. DeRosear L. Mukerji V. Trombka L. Katon W. Atypical or nonanginal chest pain. Panic disorder. or coronary artery disease? Arch Intern Med 1987 Sep;l47(9): 1548-52. Beitman BD, Kushner M, Lamberti JW. Mukerji V. Panic disorder without fear in patients with angiographically normal coronary arteries. J Nerv Ment Dis 1990 May;l78(5):307-12. Beitman BD. Kushner MG. Basha I. Lamberti J, Mukerji V. Bartels K. Follow-up status of patients with angiographically normal coronary arteries and panic disorder. JAMA 1991 Mar 27;265(12): 1545-9. Beitman BD. Lamberti JW. Mukerji V, DeRosear L, Basha I. Schmid L. Panic disorder in patients with angiographically normal coronary arteries. A pilot study. Psychosomatics 1987 Sep;28(9):480-4. Beitman BD. Mukerji V. Alpert M, Peters JC. Panic disorder in cardiology patients. Psychiatr Med 1990;8(2):67-81. Beitman BD, Mukerji V. Lamberti JW. Schmid L, DeRosear L. Kushner M. Flaker G. Basha 1. Panic disorder in patients with chest pain and angiographically normal coronary arteries. Am J Cardiol 1989 Jun l;63(18):1399-403. Beitman BD, Mukerji V, Lamberti JW. Schmid L, Kushner M. Major depression and agoraphobia in patients with angiographically normal coronary arteries and panic disorder. Can J Psychiatry 1990 May;35(4):298-304. Bell CC. Hildreth CJ, Jenkins E]. Carter C. The relationship of isolated sleep paralysis and panic disorder to hypertension. J Natl Med Assoc 1988; 80(3):289-94. Black B. Robbins DR. Panic disorder in children and adolescents. J Am Acad Child Adolesc Psychiatry 1990 Jan;29(1):36~44. Blowers GH, Mc Clenahan KL, Roth WT. Panic- disordered subjects’ perceptions of film: a repertory grid study. Percept Mot Skills 1986 Dec;63(3): 11 19-28. Borden JW. Turner SM. Is panic a unique emotional experience? Behav Res Ther 1989;27(3):263-8. Borkovec TD. "Relaxation-induced panic (RIP): When resting isn't peaceful": Commentary. A. Integr Psychiatry 1987 Jun;5(2):104-6. Bradley S. Wachsmuth R, Swinson R, Hnatko G. A pilot study of panic attacks in a child and adolescent psychiatric population. Can J Psychiatry 1990 Aug; 35(6):526-8. Bradley S]. Panic disorder in children and adolescents: a review with examples. Adolesc Psychiatry 1990; 17:433-50. Bradwejn J, Koszycki D. Comparison of the panicogenic effect of cholecystokinin 30-33 and carbon dioxide in panic disorder. Prog Neuropsychopharmacol Biol Psychiatry 1991;15(2): 237-9. Bradwejn J. Koszycki D. Meterissian G. Cholecystokinin-tetrapeptide induces panic attacks in patients with panic disorder. Can J Psychiatry 1990 Feb;35(l):83—5. Breier A. Chamey DS, Heninger GR. Agoraphobia with panic attacks. Development, diagnostic stability, and course of illness. Arch Gen Psychiatry 1986 Nov;43(11):1029-36. Breier A, Chamey DS, Heninger GR. Major depression in patients with agoraphobia and panic disorder. Arch Gen Psychiatry 1984;41(12): 1 129-35. Breier A, Chamey DS. Heninger GR. The diagnostic validity of anxiety disorders and their relationship to depressive illness. Am J Psychiatry 1985 Jul; 142(7):787-97. Brooks RB, Baltazar PL. Munjack DJ. Co-occurrence of personality disorders with panic disorder, social phobia, and generalized anxiety disorder: A review of the literature. J Anxiety Disord 1989;3(4): 259-85. Brown TA. Cash TF. The phenomenon of nonclinical panic: Parameters of panic. fear. and avoidance. J Anxiety Disord l990;4(l):15-29. Buller R, Maier W, Benkert 0. Clinical subtypes in panic disorder: their descriptive and prospective validity. J Affective Disord 1986 Sep-Oct;11(2): 105-14. Buller R, Maier W. Goldenberg 1M, Lavori PW. Benkert O. Chronology of panic and avoidance, age of onset in panic disorder, and prediction of neatment response. A report from the Cross-National Collaborative Panic Study. Eur Arch Psychiatry Clin Neurosci l991;240(3):163-8. Buller R. von Bardeleben U, Maier W. Benkert 0. Specificity of lactate response in panic disorder. panic with concurrent depression and major depression. I Affective Disord 1989 Mar-Jun; 16(2-3):109-13. Cameron 0G. Kuttesch D, McPhee K, Ctutis GC. Menstrual fluctuation in the symptoms of panic anxiety. I Affective Disord 1988 Sep-Oct; 15(2):169-74. Cameron OG. Lee MA, Kotun J, McPhee KM. Circadian symptom fluctuations in people with anxiety disorders. J Affective Disord 1986 Nov- Dec;ll(3):213-8. Carr DB. Fishman SM. Kasting NW. Sheehan DV. Vasopressin response to lactate infusion in normals and patients with panic disorder. Funct Neurol 1986 Apr-Jun;1(2):123-7. Carson SW, Halbreich U, Yeh CM. Goldstein S. Altered plasma dexarnethasone and cortisol suppressibility in patients with panic disorders. Biol Psychiatry 1988 May;24(1):56-62. Casat CD. Childhood anxiety disorders: A review of the possible relationship to adult panic disorder and agoraphobia. Special Issue: Perspectives on panic- related disorders. J Anxiety Disord 1988;2(1):5 1-60. Cassano GB. Perugi G. Musetti L. Akiskal HS. The nature of depression presenting concomitantly with panic disorder. Compr Psychiatry 1989 Nov-Dec; 30(6):473-82. Cassano GB. Petracca A, Perugi G. Toni C, Tundo A. Roth M. Derealization and panic attacks: a clinical evaluation on 150 patients with panic disorder/ agoraphobia. Compr Psychiatry 1989 Jan-Feb; 30(1):5-12. Castellani S. Quillen MA, Vaughan DA. Hund MA. Ho L, Ziegler MG, Le Vine WR. TSH and catecholamine response to TRH in panic disorder. Biol Psychiatry 1988 May;24(1):87-90. Chamey DL. "Relaxation-induced panic (RIP): When resting isn’t peace ": Commentary. Integr Psychiatry 1987 Jun;5(2):108-9. Chamey DS. Heninger GR. Price LH, Breier A. Major depression and panic disorder: diagnostic and neurobiological relationships. Psychopharrnacol Bull 1986;22(2):SO3-11. Clark DB, Taylor CB, Hayward C King R. Margraf J. Ehlers A. Roth WT. Agras WS. Motor activity and tonic heart rate in panic disorder. Psychiatry Res 1990 Apr;32(l):45-53. Clurn GA. Broyles S, Borden J, Watkins PL. Validity and reliability of the panic attack symptoms and cognitions questionnaires. J Psychopathol Behav Assess l990;12(3):233—45. Comings DE, Comings BG. A controlled study of Tourette syndrome. 111. Phobias and panic attacks. Am J Hum Genet 1987 Nov;41(5):761-81. Conti S. Savron G, Bartolucci G. Grandi S, Magelli C. Semprini F. Saviotti FM. Trombini G. Fava GA, Magnani B. Cardiac neurosis and psychopathology. Psychother Psychosom 1989;52(1-3):88-91. Cook BL, Noyes R Jr, Garvey MJ. Beach V. Sobotka J, Chaudhry D. Anxiety and the menstrual cycle in panic disorder. J Affective Disord 1990 Jul; 19(3):221-6. Coryell W. Panic disorder and mortality. Psychiatr- Clin North Am 1988 Jun;11(2):433—40. Coryell W. Endicott J, Andreasen NC, Keller MB, Clayton PJ. Hirschfeld RM, Scheftner WA. Winokur G. Depression and panic attacks: the significance of overlap as reflected in follow-up and family study data. Am J Psychiatry 1988 Mar;145(3): 293-300. 4 Coryell W. Noyes R Jr, Clancy J, Crowe R. Chaudhry D. Abnormal escape from dexamethasone suppression in agoraphobia with panic attacks. Psychiatry Res 1985 Aug;15(4):301-11. Coryell W, Noyes R Jr. House JD. Mortality among outpatients with anxiety disorders. Am J Psychiatry 1986 Apr;143(4):508-10. Coryell W. Noyes R Jr, Reich J. The prognostic significance of HPA-axis disturbance in panic disorder: a three-year follow-up. Biol Psychiatry 1991 Jan 15;29(2):96-102. Cottraux JA. Gebuhrer L, Bardi R, Betuel H. HLA system and panic attacks. Biol Psychiatry 1989 Feb;25(4):505-8. Cowley DS, Arana GW. The diagnostic utility of lactate sensitivity in panic disorder. Arch Gen Psychiatry 1990 Mar;47(3):277-84. Cowley DS, Dager SR, Dunner DL. Lactate-induced panic in primary affective disorder. Am J Psychiatry 1986 May;143(5):646-8. Cowley DS, Dager SR, Foster SI, Dunner DL. Clinical characteristics and response to sodium lactate of patients with infrequent panic attacks. Am J Psychiatry 1987 Jun;144(6):795-8. Cowley DS, Dunner DL. Response to sodium lactate in panic disorder: relationship to presenting clinical variables. Psychiatry Res 1988 Sep;25(3):253-9. Cowley DS, Hyde TS, Dager SR, Dunner DL. Lactate infusions: the role of baseline anxiety. Psychiatry Res 1987 Jun;21(2):169-79. Cowley DS, Jensen CF, Johannessen D, Parker L, Dager SR, Walker RD. Response to sodium lactate infusion in alcoholics with panic attacks. Am J Psychiatry 1989 Nov;146(11):1479-83. Cowley DS, Roy-Byme PP. Hyperventilation and panic disorder. Am J Med 1987 Nov;83(5):929-37. Cowley DS, Roy-Byme PP. Panic disorder during pregnancy. J Psychosom Obstet Gynecol 1989; 10(3): 193-210. Cox BJ. Endler NS, Swinson RP. Clinical and nonclinical panic attacks: An empirical test of a panic-anxiety continuum. J Anxiety Disord 1991; 5(1):21-34. Cox BJ, Norton GR, Swinson RP, Endler NS. Substance abuse and paniccrelated anxiety: a critical review. Behav Res Ther 1990;28(5):385-93. Cox BJ, Norton GR. Dorward J, Fergusson PA. The relationship between panic attacks and chemical dependencies. Addict Behav l989;14(1):53-60. Cox BJ, Swinson RP, Endler NS. A review of the psychophannacology of panic disorder: Individual differences and non specific factors. Can J Psychiatry 1991 ;36(2): 130-8. Coyle PK, Sterman AB. Focal neurologic symptoms in panic attacks. Am J Psychiatry 1986 May;143(5): 648-9. Craske MG, Barlow DH. A review of the relationship between panic and avoidance. Clin Psychol Rev 1988;8(6):667-85. Craske MG, Barlow DH. Nocturnal panic. J Nerv Ment Dis 1989 Mar;177(3):160-7. Craske MG. Krueger MT. Prevalence of nocturnal panic in a college population. J Anxiety Disord l990;4(2):125-39. Craske MG, Miller PP, Rotunda R. Barlow DH. A descriptive report of features of initial unexpected panic attacks in minimal and extensive avoiders. Behav Res Ther 1990;28(5):395-400. Craske MG, Rapee RM, Barlow DH. The significance of panic-expectancy for individual patterns of avoidance. Behav Ther l988;19(4):577-592. Dager SR, Comess KA, Saal AK, Sisk EJ, Beach KW, Dunner DL. Diagnostic reliability of M-mode echocardiography for detecting mitral valve prolapse in 50 consecutive panic patients. Compr Psychiatry 1989 Sep—Oct;30(5):369—75. Dager SR, Khan A, Comess KA, Raisys V, Dunner DL. Mitral valve abnormalities and catecholamine activity in anxious patients. Psychiatry Res 1987 Jan;20(1):13-8. Dajas F, Nin A, Barbeito L. Urinary norepinephn'ne excretion in panic and phobic disorders. J Neural Transm 1986;65(1):75-81. de Ruiter C, Garssen B. Social anxiety and fear of bodily sensations in panic disorder and agoraphobia: A matched comparison. I Psychopathol Behav Assess 1989;11(2):175-184. de Ruiter C, Garssen B, Rijken H, Kraaimaat F. The hyperventilation syndrome in panic disorder, agoraphobia and generalized anxiety disorder. Behav Res Ther 1989;27(4):447-52. de Ruiter C, Rijken H, Garssen B, Van Schaik A, Kraaimaat F. Comorbidity among the anxiety disorders. J Anxiety Disord 1989;3(2):57—68. Deltito JA. Cassano GB. "Panic-attack disorders". Clinical and biological correlates. Encephale 1985 Jul-Aug;l 1(4): 163-5. Deltito JA. Perugi G, Maremmani I, Mignani V, Cassano GB. The importance of separation anxiety in the differentiation of panic disorder from agoraphobia. Psychiatr Dev 1986 Autumn;4(3): 227-36. DeMet E. Stein MK. Tran C. Chicz-DeMet A, Sangdahl C, Nelson J. Caffeine taste test for panic disorder: adenosine receptor supersensitivity. Psychiatry Res 1989 Dec;30(3):231-42. Den Boer JA. Westenberg HG. Klompmakers AA. van Lint LE. Behavioral biochemical and neuroendocrine concomitants of lactate-induced panic anxiety. Biol Psychiatry 1989 Oct; 26(6):612-22. Dillon DJ . Gorman JM, Liebowitz MR. Fyer AJ. Klein DF. Measurement of lactate-induced panic and anxiety. Psychiatry Res 1987 Feb;20(2):97-105. Donnell CD. McNally RJ. Anxiety sensitivity and history of panic as predictors of response to hyperventilation. Behav Res Ther 1989;27(4): 325-32. Dube S. Jones DA, Bell J, Davies A. Ross E. Sitaram N. Interface of panic and depression: clinical and sleep EEG correlates. Psychiatry Res 1986 Oct; 19(2): l 1933. Dube S. Jones DA. Bell J, et a1. Interface of panic and depression: Clinical and sleep EEG correlates. Psychiatry Res 1986;19(2):119-33. Dunner DL. Anxiety and panic: relationship to depression and cardiac disorders. Psychos0matics 1985 Nov;26(11 Suppl):l8-22. Edlund MJ. McNamara ME, Millman RP. Sleep apnea and panic attacks. Compr Psychiatry 1991 Mar- Apr;32(2):130-2. Edlund MJ. Swarm AC. Clothier J. Patients with panic attacks and abnormal EEG results. Am J Psychiatry 1987 Apr,144(4):508-9. Ehlers A. Margraf J, Roth WT. Taylor AU - Maddock RJ, Sheikh J. Kopell ML, McClenahan KL, Gossard D. Blowers GH. et a]. Lactate infusions and panic attacks: do patients and controls respond differently? Psychiatry Res 1986 Apr;l7(4):295-308. Eriksson E. Westberg P. Alling C. Thuresson K, Modigh K. Cerebrospinal fluid levels of monoarnine metabolites in panic disorder. Psychiatry Res 1991;36(3):243-51. Evans L. Panic disorder. A new definition to anxiety. Curr Ther 1987;28(11):19-21. Faludi G, Kasko M, Perenyi A, Arato M. Frecska E. The dexarnethasone suppression test in panic disorder and major depressive episodes. Biol Psychiatry 1986 Sep;21(11):1008-14. Faravelli C. Albanesi G. Agaroaphobia with panic attacks: l-year prospective follow up. Compr Psychiatry 1987;28(6):481-7. Faravelli C, Pallanti S. Frassine R. Albanesi G, Guerrini Degl’Innocenti B. Panic attacks with and without agoraphobia: a comparison. Psychopathology 1988; 21(1):51-6. Fava GA. Grandi S. Canestrari R. Prodromal symptoms in panic disorder with agoraphobia. Am J Psychiatry 1988 Dec;145(12):1564-7. Fava GA. Grandi S. Saviotti FM. Conti S. Hypochondriasis with panic attacks. Psychosomatics 1990 Sumrner;31(3):351-3. Fava M, Anderson K, Rosenbaum JF. "Anger attacks": possible variants of panic and major depressive disorders. Am J Psychiatry 1990 Jul;147(7):867-70. Fava M, Rosenbaum JF. MacLaughlin RA, Tesar GE, Pollack MH. Cohen LS, Hirsch M. Dehydroepiandrosterone—sulfate/cortisol ratio in panic disorder. Psychiatry Res 1989 Jun;28(3): 345-50. Fawcett J. Targeting treatment in patients with mixed symptoms of anxiety and depression. J Clin Psychiatry 1990 Nov;51 Suppl:40-3. Fier M. Panic disorder and agoraphobia. N J Med 1990 Jun;87(6):475-6. Fisher DC, Wutchiett RJ. MMPI profiles of persons having panic disorder with agoraphobia. Phobia Pract Res J 1990 Spring-Summer;3(1):l9-25. Fishman SM. Sheehan DV, Carr DB. Thyroid indices in panic disorder. J Clin Psychiatry 1985 Oct; 46(10):432-3. Fleming B. Faulk A. Discriminating factors in panic disorder with and without agoraphobia. J Anxiety Disord 1989;3(4):209-19. Freedman RR, Ianni P. Ettedgui E, Puthezhath N. Ambulatory monitoring of panic disorder. Arch Gen Psychiatry 1985 Mar;42(3):244—8. Freinhar JP. Alvarez WA. Organic claustrophobia: An association between panic and carbon dioxide? Int J Psychosom 1987;34(2):18-9. 6 Fried R. Golden WL. The role of psychophysiological hyperventilation assessment in cognitive behavior therapy. J Cogn Psychother Int Q l989'.3(1):5-14. Friedman S. Paradis C. African-American patients with panic disorder and agoraphobia. J Anxiety Disord 1991;5(1):35-41. Fyer MR. Uy J. Martinez J. Goetz R. Klein DF. Fyer A. Liebowitz MR. Gorman J. C02 challenge of patients with panic disorder. Am J Psychiatry 1987 Aug; 144(8): 1080-2. Gaffney FA, Fenton BJ. Lane LD. Lake CR. Hemodynamic. ventilatory. and biochemical responses of panic patients and normal controls with sodium lactate infusion and spontaneous panic attacks. Arch Gen Psychiatry 1988 Jan;45(l):53—60. Ganellen RJ. Matuzas W. Uhlenhuth EH. Glass R. Easton CR. Panic disorder, agoraphobia. and anxiety-relevant cognitive style. I Affective Disord 1986 Nov-Dec;ll(3):219-25. Garland E]. Smith DH. Panic disorder on a child psychiatric consultation service. I Am Acad Child Adolesc Psychiatry 1990 Sep;29(5):785-8. Garvey M, Noyes R Jr. Cook B. Comparison of panic disordered patients with high versus low MHPG. J Affective Disord 1990 Sep;20(1):7-12. Garvey M. Noyes R Jr. Cook B. Does situational panic disorder represent a specific panic disorder subtype? Compr Psychiatry 1987 Jul-Aug;28(4):329—33. Garvey M, Noyes R Jr, Cook B. Tollefson G. The relationship of panic disorder and its treatment outcome to 24-hour urinary MHPG levels. Psychiatry Res 1989 Oct;30(1):53-61. Garvey M]. Cook B. Noyes R Jr. The occurrence of a prodrome of generalized anxiety in panic disorder. Compr Psychiatry 1988 Sep-Oct;29(5):445—9. Garvey MJ. Tollefson GD. Orsulak PJ. Elevations of urinary MHPG in depressed patients with panic attacks. Psychiatry Res 1987 Mar;20(3):183-7. Garvey MJ. Tollefson GD. Tuason VB. Comparison of major depreSsions with and without panic attacks. Compr Psychiatry 1987;28(1):65-7. Gelder MG. Panic disorder: fact or fiction? Psychol Med 1989 May;19(2):277-83. Gelder MG. The classification of anxiety disorders. Br J Psychiatry Suppl 1989 May;(4):28-32. George DT. Anderson P, Nutt DJ. Linnoila M. Aggressive thoughts and behavior: another symptom of panic disorder? Acta Psychiatr Scand 1989 May;79(5):500-2. George MS. Lydiard RB. Inability to walk as a symptom of panic disorder and social phobia. Neuropsychiatr Neuropsychol Behav Neurol 1989; 2(3):219-23. George DT. Nutt DJ, Dwyer BA. Linnoila M. Alcoholism and panic disorder: is the comorbidity more than coincidence? Acta Psychiatr Scand 1990 Feb;81(2):97-107. George DT. Nutt DJ. Waxman RP. Linnoila M. Panic response to lactate administration in alcoholic and nonalcoholic patients with panic disorder. Am J Psychiatry 1989 Sep;146(9):1161-5. George DT. Zerby A. Noble S. Nutt DJ. Panic attacks and alcohol withdrawal: Can subjects differentiate the symptoms? Biol Psychiatry l988;24(2):240-3. Goetz RR. Gonnan JM. Dillon DJ. Papp LA. Hollander E. Fyer AJ. Liebowitz MR. Klein DF. Do panic disorder patients indiscriminately endorse somatic complaints? Psychiatry Res 1989 Aug;29(2):207-13. Gold DD Jr. Panic Attacks: Diagnosis and management. Cardiovasc Rev Rep 1988;9(1):35-7. 40. Goldberg R. Morris P. Christian F. Badger J. Chabot S, Edlund M. Panic disorder in cardiac outpatients. Psychosomatics 1990 Spring;31(2):l68—73. Goldberg RJ. Clinical presentations of panic-related disorders. J Anxiety Disord 1988;2(1):61-75. Goldstein S. Halbreich U. Asnis G. Endicott J. Alvir J. The hypothalamic-pimitary-adrenal system in panic disorder. Am J Psychiatry 1987 Oct;l44(10): 1320-3. Gorman JM. Panic disorders. Mod Probl Pharmacopsychiatry 1987;22:36-90. Gorman JM. Battista D. Goetz RR. Dillon DJ . Liebowitz MR. Fyer AJ. Kahn JP. Sandberg D. Klein DF. A comparison of sodium bicarbonate and sodium lactate infusion in the induction of panic attacks. Arch Gen Psychiatry 1989 Feb;46(2):145-50. Gorrnan JM. Cohen BS. Liebowitz MR. Fyer AJ. Ross D. Davies SO. Klein DF. Blood gas changes and hypophosphatemia in lactate-induced panic. Arch Gen Psychiatry 1986 Nov;43(ll):1067-71. Gorman JM. Davies M. Steinman R, Liebowitz MR. Fyer AJ. Coromilas J. Klein DF. An objective marker of lactate—induced panic. Psychiatry Res 1987 Dec;22(4):341-8. German JM, Goetz RR, Dillon D, Liebowitz MR, Fyer A], Davies S. Klein DF. Sodium D-lactate infusion of panic disorder patients. Neuropsychopharmacology 1990 Jun;3(3):181-9. Gorman JM, Goetz RR, Uy J, Ross D, Martinez J, Fyer AJ, Liebowitz MR, Klein DF. Hyperventilation occurs during lactate—induced panic. J Anxiety Disord 1988;2(3):193-202. Gorman JM, Liebowitz MR, Fyer AJ, Fyer MR, Klein DF. Possible respiratory abnormalities in panic disorder. Psychopharmacol Bull 1986;22(3): 797-801. Gorman JM, Papp LA, Martinez J. Goetz RR, Hollander E, Liebowitz MR, Jordan F. High-dose carbon dioxide challenge test in anxiety disorder patients. Biol Psychiatry 1990 Nov 1;28(9):743-57. Gorman JM, Uy J. Respiratory physiology and pathological anxiety. Gen Hosp Psychiatry 1987 Nov;9(6):410-9. Green MA, Curtis GC. Personality disorders in panic patients: Response to termination of antipanic medication. J Pers Disord 1988;2(4):303-14. Griez E, de Loof C. Pols H, Zandbergen J, Lousberg H. Specific sensitivity of patients with panic attacks to carbon dioxide inhalation. Psychiatry Res 1990 Feb;31(2):193-9. Griez E, Pols HJ. van den Hout MA. Acid-base balance in real life panic. J Affective Disord 1987 May-Jun;12(3):263-6. Griez E, van den Hout MA, Verstappen F. Body fluids after CO2 inhalation: insight into panic mechanisms? Eur Arch Psychiatry Neurol Sci 1987;236(6):369-71. Griez E, Zandbergen J, Pols H, de Loof C. Response to 35% C02 as a marker of panic in severe anxiety. Am J Psychiatry 1990 Jun;147(6):796—7. Griez EJ. Lousberg H, van den Hout MA. van der Molen GM. C02 vulnerability in panic disorder. Psychiatry Res 1987 Feb;20(2):87-95. Griffin GC. From panic attacks to lethal arrhythmias. Postgrad Med l990;88(6):19. Grunhaus L. Clinical and psychobiological characteristics of simultaneous panic disorder and major depression. Am J Psychiatry 1988 Oct; 145(10):1214-21. Grunhaus L. Birmaher B. The clinical spectrum of panic attacks. J Clin Psychopharmacol 1985 Apr; 5(2):93-9. Grunhaus L, Flegel P, Haskett RF, Greden JF. Serial dexamethasone suppression tests in simultaneous panic and depressive disorders. Biol Psychiatry 1987 Mar;22(3):332-8. Grunhaus l... Haskett RF, Pande AC. Catecholamine and cortisol response to yohimbine infusions in comorbidity of depression and panic attacks. Eur J Pharmacol l990;183(5):1652-3. Grunhaus L, King D, Greden JF, Flegel P. Depression and panic in patients with borderline personality disorder. Biol Psychiatry 1985 Jun;20(6):688-92. Grunhaus L, Rabin D, Harel Y, Greden IF. Feinberg M, Hermann R. Simultaneous panic and depressive disorders: clinical and sleep EEG correlates. Psychiatry Res 1986 Apr;17(4):251—9. Grunhaus L, Tiongco D, Haskett RF. Greden JF. The dexamethasone suppression test in inpatients with panic disorder or agoraphobia with panic attacks. Biol Psychiatry 1987 Apr;22(4):517-21. Grunhaus LI, Cameron 0, Pande'AC. Haskett RF, Hollingsworth PJ, Smith CB. Comorbidity of panic disorder and major depressive disorder: effects on platelet alpha 2 adrenergic receptors. Acta Psychiatr Scand 1990 Mar;81(3):216—9. Gurguis GNM, Cameron 0G, Ericson WA, Curtis GC. The daily distribution of panic attacks. Compr Psychiatry 1988;29(1):1-3. Hauri PJ, Friedman M. Ravaris CL. Sleep in patients with spontaneous panic attacks. Sleep 1989 Aug; 12(4):323-37. Hayward C, Killen JD, Taylor CB. Panic attacks in young adolescents. Am J Psychiatry 1989 Aug; 146(8):1061-2. Hayward C, Taylor CB. Roth WT, King R, Agras WS. Plasma lipid levels in patients with panic disorder or agoraphobia. Am J Psychiatry 1989 Jul;146(7): 917-9. Hebenstreit M, Bullet R, Maier W, Philipp M, Frommberger U. The personality sphere in patients with panic attacks. Pharrnacopsychiatry 1988 Nov; 21(6):463-4. Hibbert G, Pilsbury D. Hyperventilation in panic attacks. Ambulant monitoring of transcutaneous carbon dioxide. Br J Psychiatry 1988 Jul;153:76-80. Hoehn-Saric R, McLeod DR. Zimmerli WD. Psychophysiological response patterns in panic disorder. Acta Psychiatr Scand 1991 Jan;83(1):4-11. 8 Hoes MJ, Colla P. van Doom P. Folgering H. de Swan J. Hyperventilation and panic attacks. J Clin Psychiatry 1987 Nov;48(11):435-7. Hollander B. Liebowitz MR. Cohen B. Gorman JM. Fyer AJ, Papp LA, Klein DF. Prolactin and sodium lactate-induced panic. Psychiatry Res 1989 May;28(2):181-91. Hollander E. Liebowitz MR. Gorman JM, Cohen B. Fyer A, Klein DF. Cortisol and sodium lactate- induced panic. Arch Gen Psychiatry 1989 Feb; 46(2):135—40. Hollifield M. Katon W. Spain D. Pule L. Anxiety and depression in a village in Lesotho. Africa: a comparison with the United States. Br J Psychiatry 1990 Mar;156:343-50. Holrnberg G. The nosologic specificity of panic disorder/agoraphobia. Proceedings of the World Psychiatric Associalion on the Psychopathology of Panic Disorders: Many faces of panic disorder (1988. Espoo. Finland). Psychiatr Fenn 1989; Suppl:53-7. Holt PE. Andrews G. Hyperventilation and anxiety in panic disorder, social phobia. GAD and normal controls. Behav Res Ther 1989;27(4):453-60. Hudson 11. Pope HG Jr. Affective spectrum disorder: does antidepressant response identify a family of disorders with a common pathophysiology? Am J Psychiatry 1990 May;147(5):552-64. Innis RB. Chamey DS. Heninger GR. Differential 3H- irnipramine platelet binding in patients with panic disorder and depression. Psychiatry Res 1987 May; 21(1):33-41. Jacob RG. Panic disorder and the vestibular system. Psychiatr Clin North Am 1988 Jun;11(2):36l-74. Jacob RG. Lilienfcld SO. Furman JMR. Durrant JD. Turner SM. Panic disorder with vestibular dysfunction: Further clinical observations and description of space and motion phobic stimuli. J Anxiety Disord 1989;3(2):117-30. Jacob RG. Muller MB. Turner SM. Wall C 3d. Otoneurological examination in panic disorder and agoraphobia with panic attacks: a pilot study. Am J Psychiatry 1985 Jun;142(6):715-20. Jefferson JW. Anxiety and the aching heart. Stress Med 1987;3(1):33-9. Johannessen DJ. Cowley DS, Walker RD, Jensen CF. Parker L. Prevalence. onset. and clinical recognition of panic states in hospitalized male alzcoholics. Am J Psychiatry 1989 Sep;146(9): 1 01-3. Johnson J. Weissman MM. Klerman GL. Panic disorder, comorbidity. and suicide attempts. Arch Gen Psychiatry 1990 Sep;47(9):805-8. Johnston AL, File SE. Profiles of the antipanic compounds. triazolobenzodiazepincs and phenelzine. in two animal tests of anxiety. Psychiatry Res 1988 Ju1;25(1):81-90. Judd FK. Norman TR. Burrows GD. McIntyre IM. The dexamethasone suppression test in panic disorder. Pharmacopsychiatry 1987 May;20(3):99-101. Kahn JP. Drusin RE. Klein DF. Idiopathic cardiomyopathy and panic disorder: clinical association in cardiac transplant candidates. Am J Psychiatry 1987 Oct;l44(10):1327-30. Kahn RS. Wetzler S, Asnis GM. Kling MA. Suckow RF. Van Praag HM. Pituitary hormone responses to meta-chlorophenylpiperazine in panic disorder and healthy control subjects. Psychiatry Res 1991;37(1):25-34. Kane FJ Jr. Wittels E. Harper RG. Chest pain and anxiety disorder. Tex Med 1990 Jul;86(7):104—10. Kasdorf JA, Kasdorf JL, Janzen WB. Panic attacks: Are they spontaneous? Phobia Pract Res J 1988 Spring;1(l):32-47. Katemdahl DA. Infrequent and limited-symptom panic attacks. J Nerv Ment Dis 1990 May;178(5):3l3-7. Katemdahl DA. Panic is panic: homogeneity of the panic attack experience. Fam Pract Res J 1990 Spring-Surnmer;9(2):l47-55. Katemdahl DA. The sequence of panic symptoms. J Fam Pract 1988 Jan;26(l):49-52. Katemdahl DA. Gabel LL. Monk JS. Comparative symptomatology of phobic and nonphobic panic attacks. Fam Pract Res J 1986 Winter;6(2):106—13. Kathol RG. Noyes R. Lopez A. Similarities in hypothalamic-pituitary-adrenal axis activity between patients with panic disorder and thoSe experiencing external stress. Psychiatr Clin North Am 1988 Jun; 11(2):335—48. Kathol RG. Noyes R Jr, Lopez AL. Reich JH. Relationship of urinary free cortisol levels in patients with panic disorder to symptoms of depression and agoraphobia. Psychiatry Res 1988 May;24(2):211-21. Katon WJ. Chest pain. cardiac disease. and panic disorder. J Clin Psychiatry 1990 May;51 Suppl: 27-30; discussion 50-3. Katon W. Roy-Byme PP. Panic disorder in the medically ill. J Clin Psychiatry 1989 Aug; 50(8):299-302. Katon W. Vitaliano PP, Anderson K. et al. Panic disorder: Residual symptoms after the acute attacks abate. Compr Psychiatry l987;28(2):151-8. Katon W. Vitaliano PP, Russo J. Jones M. Anderson K. Panic disorder. Spectrum of severity and somatization. J Nerv Ment Dis 1987 Jan; 175(1): 12-9. Kenardy J. Evans L. Oei TP. Attributional style and panic disorder. J Behav Ther Exp Psychiatry 1990 Mar;21(1):9-13. Keyl PM, Eaton WW. Risk factors for the onset of panic disorder and other panic attacks in a prospective, population-based study. Am J Epidemiol 1990 Feb;131(2):301-11. King LJ. Major depressive disorder and panic disorder in children of parents with alcohol dependence. Ann Clin Psychiatry l989;l(4):269-270. King R]. Bayon EP. Clark DB. Taylor CB. Tonic arousal and activity: relationships to personality and personality disorder traits in panic patients. Psychiatry Res 1988 Jul;25(1):65-72. Klein DF, Klein HM. The status of panic disorder. Curr Opin Psychiatry 1988;1(2):177-83. Klein DF, Klein HM. The utility of the panic disorder concept. Eur Arch Psychiatry Neurol Sci 1989; 238(5-6):268-79. Kleiner L. Agoraphobia or panic disorder? Behav Ther 1986 Jan;9(l):14-5. Klerman GL. Freedman DX. Shader RI. The separation of panic and agoraphobia from other anxiety disorders: Introduction of the conference proceedings. J Psychiatr Res 1988;22 Suppl 1:3-5. Knott VJ. Lapierre YD. Effects of lactate-induced panic attacks on brain stem auditory evoked potentials. Neuropsychobiology 1986;l6(l):9-14. Knott VJ. Lapierre YD. Neuropsychophysiological correlates of lactate-induced panic. Prog Neuropsychopharmacol Biol Psychiatry 1988; 12(2-3):183-92. Koehler K. Vartzopoulos D. Ebel H. The relationship of panic attacks to autonomically labile generalized anxiety. Compr Psychiatry 1988;29(2):91-7. Koenigsberg HW. Pollak C. Sullivan T. The sleep lactate infusion: arousal and the panic mechanism. Biol Psychiatry 1987 Jun;22(6):789-91. Kopp MS. Arato M. Magyar I, Buza K. Basal adrenocortical activity and DST in electrodermally differentiated subgroups of panic patients. Int J Psychophysiol 1989 Mar;7(1):77-83. Krakowski AJ. Panic disorder associated with mitral valve prolapse: psychosomatic implications. Psychother Psychosom 1987;47(3-4):211-8. Kushner MG. Beitman BD. Panic attacks without fear: an overview. Behav Res Ther 1990;28(6):469-79. Kushner MG. Beitman BD. Beck NC. Factors predictive of panic disorder in cardiology patients with chest pain and no evidence of coronary artery disease: a cross-validation. J Psychosom Res 1989; 33(2):207-15. Kushner MG. Sher KJ. Beitman BD. The relation between alcohol problems and the anxiety disorders. Am J Psychiatry 1990 Jun;147(6):685-95. Kwon S-M. Evans L, Oei TPS. Factor structure of the mobility inventory for agoraphobia: A validational study with Australian samples of agoraphobic patients. J Psychopathol Behav Assess 1990; 12(4):365-74. Lane JW. Pollard CA. Cox GL. Validity study of the Anxiety Symptoms Interview. J Clin Psychol 1990 Jan;46(l):52-7. Lapierre YD. Clinical and biological correlates of panic states. Prog Neuropsychopharmacol Biol Psychiatry 1987;l l(2-3):91-6. Last CG. Strauss CC. Panic disorder in children and adolescents. J Anxiety Disord 1989;3(2):87-95. Lee MA, Flegel P. Greden JF, Cameron 0G. Anxiogenic effects of caffeine on panic and depressed patients. Am J Psychiatry 1988 May; l45(5):632-5. Lelliott P, Bass C. Symptom specificity in patients with panic. Br J Psychiatry 1990 Oct;157:593-7. Lepine JP, Chignon IM. Teherani M. Onset of panic disorder and suicide attempts. Psychiatr Psychobiol 1990;5(6):339-42. Lepola U. Recognition of panic disorder. Nord Psykiatr Tidsskr 1989;43(6):511-3. Lepola U, Jolkkonen J, Pitk:anen A. Riekkinen P. Rimzon R. Cerebrospinal fluid monoamine metabolites and neuropeptides in patients with panic disorder. Ann Med 1990;22(4):237-9. 10 Lepola U, Nousiainen U, Puranen M. Riekkinen R, Rimon R. EEG and CT findings in patients with panic disorders. Biol Psychiatry l990;28(8):721-7. Lesser 1M. The relationship between panic disorder and depression. J Anxiety Disord 1988;2(1):3-15. Lesser 1M, Rubin RT. Diagnostic considerations in panic disorders. J Clin Psychiatry 1986 Jun;47 Suppl:4-10. Lesser IM, Rubin RT, Lydiard RB. Swinson R, Pecknold J. Past and current thyroid function in subjects with panic disorder. J Clin Psychiatry 1987 Dec;48(12):473-6. Lesser 1M, Rubin RT, Pecknold JC. Rifltin A, Swinson RP, Lydiard RB, Burrows GD, Noyes R Jr, DuPont RL Jr. Secondary depression in panic disorder and agoraphobia. I. Frequency, severity. and response to treatment. Arch Gen Psychiatry 1988 May;45(5): 437-43. Lesser IM, Rubin RT. Rifltin A, Swinson RP, Ballenger JC, Burrows GD, Dupont RL, Noyes R, Pecknold JC. Secondary depression in panic disorder and agoraphobia. II. Dimensions of depressive symptomatology and their response to treatment. I Affective Disord 1989 Jan-Feb;l6(l):49-58. Levin AP, Doran AR, Liebowitz MR, Fyer AJ, Gorman M, Klein DF, Paul SM. Pituitary adrenocortical unresponsiveness in lactate-induced panic. Psychiatry Res 1987 May;21(l):23-32. Levinson HN. A cerebellar-vestibular explanation for fears/phobias: hypothesis and study. Percept Mot Skills 1989 Feb;68(1):67-84. Lewis RP, Wooley CF, Kolibash AJ, Boudoulas H. The mitral valve prolapse epidemic: fact or fiction. Trans Am Clin Clirnatol Assoc 1986;98:222-336. Liberthson RR, King ME. "Mitral valve prolapse in a psychiatric setting: Diagnostic assessment, research, and clinical implications": Comment. Integr Psychiatry 1987 Mar;5(1):56-7. Liebowitz MR, Ballenger J, Barlow DH, Davidson I, Foa EB, Fyer A. New perspectives on anxiety disorders in DSM-IV and ICD-10. Drug Ther 1990;20 Suppl:129-36. Liebowitz MR, Fyer AJ, Gorman IM, Dillon D, Davies S, Stein M, Cohen BS, Klein DF. Specificity of lactate infusions in social phobia versus panic disorders. Am J Psychiatry 1985 Aug;l42(8): 947-50. Liebowitz MR, Gorman IM, Fyer AJ, Levitt M, Dillon D, Levy G, Appleby IL, Anderson S, Palij M, Davies SC, et a1. Lactate provocation of panic attacks. H. Biochemical and physiological findings. Arch Gen Psychiatry 1985 Jul;42(7):709—19. Lirmoila MI. Anxiety and alcoholism. J Clin Psychiatry 1989 Nov;50 Suppl:26-9. Lousberg H, Griez E, van den Hout MA. Carbon dioxide chemosensitivity in panic disorder. Acta Psychiatr Scand 1988 Feb;77(2):214-8. Lucas JA, Telch MJ. Bigler ED. Memory functioning in panic disorder: A neuropsychological perspective. J Anxiety Disord 199l;5(1):1-20. Luchins DJ , Rose RP. Late-life onset of panic disorder with agoraphobia in three patients. Am J Psychiatry 1989 Ju1;146(7):920-1. Lydiard RB, Laraia MT, Howell EF, Ballenger JC. Can panic disorder present as irritable bowel syndrome? J Clin Psychiatry 1986 Sep;47(9):470-3. Lydiard RB, Zealberg J, Laraia MT, Fossey M, Prockow V, Gross J, Ballenger JC. Electroencephalography during sleep of patients with panic disorder. J Neuropsychiatry Clin Neurosci 1989;1(4):372—6. Macaulay IL, Kleinknecht RA. Panic and panic attacks in adolescents. J Anxiety Disord 1989;3(4):221—41. Maddock RJ, Blacker KH. Response to treatment in panic disorder with associated depression. Psychopathology 1991;24(1): 1-6. Maddock RJ, Matco-Bermudez J. Elevated serum lactate following hyperventilation during glucose infusion in panic disorder. Biol Psychiatry 1990 Feb 15;27(4):411-8. Maier W, Buller R. Frommberger U, Philipp M. One- year follow-up of cardiac anxiety syndromes. Outcome and predictors of course. Eur Arch Psychiatry Neurol Sci l987;237(l):16-20. Maier W, Buller R, Rieger H, Benkert O. The cardiac anxiety syndrome--a subtype of panic attacks. Eur Arch Psychiatry Neurol Sci 1985;235(3):146-52. Maier W, Buller R, Sonntag A, Heuser I. Subtypes of panic attacks and ICD-9 classification. Eur Arch Psychiatry Neurol Sci 1986;235(6):361-6. Maier W, Rosenberg R, Argyle N, Buller R, Roth M, Brandon S, Benkert O. Avoidance behaviour and major depression in panic disorder: a report from the Cross-National Collaborative Panic Study. Psychiatr Dev 1989 Summer;7(2):l23-42. Manu P, Matthews DA, Lane TJ. Panic disorder among patients with chronic fatigue. South Med J 1991 Apr,84(4):451-6. Margraf J. Ambulatory psychophysiological monitoring of panic attacks. J Psychophysiol 1990;4(4): 321-30. ‘ Margraf J, Ehlers A, Roth WT. Mitralvalve prolapse and panic disorder: a review of their relationship. Psychosom Med 1988 Mar-Apr;50(2):93-113. Margraf J, Ehlers A. Roth WT. Panic attack associated with perceived heart rate acceleration: A case report. Behav Ther 1987;18(1):84-9. Margraf J, Ehlers A, Roth WT. Sodium lactate infusions and panic attacks: a review and critique. Psychosom Med 1986 Jan-Feb;48(1-2):23-51. Margraf J, Taylor B, Ehlers A, Roth WT, Agras WS. Panic attacks in the natural environment. J Nerv Ment Dis 1987 Sep;175(9):558-65. Marks 1. Agoraphobia, panic disorder and related conditions in the DSM-IIIR and ICD-lO. J Psychopharmacol l987;l(1):6-12. Marriott IA. The "cor " component in panic attack syndrome: Five case studies. Aust J Clin Hypnother Hypnosis 1989 Mar;10(l):17-24. Marshall JR. Are some irritable bowel syndromes actually panic disorders? Postgrad Med 1988 May l;83(6):206-9. Marshall JR. Hyperventilation syndrome or panic disorder--what‘s in the name? Hosp Pract [Off] 1987 Oct 15;22(10):105-8, 111-2, 117-8. Mathew RJ, Wilson WH. Behavioral and eerebrovascular effects of caffeine in patients with anxiety disorders. Acta Psychiatr Scand 1990 Jul; 82(1):]7-22. Mathew RJ, Wilson WI-l, Tant S. Responses to hypercarbia induced by acetazolamide in panic disorder patients. Am J Psychiatry 1989 Aug; 146(8):996-1000. Mavissakalian M. The relationship between panic disorder/agoraphobia and personality disorders. Psychiatr Clin North Am 1990 Dec;13(4):661-84. Mavissakalian M. Hamann MS. Correlates of DSM-III personality disorder in panic disorder and agoraphobia. Compr Psychiatry 1988 Nov- Dec;29(6):535-44. Mavissakalian M, Hamann MS. DSM-IJI personality disorder in agoraphobia: H. Changes with treatment. Comp Psychiatry 1987 Jul-Aug;28(4):356-6l. Mavissakalian M, Harnann MS, Jones B. A comparison of DSM-Ill personality disorders in panic/agoraphobia and obsessive—compulsive 11 disorder. Compr Psychiatry 1990 May-Jun; 31(3):238—44. McGrath PJ. Stewart JW. Liebowitz MR, Markowitz IM, Quitkin FM, Klein DF, Gorman IM, Lactate provocation of panic attacks in depressed outpatients. Psychiatry Res 1988 Jul;25(l):41-7. McIntyre IM, Judd FK, Burrows GD, Armstrong SM, Norman TR. Plasma concentrations of melatonin in panic disorder. Am J Psychiatry 1990 Apr; 147(4):462-4. McIntyre IM, Norman TR, Marriott PF, Burrows GD. The pineal hormone melatonin in panic disorder. J Affective Disord 1987 May-Jun;12(3):203-6. McNally RJ, Riemann BC, Kim E. Selective processing of threat cues in panic disorder. Behav Res Ther 1990;28(5):407-12. Mellman TA, Uhde TW. Electroencephalographic sleep in panic disorder. A focus on sleep-related panic attacks. Arch Gen Psychiatry 1989 Feb; 46(2):l78-84. Mellman TA, Uhde TW. Obsessive—compulsive symptoms in panic disorder. Am J Psychiatry 1987 Dec;l44(12):1573-6. Mellrnan TA, Uhde TW. Patients with frequent sleep panic: clinical findings and response to medication treatment. J Clin Psychiatry 1990 Dec;‘Sl(12): 51 3-6. Mellrnan TA, Uhde TW. Sleep panic attacks: new clinical findings and theoretical implications. Am J Psychiatry 1989 Sep;l46(9):1204—7. Metz A, Sichel DA, Goff DC. Postpartum panic disorder. J Clin Psychiatry 1988 Jul;49(7):278-9. Middleton HC. Cardiovasuclar dystonia in recovered panic pateints. J Affective Disord 1990 Aug; 19(4):229-36. Modestin J. Symptomatic panic disorder in borderline personality disorder. Eur J Psychiatry 1989 Jul- Sep;3(3):133-7. Moreau DL. Weissman M, Warner V. Panic disorder in children at high risk for depression. Am J Psychiatry 1989 Aug;l46(8):1059-60. Mukerji V, Beitman BD, Alpert MA, Larnberti JW. DeRosear L, Basha 1M. Panic disorder: a frequent occurrence in patients with chest pain and normal coronary arteries. Angiology 1987 Mar;38(3): 236-40. 12 Munjack DJ. Brown RA. McDowell DE. Comparison of social anxiety in patients with social phobia and panic disorder. J Nerv Ment Dis 1987 Jan;175(l): 49-5 1. Munjack DJ, Palmer R. Thyroid hormones in panic disorder, panic disorder with agoraphobia, and generalized anxiety disorder. J Clin Psychiauy 1988 Jun;49(6):229-31. Murphy DL. Pigott TA. A comparative examination of a role for serotonin in obsessive compulsive disorder. panic disorder. and anxiety. J Clin Psychiatry 1990 Apr;51 Suppl:53-8; discussion 59-60. Murray JB. Psychopharmacological investigation of panic disorder by means of lactate infusion. J Gen Psychol 1987 Jul;114(3):297-311. Neenan P, Felkner J, Reich J. Schizoid personality traits developing secondary to panic disorder. J Nerv Ment Dis 1986 Aug;174(8):483. Nelles WB. Barlow DH. Do children panic? Clin Psychol Rev 1988;8(4):359-72. Nesse RM. Cameron OG, Buda AJ. McCann DS. Curtis GC, Huber-Smith MJ. Urinary catecholamines and mitral valve prolapse in panic-anxiety patients. Psychiatry Res 1985 Jan;14(1):67-75. Nordahl TE, Semple WE, Gross M. Mellrnan TA. Stein MB. Goyer P. King AC. Uhde TW. Cohen RM. Cerebral glucose metabolic differences in patients with panic disorder. Neuropsychopharrnacology 1990 Aug;3(4):261-72. Norton GR. Harrison B. Hauch J, Rhodes L. Characteristics of people with infrequent panic attacks. J Abnorm Psychol l985;94(2):216-21. Noyes R. Is panic disorder a disease for the medical model? Psychosomatics 1987 Nov;28(11):582-4. 586. Noyes R, Reich J. Clancy J. O'Gorman TW. Reduction in hypochondriasis with treatment of panic disorder [published erratum appears in Br J Psychiatry 1987 Feb;150:273]. Br J Psychiatry 1986 Nov;l49:631-5. Noyes R Jr. The comorbidity and mortality of panic disorder. Psychiatr Med l990;8(2):41-66. Noyes R Jr. Clancy J. Garvey MJ, Anderson DJ. Is agoraphobia a variant of panic disorder or a separate illness? I Anxiety Disord 1987;1(1):3-l3. Noyes R Jr. Cook B. Garvey M. Summers R. Reduction of gastrointestinal symptoms following treatment for panic disorder. Psychosomatics 1990 Winter;31(l):75-9. Noyes R Jr, Crowe RR. Harris EL, Hamra BJ, McChesney CM, Chaudhry DR. Relationship between panic disorder and agoraphobia. A family study. Arch Gen Psychiatry 1986 Mar;43(3): 227-32. Noyes R Jr. Reich J , Christiansen J . Suelzer M, Pfohl B, Coryell WA. Outcome of panic disorder. Relationship to diagnostic subtypes and comorbidity. Arch Gen Psychiatry 1990 Sep;47(9):809-18. Nutzinger DO. Zapotoczky HG. The influence of depression on the outcome of cardiac phobia (panic disorder). Psychopathology 1985;18(2-3):155-62. Oei TP, Gross PR. Evans L. Phobic disorders and anxiety states: how do they differ? Aust N Z J Psychiatry 1989 Mar;23(l):81-8. Oei TPS, Wanstall K, Evans L. Sex differences in panic disorder with agoraphobia. J Anxiety Disord 1990;4(4):317-24. Ontiveros A. Fontaine R. Panic attacks and multiple sclerosis. Biol Psychiauy 1990 Mar;27(6):672-3. Ontiveros A, Fontaine R. Breton G. Elie R. et a1. Correlation of severity of panic disorder and neuroanatomical changes on magnetic resonance imaging. J Neuropsychiatry Clin Neurosci 1989 Fall;1(4):404-8. Orenstein H. Peskind A, Raskind MA. Thyroid disorders in female psychiatric patients with panic disorder or agoraphobia. Am J Psychiatry 1988 Nov; 1450 1): 1428-30. Orsini A, Sciuto G. Smeraldi E. A familial validation of dissection between panic and generalized anxiety disorders. New Trends Exp Clin Psychiatry 1990; 6(2):69-77. Ottaviani R, Beck RT. Cognitive aspects of panic disorders. J Anxiety Disord 1987;1(1):15-28. Overall JE, Sheehan DV. Multivariate analysis of changes in panic frequency counts. Clin Neuropharmacol 1986;9 Suppl 4:155-7. Pain MC, Biddle N. Tiller JW. Panic disorder. the ventilatory response to carbon dioxide and respiratory variables. Psychosom Med 1988 Sep- Oct;50(5):541-8. Papp LA, Goetz R. Cole R, Klein DF. Jordan F, Liebowitz MR. Fyer AJ. Hollander E, Gorman JM. Hypersensitivity to carbon dioxide in panic disorder. Am J Psychiatry 1989 Jun;146(6):779—81. Papp LA. Martinez M. Klein DF. Ross D. Liebowitz MR. Fyer AJ. Hollander E. Gorman JM. Arterial blood gas changes in panic disorder and lactate- induced panic. Psychiatry Res 1989 May;28(2): 171-80. Paulsen AS. Crowe RR. Noyes R. Pfohl B. Reliability of the telephone interview in diagnosing anxiety disorders. Arch Gen Psychiatry 1988 Jan; 45(1):62-3. Pecknold JC. Chang H. Fleury D, Koszychi D. Quirion R. Nair NP, Suranyi-Cadotte BE. Platelet imipramine binding in patients with panic disorder and major familial depression. J Psychiatr Res l987;21(3):319—26. Pecknold JC. Luthe L. Sleep studies and neurochemical correlates in panic disorder and agoraphobia. Prog Neuropsychopharmacol Biol ' Psychiatry 1990;14(5):753—8. Pecknold JC. Suranyi-Cadotte B. Chang H. Nair NP. Serotonin uptake in panic disorder and agoraphobia. Neuropsychopharmacology 1988 May;1(2):173-6. Perugi G. Deltito J. Soriani A. Musetti L, Petracca A. Nisita C. Maremmani I. Cassano GB. Relationships between panic disorder and separation anxiety with school phobia. Compr Psychiatry 1988 Mar-Apr;29(2):98-107. Peters JC. Alpert M. Beitman BD. Kushner M. Webel R. Panic disorder associated with permanent pacemaker implantation. Psychosomatics 1990 Summer;31(3):345-7. Pohl R. Yeragani VK. Balon R. Rainey IM. Lycaki H. Ortiz A. Berchou R. Weinberg P. Isoproterenol- induced panic attacks. Biol Psychiatry 1988 Dec; 24(8):891-902. Pollack MH, Otto MW, Rosenbaum JF. Sachs GS. O’Neil C, Asher R. Meltzer-Brody S. Longitudinal course of panic disorder: findings from the Massachusetts General Hospital Naturalistic Study. J Clin Psychiatry 1990 Dec;51 Suppl A:12-6. Pollard CA. Cox GL. Social-evaluative anxiety in panic disorder and agoraphobia. Psychol Rep 1988 Feb;62(1):323-6. Pollard CA. Detrick P. Flynn T. Frank M. Panic attacks and related disorders in alcohol~dependent. depressed. and nonclinical samples. J Nerv Ment Dis 1990 Mar;178(3):180-5. Pollock C. Andrews G. Defense styles associated with specific anxiety disorders. Am J Psychiatry 1989 Nov;146(11):1500-2. 13 Rachman S. Levitt K. Parties and their consequences. Behav Res Ther 1985;23(5):585-600. Rachman S. Levitt K. Lopatka C. A simple method for distinguishing between expected and unexpected panics. Behav Res Ther 1987;25(2):149-54. Rachman S. Levitt K. Lopatka C. Experimental analyses of panic--III. Claustrophobic subjects. Behav Res Ther 1988;26(1):41-52. Rachman S. Lopatka C. Levitt K. Experimental analyses of panic-J]. Panic patients. Behav Res Ther 1988;26(1):33-40. Raj A. Sheehan DV. Mitral valve prolapse and panic disorder. Bull Menninger Clin 1990 Spring;54(2): 199-208. Rapaport MH. Risch SC. Gillin JC. Golshan S. Janowsky DS. Blunted growth hormone response to peripheral infusion of human growth hormone- releasing factor in patients with panic disorder. Am J Psychiatry 1989 Jan;l46(1):92-5. Rapee R. Differential response to hyperventilation in panic disorder and generalized anxiety disorder. J Abnorrn Psychol 1986;95(1):24-8. Rapee RM. Distinctions between panic disorder and generalised anxiety disorder: clinical presentation. Aust N Z J Psychiatry 1985 Sep;19(3):227-32. Rapee RM. Ancis IR, Barlow DH. Emotional reactions to physiological sensations: Panic disorder patients and non-clinial Ss. Behav Res Ther l988;26(3): , 265-9. Rapee RM. Craske MG, Barlow DH. Subject-described features of panic attacks using self-monitoring. J Anxiety Disord 1990;4(2):17l-81. Raymond C. Chest pain not always what it seems; panic disorder may be cause in some . JAMA 1989 Feb 24;261(8):1101-2. Reich J. DSM-III personality disorders and family history of mental illness. J Nerv Ment Dis 1988 Jan;l76(1):45—9. Reich J. Chaudry D. Personality of panic disorder alcohol abusers. J Nerv Ment Dis 1987 Apr;l75(4): 224-8. Reich J. Noyes R. Yates W. Anxiety symptoms distinguishing social phobia from panic and generalized anxiety disorders. J Nerv Ment Dis 1988 Aug;176(8):510-3. 14 Reich J, Noyes R Jr, Coryell W, O'Gorman TW. The effect of state anxiety on personality measurement. Am J Psychiatry 1986 Jun;143(6):760-3. Reich J, Noyes R Jr, Hirschfeld R. Coryell W, O'Gorman T. State and personality in depressed and panic patients. Am J Psychiatry 1987 Feb; 144(2):181—7. Reich J , Noyes R Jr, T‘roughton E. Dependent personality disorder associated with phobic avoidance in patients with panic disorder. Am J Psychiatry 1987 Mar;l44(3):323-6. Reich J, Troughton E. Comparison of DSM-HI personality disorders in recovered depressed and panic disorder patients. J Nerv Ment Dis 1988 May;l76(5):300-4. Reich J, Troughton E. Frequency of DSM-III personality disorders in patients with panic disorder: comparison with psychiatric and normal control subjects. Psychiatry Res 1988 Oct;26(1):89-100. Reich JH. DSM-III personality disorders and the outcome of treated panic disorder. Am J Psychiatry 1988 Sep;145(9):1149-52. Reich IH, Green AI. Effect of personality disorders on outcome of treatment. J Nerv Ment Dis 1991 Feb; 179(2):74-82. Reich P. Panic attacks and the risk of suicide [editorial]. N Engl J Med 1989 Nov 2;321(18): 1260-1. Reirnan EM. The study of panic disorder using positron emission tomography. Psychiatr Dev 1987 Spring;5(l):63-78. Reiman EM, Raichle ME, Robins E, Mintun MA, Fusselman MJ, Fox PT, Price JL, Hackman KA. Neuroanatomical correlates of a lactate-induced anxiety attack. Arch Gen Psychiatry 1989 Jun; 46(6):493-500. Rickels K, Schweizer E, Case WG. The uncontrolled case report: A double-edged sword. J Nerv Ment Dis 1988 Jan;176(1):50-2. Rifldn A. Nakai BS. Difficulty walking as a symptom of panic disorder. Comp Psychiatry 1987 Sep-Oct; 28(5):428-9. Rosenbaum JF. Limited-symptom panic attacks. Psychosomatics 1987 Aug;28(8):407-12. Rosenberg NK, Andersen R. Rorschach-profile in panic disorder. Scand J Psychol 1990;31(2):99-109. Rosenberg R, Bech P, Plenge P, et al. MAO activity and sup 3H-imipramine binding in platelets from patients with panic disorder. Nord Psykiatr Tidsskr 1986;40(6):440. Rosenberg R, Bech P, Mellergard M, Ottosson J~O. Secondary depression in panic disorder: An indicator of severity with a weak effect on outcome in alprazolam and imipramine treatment. Acta Psychiatr Scand Suppl 1991;83(365):39—45. Rosenberg R. Ottosson J-O, Bech P, Mellergard M, Rosenberg NK. Validation criteria for panic disorders as a nosological entity. Acta Psychiatr Scand Suppl 1991;83(365):7-17.> Rosenblat H. Panic attacks triggered by photic stimulation. Am J Psychiatry 1989 Jun;146(6): 801-2. Roth WT, Ehlers A, Taylor CB, Margraf J, Agras WS. Skin conductance habituation in panic disorder patients. Biol Psychiatry 1990 Jun 1;27(11): 1231-43. Roy-Byme PP, Bierer LM, Uhde TW. The dexamethasone suppression test in panic disorder: Comparison with normal controls. Biol Psychiatry 1985;20(11):1237—40. Roy-Byme PP, Cowley DS, Greenblatt DJ, Shader RI, Hemmer D. Reduced benzodiazepine sensitivity in panic disorder. Arch Gen Psychiatry 1990 Jun; 47(6):534-8. Roy-Byme PP, Lewis N, Villacres E, Diem H, Greenblatt DJ, Shader RI, Veith R. Preliminary evidence of benzodiazepine subsensitivity in panic disorder. Biol Psychiatry 1989 Nov;26(7):744-8. Roy-Byme PP. Mellman TA, Uhde TW. Biologic findings in panic disorder: neuroendocrine and sleep-related abnormalities. J Anxiety Disord 1988;2(1):17-29. Roy-Byme PP, Schmidt P, Cannon R0, Diem H, Rubinow DR. Microvascular angina and panic disorder. Int J Psychiatry Med 1989;19(4):315-25. Roy-Byme PP, Uhde TW. Panic disorder and major depression: Biological relationships. Psychophannacol Bull 1985;21(3):551-4. Roy-Byme PP, Uhde TW, Gold PW, Rubinow DR, Post RM. Neuroendocrine abnormalities in panic disorder. Psychopharrnacol Bull 1985;21(3):546-50. Roy-Byme PP, Uhde TW. Post RM. Effects of one night’s sleep deprivation on mood and behavior in panic disorder. Patients with panic disorder compared with depressed patients and normal controls. Arch Gen Psychiatry 1986 Sep;43(9): 895-9. Roy-Byrne PP, Uhde TW. Post RM, Gallucci W, Chrousos GP, Gold PW. The corticotropin- releasing hormone stimulation test in patients with panic disorder. Am J Psychiatry 1986 Jul;143(7): 896-9. Roy-Byrne P. Uhde TW. Post RM, King AC. Buchsbaurn MS. Normal pain sensitivity in patients with panic disorder. Psychiatry Res 1985 Jan;14(1):77-84. Roy-Byme PP, Uhde TW. Rubinow DR, Post RM. Reduced TSH and prolactin responses to TRH in patients with panic disorder. Am J Psychiatry 1986 Apr;143(4):503-7. Roy-Byme PP. Uhde TW, Sack DA. Linnoila M. Post RM. Plasma HVA and anxiety in patients with panic disorder. Biol Psychiatry 1986 Jul; 21(8-9):849-53. Russell JL, Kushner MG, Beitman BD, Bartels KM. Nonfearful panic disorder in neurology patients validated by lactate challenge. Am J Psychiatry 1991 Mar;l48(3):361-4. Sabelli HC, Javaid JI. Fawcett J. Kravitz HM, Wynn P. Urinary phenylacetic acid in panic disorder with and without depression. Acta Psychiatr Scand 1990 Jul; 82(1):14-6. Salkovskis PM, Warwick HMC. Clark DM. Wessels DJ. A demonstration of acute hyperventilation during naturally occurring panic attacks. Behav Res Ther 1986;24(1):91-4. Sanderson WC, Rapee RM, Barlow DH. Panic induction via inhalation of 5.5% C02 enriched air: a single subject analysis of psychological and physiological effects. Behav Res Ther 1988;26(4): 333-5. Sanderson WC. Wetzler S. Five percent carbon dioxide challenge: valid analogue and marker of panic disorder? Biol Psychiatry 1990 Apr l;27(7): 689-701. Scharfman EL. "Relaxation-induced panic (RIP): When resting isn't peace ": Commentary. Integr Psychiatry 1987 Jun;5(2):110-2. Schittecatte M. Charles G, Depauw Y. Mesters P. Wilrnotte J. Growth hormone response to clonidine in panic disorder patients. Psychiau'y Res 1988 Feb;23(2):147-51. Schneider LS, Munjack D, Severson JA, Palmer R. Platelet [3H]imipramine binding in generalized anxiety disorder. panic disorder, and agoraphobia with panic attacks. Biol Psychiatry 1987 Jan; 22(1):59-66. 15 Schneier FR. Fyer A]. Martin LY. Ross D. Mannuzza S, Liebowitz MR, Gorman M. Klein DF. A comparison of phobic subtypes within panic disorder. J Anxiety Disord 1991;5(1):65-75. Schweizer E, Winokur A, Rickels K. Insulin-induced hypoglycemia and panic attacks. Am J Psychiatry 1986 May;l43(5):654-5. Scrignar CB. Postpanic anxiety disorder: diagnosis and treatment. South Med J 1986 Apr;79(4):400-4. Seibyl JP. Krystal JH, Charney DS. Marijuana (cannabis) use is anecdotally said to precipitate anxiety symptoms in patients with panic disorder. Is there any research evidence to support this? Also, can marijuana use precipitate or expose paranoia in patients with an underlying bipolar disorder? J Clin Psychopharmacol 1990 Feb;10(1):78. Shear MK, Kligfield P, Harshfield G, Devereux RB, Polan JJ, Mann JJ. Pickering T, Frances A]. Cardiac rate and rhythm in panic patients. Am J Psychiatry 1987 May;144(5):633-7. Sheehan DV, Carr DB, Fishman SM. Walsh MM, Peltier-Saxe D. Lactate infusion in anxiety research: its evolution and practice. J Clin Psychiatry 1985 May;46(5):158-65. Siegel L. Jones WC, Wilson JO. Economic and life consequences experienced by a group of individuals with panic disorder. J Anxiety Disord 1990;4(3): 201-1 1. Sietsema KE, Simon JI, Wasserrnan K. Pulmonary hypertension presenting as a panic disorder. Chest 1987 Jun;9l(6):910-2. Sklare DA, Stein MB, Pikus AM. Uhde TW. Dysequilibrium and audiovestibular function in panic disorder: symptom profiles and test findings. Am J Otol 1990 Sep;ll(5):338—41. Spitz MC. Panic disorder in seizure patients: a diagnostic pitfall. Epilepsia 1991 Jan-Feb;32(l): 33-8. Starcevic V. Pathological fear of death. panic attacks, and hypochondriasis. Am J Psychoanal 1989 Dec; 49(4): 347 -61 . Stein MB. Panic disorder and medical illness. Psychosomatics 1986;27(12):833-40. Stein MB, Schmidt PJ. Rubinow DR. Uhde TW. Panic disorder and the menstrual cycle: panic disorder patients, healthy control subjects, and patients with premenstrual syndrome. Am J Psychiatry 1989 Oct; 146(10):1299-303. 16 Stein MB. Shea CA, Uhde TW. Social phobic symptoms in patients with panic disorder: practical and theoretical implications. Am J Psychiatry 1989 Feb;146(2):235-8. Stein MB. Tancer ME. Uhde TW. Major depression in patients with panic disorder: factors associated with course and recurrence. J Affective Disord 1990 Aug;19(4):287-96. Stein MB. Uhde TW. Autoimmune thyroiditis and panic disorder. Am J Psychiatry 1989 Feb; l46(2):259-60. Stein MB, Uhde TW. Endocrine. cardiovascular. and behavioral effects of intravenous protirelin in patients with panic disorder. Arch Gen Psychiatry 1991 Feb;48(2):148-56. Stein MB. Uhde TW. Panic disorder and major depression. A tale of two syndromes [published erratum appears in Psychiatr Clin North Am 1988 Dec;ll(4):following vii]. Psychiatr Clin North Am 1988 Jun;11(2):441-61. Stein MB. Uhde TW. Thyroid indices in panic disorder. Am J Psychiatry 1988 Jun;145(6):745-7. Stewart RS. Devous MD Sr. Rush AJ. Lane L. Home FJ. Cerebral blood flow changes during sodium- lactate-induced panic attacks. Am J Psychiatry 1988 Apr;145(4):442-9. Stewart WF. Linet MS. Celentano DD. Migraine headaches and panic attacks. Psychosom Med 1989 Sep-Oct;51(5):559-69. Street LL. Craske MG. Barlow DH. Sensations. cognitions and the perception of cues associated with expected and unexpected panic attacks. Behav Res Ther 1989;27(2)2189-98. Szuster RR. Pontius EB. Campos PE. Marijuana sensitivity and panic anxiety. J Clin Psychiau'y‘ 1988 Nov;49(l l):427-9. Tancer ME. Stein MB. Moul DE, Uhde TW. Normal serum cholesterol in panic disorder. Biol Psychiatry 1990 Jan l;27(1):99-101. Tancer ME. Stein NIB. Uhde TW. Effects of thyrotropin-releasing hormone on blood pressure and heart rate in phobic and panic patients: a pilot study. Biol Psychiatry 1990 Apr 1;27(7):781-3. Tancer ME. Stein MB. Uhde TW. Paradoxical growth- hormone responses to thyrotropin—releasing hormone in panic disorder. Biol Psychiatry 1990 Jun 1; 27(11):1227-30. Targum SD. Differential responses to anxiogenic challenge studies in patients with major depressive disorder and panic disorder. Biol Psychiatry 1990 Jul 1;28(l):21-34. Targurn SD. Panic attack frequency and vulnerability to anxiogenic challenge studies. Psychiatry Res 1991 Jan;36(1):75-83. Tavel ME. Hyperventilation syndrome--hiding behind pseudonyms? Chest 1990 Jun;97(6)21285-8. Taylor CB. King R. Ehlers A. Margraf J. Clark D, Hayward C. Roth WT. Agras S. Treadmill exercise test and ambulatory measures in panic attacks. Am J Cardiol 1987 Dec 28;60(18):48J-52J. Taylor CB. Sheikh J. Agras WS. Roth WT, Margraf J, Ehlers A. Maddock RJ. Gossard D. Ambulatory heart rate changes in patients with panic attacks. Am J Psychiatry 1986 Apr;143(4):478-82. Telch MJ. Lucas JA. Nelson P. Nonclinical panic in college students: an investigation of prevalence and symptomatology. J Abnorm Psycho] 1989 Aug; 98(3):300-6. Thompson AH. Bland RC. Om HT. Relationship and chronology of depression. agoraphobia. and panic disorder in the general population. J Nerv Ment Dis 1989 Aug;l77(8):456-63. Thyer BA. Himle J. Curtis GC. et a]. A comparison of panic disorder and agoraphobia with panic attacks. Compr Psychiatry l985;26(2):208-14. Thyer BA. Parrish RT. Himle J, et a]. Case histories and shorter communications. Alcohol abuse among clinically anxious patients. Behav Res Ther 1986; 24(3):357-359. Turner SM. McCann BS. Beidel DC, Mezzich JE. DSM-III classification of the anxiety disorders: a psychometric study. J Abnorm Psychol 1986 May; 95(2):168-72. Turner SM. Williams SL. Beidel DC. Mezzich IE. Panic disorder and agoraphobia with panic attacks: Covariation along the dimensions of panic and agoraphobic fear. J Abnorm Psychol 1986;95(4): 384-8. Tyrer P. Classification of anxiety disorders: A critique of DSM-III. J Affect Disord 1986 Sep—Oct;11(2): 99-104. Tyrer P. Seivewright N. Ferguson B. Murphy S. Darling C. Brothwell J. Kingdon D. Johnson AL. The Nottingham Study of Neurotic Disorder: relationship between personality status and symptoms. Psychol Med 1990 May;20(2):423-3l. Uhde TW, Berrettini WH. Roy-Byme PP, Boulenger JP. Post RM. Platelet [3H]imipramine binding in patients with panic disorder. Biol Psychiatry 1987 Jan;22(1):52-8. Uhde TW. Boulenger JP. Roy-Byme PP. Geraci MF. Vittone BJ, Post RM. Longitudinal course of panic disorder: clinical and. biological considerations. Prog Neuropsychopharmacol Biol Psychiatry 1985; 9(1):39-51. Uhde TW. Joffe RT, Jirnerson DC. Post RM. Normal urinary free cortisol and plasma MHPG in panic disorder: clinical and theoretical implications. Biol Psychiatry 1988 Mar 15;23(6):575-85. Uhde TW. Kellner CH. Cerebral ventricular size in panic disorder. J Affective Disord 1987 Mar-Apr; 12(2):175-8. Uhde TW. Mellman TA. "Relaxation-induced panic (RIP): When resting isn't peaceful": Commentary. Integr Psychiatry 1987 Jun;5(2):101—4. van den Hout MA, De Jong P. Zandbergen J. Merckelbach H. Waning of panic sensations during prolonged hyperventilation. Behav Res Ther 1990; 28(5):445-8. van den Hout MA, Griez E, van der Molen GM, Lousberg H. Pulmonary carbon dioxide and panic- arousing sensations after 35% carbon dioxide inhalation: hypercapnia/hyperoxia versus hypercapnia/normoxia. J Behav Ther Exp Psychiatry 1987 Mar;18(1):l9—23. van den Hout MA. van der Molen GM. Griez E. Lousberg H. Specificity of interoceptive fear to panic disorders. J Psychopathol Behav Assess 1987; 9(1):99-106. Villacres EC. Hollifleld M, Katon WJ. Wilkinson CW, Veith RC. Sympathetic nervous system activity in panic disorder. Psychiatry Res 1987 Aug;21(4): 313-21. Vitiello B. Behar D, Wolfson S, McLeer SV. Diagnosis of panic disorder in prepubertal children. J Am Acad Child Adolesc Psychiatry 1990 Sep; 29(5):782—4. von Bardeleben U. Holsboer F. Human corticotropin releasing hormone: clinical studies in patients with affective disorders. alcoholism. panic disorder and in normal controls. Prog Neuropsychopharmacol Biol Psychiatry 1988;12 Supp1:8165-87. Weiler MA. Val ER. Gaviria M, Prasad RB. Lahmeyer HW, Rodgers P. Panic disorder is borderline personality disorder. Psychiatr J Univ Ott 1988 Sep;13(3):140-3. 17 Weiss KJ. Panic disorder: fear disguised as medical illness. J Med Soc N J 1985 Feb;82(2):141-2. Weissman MM. Panic and generalized anxiety: are they separate disorders? J Psychiatr Res 1990;24 Suppl 2:157-62. Weissman MM. Panic disorder: impact on quality of life. J Clin Psychiatry 1991 Feb;52 Supplz6-8; discussion 9. Weissman MM. The hidden patient: unrecognized panic disorder. J Clin Psychiatry 1990 Nov;51 Supp1:5-8. Weissman MM. Klerman GL. Markowitz JS. Ouellette R. Suicidal ideation and suicide attempts in panic disorder and attacks. N Engl J Med 1989 Nov 2; 321(18):1209—14. Weissman MM, Markowitz JS. Ouellette R, Greenwald S, Kahn JP. Panic disorder and cardiovascular/ cerebrovascular problems: results from a community survey. Am J Psychiatry 1990 Nov;l47(11):1504-8. Weissman NJ. Shear MK. Kramer-Fox R. Devereux RB. Contrasting patterns of autonomic dysfunction in patients with mitral valve prolapse and panic attacks. Am J Med 1987 May;82(5):880-8. Wetzler S. Kahn RS, Cahn W. van Praag HM. Asnis GM. Psychological test characteristics of depressed and panic patients. Psychiatry Res 1990 Feb;31(2): 179-92. White WB, Baker LH. Ambulatory blood pressure monitoring in patients with panic disorder. Arch Intern Med 1987 Nov;l47(11):1973-5. Whiteford HA. Evans L. Agoraphobia and the dexamethasone suppression test: Atypical depression? Aust N Z J Psychiatry 1984; 18(4):374-7. Woodruff BJ, Clum GA. Broyles SE. MMPI correlates of panic disorder and panic attacks. I Anxiety Disord 1989;3(2):107-15. Woods SW, Chamey DS. Applications of the pharmacologic challenge strategy in panic disorders research. J Anxiety Disord 1988;2(1):31-49. Woods SW, Chamey DS. Delgado PL, Heninger GR. The effect of long-term imipramine treatment on carbon dioxide-induced anxiety in panic disorder patients. J Clin Psychiatry 1990 Dec;51(12):505-7. 18 Woods SW. Chamey DS. Goodman WK. Heninger GR. Carbon dioxide-induced anxiety. Behavioral. physiologic. and biochemical effects of carbon dioxide in patients with panic disorders and healthy subjects. Arch Gen Psychiatry 1988 Jan;45(1): 43-52. Yeragani V. Balon R. Pohl R. Lactate infusions in panic disorder patients and normal controls: autonomic measures and subjective anxiety. Acta Psychiatr Scand 1989 Jan ,79(1): 32-40. Yeragani VK, Balon R. Pohl R. Ortiz A. Weinberg P. Rainey JM. Do higher preinfusion heart rates predict laboratory-induced panic attacks? Biol Psychiatry 1987 May;22(5):554-8. Yeragani VK, Balon R. Pohl R. Ramesh C. Glitz D. Weinberg P. Merlos B. Decreased R-R variance in panic disorder patients. Acta Psychiatr Scand 1990 Jun;81(6):554-9. Yeragani VK, Balon R, Rainey JM. Ortiz A, Berchou R. Lycaki H. Pohl R. Effects of laboratory-induced panic-anxiety on subsequent provocative infusions. Psychiatry Res 1988 Feb;23(2):l6l-6. Yeragani VK, Meiri PC. Pohl R. Balon R, Desai N, Golec S. Heart rate and blood pressure changes during postural change and isometric handgrip exercise in patients with panic disorder and normal controls. Acta Psychiatr Scand 1990 Jan;8l(1):9-13. Yeragani VK, Pohl R, Balon R. Ramesh C. Glitz D, Sherwood P. Risk factors for cardiovascular illness in panic disorder patients. Neuropsychobiology l990-9l;23(3):134-9. Yeragani VK, Pohl R, Balon R. Weinberg P, Berchou R. Rainey JM. Preinfusion anxiety predicts lactate- induced panic attacks in normal controls. Psychosom Med 1987 Jul-Aug;49(4):383-9. Yeragani VK, Pohl R. Rainey JM. Balon R. Ortiz A. Lycaki H. Gershon S. Pre- infusion heart rates and laboratory- ~induced panic anxiety. Acta Psychiatr Scand 1987 Jan .7:5(1) 51-4. Yeragani VK. Rainey M Jr. Pohl R. Balon R, Berchou R. Jolly S. Lycaki H. Preinfusion anxiety and laboratory-induced panic attacks in panic disorder patients. J Clin Psychiatry 1988 Aug;49(8):302—6. Zander JR, McNally RI. Bio-informational processing in agoraphobia. Special Issue: A selection of papers to mark The Third World Congress of Behaviour Therapy. Behav Res Ther 1988;26(5):421-9. Zane MD. "Relaxation-induced panic (RIP): When resting isn‘t peaceful": Commentary. Integr Psychiatry 1987 Jun;5(2):106-8. Zitrin CM. "Relaxation-induced panic (RIP): When resting isn't peace ": Commentary. Integr Psychiatry 1987 Dec;5(4):294-5. EPIDEMIOLOGY Angst J. Dobler—Mikola A. The Zurich Study. V. Anxiety and phobia in young adults. Eur Arch Psychiatry Neurol Sci 1985;235(3):17l-8. Anthony JC. Tien AY. Petronis KR. Epidemiologic evidence on cocaine use and panic attacks. Am J Epidemiol 1989 Mar;129(3):543-9. Faravelli C. Guerrini Degl'Innocenti B. Giardinelli L. Epidemiology of anxiety disorders in Florence. Acta Psychiatr Scand 1989 Apr;79(4):308-12. Joyce PR. Bushnell JA, Oakley-Browne MA. Wells JE. Homblow AR. The epidemiology of panic symptomatology and agoraphobic avoidance. Compr Psychiatry 1989 Jul-Aug;30(4):303-12. Kamo M. Golding JM. Bumam MA. Hough RL, Escobar JI. Wells KM. Boyer R. Anxiety disorders among Mexican Americans and non-Hispanic whites in Los Angeles. J Nerv Ment Dis 1989 Apr; 177(4):202-9. Karno M, Hough RL. Bumam MA. Escobar JI. Timbers DM. Santana F. Boyd JH. Lifetime prevalence of specific psychiatric disorders among Mexican Americans and non-Hispanic whites in Los Angeles. Arch Gen Psychiatry 1987 Aug;44(8):695-701. Katon W. Vitaliano PP. Russo J. Cormier L. Anderson K, Jones M. Panic disorder: epidemiology in primary care. J Farn Pract 1986 Sep;23(3):233-9. Klerman GL. Weissman MM, Ouellette R. Johnson J. Greenwald S. Panic attacks in the community. Social morbidity and health care utilization. JAMA 1991 Feb 13;265(6):742-6. Lepine JP, Lellouch J. Lovell A. Teherani M. Ha C. Verdier-Taillefer MH. Rambourg N. Lemperiere T. Anxiety and depressive disorders in a French population: methodology and preliminary results. Psychiatr Psychobiol 1989;4(5):267-74. Lepine JP. Pariente P, Boulenger JP, Hardy P. Zarifian E, Lemperiere T. Lellouch J. Anxiety disorders in a French general psychiatric outpatient sample. Comparison between DSM-III and DSM-IIIR criteria. Soc Psychiatry Psychiatr Epidemiol 1989 Nov;24(6):301-8. Maier W. Buller R. One-year follow-up of panic disorder. Outcome and prognostic factors. Eur Arch Psychiatry Neurol Sci 1988;238(2):105-9. Markowitz JS. Weissman MM. Ouellette R. Lish JD, Klerrnan GL. Quality of life in panic disorder. Arch Gen Psychiatry 1989 Nov;46(11):984-92. 19 Otakpor AN. A prospective study of panic disorder in a Nigerian psychiatric out-patient population. Acta Psychiatr Scand 1987 Nov;76(5):541-4. Regier DA. Narrow WE. Rae DS. The epidemiology of anxiety disorders: the Epidemiologic Catchment Area (ECA) experience. J Psychiatr Res 1990;24 Suppl 223-14. Reich J. The epidemiology of anxiety. J Nerv Ment Dis 1986 Mar;174(3):129-36. Salge RA. Beck JG. Logan AC. A community survey of panic. J Anxiety Disord 1988;2(2):157-67. Stirton RF. Brandon S. Preliminary report of a community survey of panic attacks and panic disorder. J R Soc Med 1988 Jul;81(7):392-3. Takahashi S. Nakamura M. Iida H. Iritani S. Fujii M. Yamashita Y. Yoichi I. Prevalence of panic disorder and other subtypes of anxiety disorder and their background. Jpn J Psychiatry Neurol 1987 Mar;4l(1):9-18. Thyer BA. Parrish RT. Curtis GC. Nesse RM. Cameron 06. Ages of onset of DSM-III anxiety disorders. Compr Psychiatry 1985 Mar-Apr;26(2):113-22. Vollrath M. Angst J. Outcome of panic and depression in a seven-year follow-up: results of the Zurich study. Acta Psychiatr Scand 1989 Dec;80(6):591-6. Vollrath M, Koch R. Angst J. The Zurich Study. IX. Panic disorder and sporadic panic: symptoms. diagnosis, prevalence, and overlap with depression. Eur Arch Psychiatry Neurol Sci 1990;239(4):221-30. Von Korff MR. Eaton WW. Keyl PM. The epidemiology of panic attacks and panic disorder. Results of three community surveys. Am J Epidemiol 1985 Dec;122(6):970-81. Weissman MM. Epidemiology of panic disorder and agoraphobia. Psychiatr Med 1990;8(2):3-13. Weissman MM. Leaf PJ. Blazer DG. Boyd JH. Florio L. The relationship between panic disorder and agoraphobia: an epidemiologic perspective. Psychopharmacol Bull 1986;22(3):787-91. Weissman MM, Leaf PJ, Holzer CE 3d. Merikangas KR. The epidemiology of anxiety disorders: a highlight of recent evidence. Psychopharrnacol Bull 1985;21(3):538-41. Weissman MM, Merikangas KR. The epidemiology of anxiety and panic disorders: an update. J Clin Psychiatry 1986 Jun;47 Suppl:11-7. 20 Zgourides GD. Warren R. Prevalence of panic in adolescents: a brief report. Psychol Rep 1988 Jun;62(3):935-7. ETIOLOGY AND MAINTENANCE Aronson TA, Logue CM. On the longitudinal course of panic disorder: development history and predictors of phobic complications. Compr Psychiatry 1987 Jul-Aug;28(4):344-55. Aronson TA. Whitaker-Aunitia P. Caraseti 1. Differential reactivity to lactate infusions: the relative role of biological, psychological, and conditioning variables. Biol Psychiatry 1989 Feb 15;25(4):469-81. Ayuso IL. Alfonso S, Rivera A. Childhood separation anxiety and panic disorder: a comparative study. Prog Neuropsychopharmacol Biol Psychiatry 1989; 13(5):665-71. Ballenger JC. Toward an integrated model of panic disorder. Am J Orthopsychiatry 1989 Apr;59(2): 284-93. Balon R, Jordan M. Pohl R, Yeragani VK. Family history of anxiety disorders in control subjects with lactate-induced panic attacks. Am J Psychiatry 1989 Oct;146(10):1304-6. Bass C, Gardner W. Emotional influences on breathing and breathlessness. J Psychosom Res l985;29(6): 599-609. Baum M. An animal model for situational panic attacks. Behav Res Ther 1986;24(5):509-12. Ben-Noun L. Mitral valve prolapse syndrome. panic disorder and agoraphobia. Practitioner 1989 Mar 22;233(l465):379—80. Brown SL, Chamey DS, Woods SW. Heninger GR. Tallman J. Lymphocyte beta-adrenergic receptor binding in panic disorder. Psychopharmacology (Berlin) 1988;94(1):24-8. Burrows GD, Judd FK, Hopper IL. The biology of panic-genetic evidence. Int J Clin Pharmacol Res 1989;9(2): 147 -9. Cameron OG, Nesse RM. Systemic hormonal and physiological abnormalities in anxiety disorders. Psychoneuroendocrinology 1988:l3(4):287-307. Cameron OG. Smith CB, Lee MA, Hollingsworth PI. Hill EM, Curtis GC. Adrenergic status in anxiety disorders: platelet alpha 2-adrenergic receptor binding, blood pressure, pulse. and plasma catecholamines in panic and generalized anxiety disorder patients and in normal subjects. Biol Psychiatry 1990 Jul 1;28(1):3-20. Carney RM. Freedland KE. Ludbrook PA, Saunders RD, Jaffe AS. Major depression. panic disorder. and mitral valve prolapse in patients who complain of chest pain. Am J Med 1990 Dec;89(6):757-60. Chamey DS. Heninger GR. Abnormal regulation of noradrenergic function in panic disorders. Effects of clonidine in healthy subjects and patients with agoraphobia and panic disorder. Arch Gen Psychiatry 1986 Nov;43(11):1042-54. Chamey DS. Heninger GR. Jatlow PI. Increased anxiogenic effects of caffeine in panic disorders. Arch Gen Psychiatry 1985 Mar;42(3):233—43. Chamey DS. Innis RB. Duman RS, Woods SW. Heninger GR. Platelet alpha-Z-receptor binding and adenylate cyclase activity in panic disorder. Psychopharmacology (Berlin) 1989;98(1):102-7. Chamey DS. Woods SW, Goodman WK. Heninger GR. Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine- induced panic attacks. Am J Psychiatry 1987 Aug; 144(8): 1030-6. Chamey DS. Woods SW, Goodman WK, Heninger GR. Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects. Psychopharmacology (Berlin) l987;92(1):14-24. Chamey DS. Woods SW. Nagy LM. Southwick SM, Krystal JH. Heninger GR. Noradrenergic function in panic disorder. J Clin Psychiatry 1990 Dec;51 Suppl A:5-11. Coulehan JL. Mitral valve prolapse as metaphor. Perspect Biol Med 1988 Winter;31(2):252-9. Cowley DS. Roy-Byme PP. Psychosocial aspects. Psychiatr Ann 1988 Aug;18(8):464-7. Craske MG, Barlow DH. Nocturnal panic: response to hyperventilation and carbon dioxide challenges. J Abnorm Psychol 1990 Aug;99(3):302-,7. Crowe RR. Mitral valve prolapse and panic disorder. Psychialr Clin North Am 1985 Mar;8(1):63-71. Crowe RR. Panic disorder: genetic considerations. J Psychiatr Res 1990;24 Suppl 2:129-34. Crowe RR. The genetics of panic disorder and agoraphobia. Psychiatr Dev 1985 Summer; 3(2):17I-85. Crowe RR. Noyes R Jr. Wilson AF. Elston RC, Ward L]. A linkage study of panic disorder. Arch Gen Psychiatry 1987 Nov;44(11):933-7. 21 Crowe RR. Noyes R Jr. Samuelson S, Wesner R. Wilson R. Close linkage between panic disorder and alpha-haptoglobin excluded in 10 families. Arch Gen Psychiatry 1990 Apr;47(4):377-80. Crowe RR. Noyes R Jr. Persico AM. Pro- opiomelanocortin (POMC) gene excluded as a cause of panic disorder in a large family. J Affective Disord 1987 Jan-Feb;12(1):23-7. Dager SR. Saal AK, Comess KA. Dunner DL. Mitral valve prolapse and the anxiety disorders. Hosp Community Psychiatry 1988 May;39(5):517-27. De Loof C, Zandbergen J. Lousberg H, Pols H, Griez E. The role of life events in the onset of panic disorder. Behav Res Ther 1989;27(4):461-3. de Montigny C. Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers. Preliminary findings. Arch Gen Psychiatry 1989 Jun;46(6): 51 1-7. Deltito JA, Argyle N, Buller R, Nutzinger D. Ottosson JO. Brandon S. Mellergard M. Shera D. The sequence of improvement of the symptoms encountered in patients with panic disorder. Compr Psychiatry 1991 Mar-Apr;32(2):120-9. Den Boer JA. Westenberg HG. Behavioral. neuroendocrine. and biochemical effects of 5- hydroxytryptophan administration in panic disorder. Psychiatry Res 1990 Mar;31(3):267-78. Den Boer JA. Westenberg HG, Verhoeven WM. Biological aspects of panic anxiety. Psychiatric Ann 1990 Sep;20(9):494-500. 502. Edlund MJ, Swann AC. Davis CM. Plasma MHPG in untreated panic disorder. Biol Psychiatry 1987 Dec; 22(12):1491-5. Ehlers A. Margraf J, Roth WT. Taylor CB, Birbaumer N. Anxiety induced by false heart rate feedback in patients with panic disorder. Behav Res Ther 1988; 26(1):1-11. Evans L. Some biological aspects of panic disorder. Int J Clin Pharmacol Res 1989;9(2):139-45. Familial analysis of panic disorder and agoraphobia. Gruppo Italiano Disturbi d’Ansia. J Affective Disord 1989 Jul—Aug;l7(1):l—8. Faravelli C. Life events preceding the onset of panic disorder. J Affective Disord 1985 Ju1;9(1):103-5. Faravelli C. Pallanti S. Recent life events and panic disorder. Am J Psychiatry 1989 May;146(5):622-6. 22 Fontaine R. Breton G, Dzery R, Fontaine S, Elie R. Temporal lobe abnormalities in panic disorder: an MRI study. Biol Psychiatry 1990 Feb 1;27(3): 304-10. Fontana DJ, Carbary TJ, Commissaris RL. Effects of acute and chronic anti-panic drug administration on conflict behavior in the rat. Psychopharmacology (Berlin) 1989;98(2):157-62. Fontana DJ, Commissaris RI... Effects of acute and chronic irnipramine administration on conflict behavior in the rat: a potential "animal mode " for the study of panic disorder? Psychophannacology (Berlin) 1988;95(2):147-50. Friedman S. Sunderland GS, Rosenblum LA. A nonhuman primate model of panic disorder. Psychiatry Res 1988 Jan;23(1):65-75. Fyer AJ. Liebowitz MR. German JM. Davies SO. Klein DF. Lactate vulnerability of remitted panic patients. Psychiatry Res 1985 Feb;14(2):143-8. Gelder MG. Panic attacks: new approaches to an old problem. Br J Psychiatry 1986 Sep;l49:346-52. Gentil V. Towards an integrated model for panic disorder. Stress Med l988;4(3):131-4. George DT. Adinoff B. Ravitz B. Nutt DJ. De Jong J. Berrettini W. Mefford IN, Costa E, Linnoila M. A cerebrospinal fluid study of the pathophysiology of panic disorder associated with alcoholism. Acta Psychiatr Scand 1990 Jul;82(1):1-7. George DT. Nutt DJ. Walker WV. Porges SW. Adinoff B, Linnoila M. Lactate and hyperventilation substantially attenuate vagal tone in normal volunteers. A possible mechanism of panic provocation? Arch Gen Psychiatry 1989 Feb; 46(2): 153-6. Gold PW. Pigott TA, Kling MA. Kalogeras K, Chrousos GP. Basic and clinical studies with corticotropin- releasing hormone. Implications for a possible role in panic disorder. Psychiatr Clin North Am 1988 Jun;ll(2):327-34. Gorman J, Liebowitz MR, Fyer AJ. Levitt M, Baron M, Davies S. Klein DF. Platelet monoamine oxidase activity in patients with panic disorder. Biol Psychiatry 1985 Aug;20(8):852—7. Gonnan IM. "Relaxation-induced panic (RIP): When resting isn‘tpeaceful": Commentary. Integr Psychiatry 1987 Jun;5(2):100-1. Gor'man IM. Fyer MR. Goetz R. Askanazi J, Liebowitz MR. Fyer AJ. Kinney J. Klein DF. Ventilatory physiology of patients with panic disorder [published erratum appears in Arch Gen Psychiatry 1991 Feb;48(2):181]. Arch Gen Psychiatry 1988 Jan;45(1):31-9. Gorman IM, Goetz RR. Fyer M. King DL. Fyer AI, Liebowitz MR. Klein DF. The rnitral valve prolapse--panic disorder connection. Psychosom Med 1988 Mar-Apr;50(2):ll4-22. Gonnan JM. Liebowitz MR. Fyer AJ. Stein J. A neuroanatomical hypothesis for panic disorder. Am J Psychiatry 1989 Feb;146(2):148-61. Gorman IM. Shear MK. Devereaux RB. King DL. Klein DF. Prevalence of mitral valve prolapse in panic disorder: effect of echocardiographic criteria. Psychosom Med 1986 Mar-Apr;48(3-4):167-71. Gottlieb SH. Mitral valve prolapse: from syndrome to disease. Am J Cardiol 1987 Dec 28;60(18):53J-58J. Griez E. Zandbergen J. Lousberg H, van den Hout M. Effects of low pulmonary C02 on panic anxiety. Compr Psychiatry 1988 Sep—Oct;29(5):490-7. Gurguis GN. Uhde TW. Effect of yohirnbine on plasma homovanillic acid in panic disorder patients and normal controls. Biol Psychiatry 1990 Aug 15; 28(4):292-6. Gurguis GN. Uhde TW. Plasma 3—methoxy—4- hydroxyphenylethylene glycol (MHPG) and growth hormone responses to yohirnbine in panic disorder patients and normal controls. Psychoneuroendocrinology l990;15(3):217-24. Heninger GR, Chamey DS. Monoamine receptor systems and anxiety disorders. Psychiatr Clin North Am 1988 Jun;11(2):309-26. Heninger GR. Chamey DS. Price LH. Noradrenergic and serotonergic receptor system function in panic disorder and depression. Acta Psychiatr Scand Suppl 1988;341:138-50. Hibbert G. Pilsbury D. Hyperventilation: is it a cause of panic attacks? Br J Psychiatry 1989 Dec;155: 805-9. Hickie I. Silove D. A family panics. Aust N Z J Psychiatry 1989 Sep;23(3):418-21. Holt PE. Andrews G. Provocation of panic: three elements of the panic reaction in four anxie disorders. Behav Res Ther 1989;27(3):253-61. Hopper IL, Judd FK. Derrick PL, Macaskill GT. Burrows GD. A family study of panic disorder. reanalysis using a regressive logistic model that incorporates a sibship environment. Genet Epidemiol l990;7(2):151~61. Hopper JL. Judd FK. Derrick PL. Burrows GD. A family study of panic disorder. Genet Epidemiol 1987;4(1):33-41. Humble M. Aetiology and mechanisms of anxiety disorders. Acta Psychiatr Scand Suppl 1987; 335:15-30. Judd FK. Burrows GD. Hay DA. Genetic aspects of panic disorder. Aust N Z J Psychiatry 1987; 21:197-210. Judd FK, Burrows GD. Hay DA. Panic disorder: evidence for genetic vulnerability. Aust N Z J Psychiatry 1987 Jun;21(2):l97-208. Kagan BL. A molecular mechanism of panic attacks. Specul Sci Technol 1989;12(3):199-208. Kahn JP, Gonnan JM. King DL. Fyer AJ. Liebowitz MR. Klein DF. Cardiac left ventricular hypertrophy and chamber dilatation in panic disorder patients: implications for idiopathic dilated cardiomyopathy. Psychiatry Res 1990 Apr,32(l): 55-61. Kahn RS, Asnis GM. Wetzler S. van Praag HM. Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorder. Psychopharmacology (Berlin) 1988;96(3):360-4. Kahn RS. Van Haag HM. A serotonin hypothesis of panic disorder. Hum Psychopharmacol 1988;3(4): 285-8. Kahn RS. Van Praag HM. Panic disorder: A presynaptic serotonin defect? Psychiatry Res 1990 Feb;31(2):209-10. Kahn RS, Wetzler S. van Praag HM, Asnis GM. Strauman T. Behavioral indications for serotonin receptor hypersensitivity in panic disorder. Psychiatry Res 1988 Jul;25(l):101—4. Katemdahl DA. Comparison of panic symptom sequences and pathophysiologic models. J Behav Ther Exp Psychiatry 1990 Jun;21(2):101-11. Kenardy J. Evans L. Oei TPS. Cognitions and heart rate in panic disorders during everyday activity. J Anxiety Disord 1989;3(1):33-43. Kenardy J. Oei Tian P. Ryan P, Evans L. Attribution of panic attacks: Patient perspective. J Anxiety Disord 1988;2(3):243-51. Kenardy J. Oei TP. Evans L. Hyperventilation and panic attacks. Aust N Z J Psychiatry 1990 Jun; 24(2):261-7. 23 Klein DF. Gonnan JM. A model of panic and agoraphobic development. Acta Psychiatr Scand Suppl 1987;335:87-95. Knott VJ. Neuroelectrical activity related to panic disorder. Prog Neuropsychopharmacol Biol Psychiatry 1990;14(5):697-707. Leckrnan JF, Weissman MM. Merikangas KR. Pauls .DL. Prusoff BA. Kidd KK. Major depression and panic disorder: a family study perspective. Psychopharrnacol Bull 1985;21(3):543-5. Lelliott P. Marks I. McNamee G, Tobe:na A. Onset of panic disorder with agoraphobia. Toward an integrated model. Arch Gen Psychiatry 1989 Nov; 46(11):1000-4. Leonard BE. Changes in biogenic amine neurotransmitters in panic disorder. Stress Med l990;6(4):267-74. Levinson HN. The cerebellar-vestibular predisposition to anxiety disorders. Percept Mot Skills 1989 Feb; 68(1):323-38. Ley R. Hyperventilation and lactate infusion in the production of panic attacks. Clin Psychol Rev 1988;8(1):1-18. Ley R. Panic attacks during relaxation and relaxation- induced anxiety: a hyperventilation interpretation. J Behav Ther Exp Psychiatry 1988 Dec;19(4):253-9. Ley R. Panic attacks during sleep: a hyperventilation- probability model. J Behav Ther Exp Psychiatry 1988 Sep;19(3):181-92. Ley R. Panic disorder and agoraphobia: fear of fear or fear of the symptoms produced by hyperventilation? J Behav Ther Exp Psychiatry 1987 Dec;l8(4): 305-16. Liberthson R, Sheehan DV. King ME, Weyman AB. The prevalence of mitral valve prolapse in patients with panic disorders. Am J Psychiatry 1986 Apr; 143(4):511—5. Liebowitz MR. Gorman JM. Fyer A. Dillon D. Levitt M. Klein DF. Possible mechanisms for lactate‘s induction of panic. Am J Psychiatry 1986 Apr; 143(4):495-502. Lilienfeld SO. Jacob RG. Furman JM. Vestibular dysfunction followed by panic disorder with agoraphobia. J Nerv Ment Dis 1989 Nov;177(1 1): 700-1. Lynch P. Bakal DA. Whitelaw W. Fung T. Chest muscle activity and panic anxiety: a preliminary investigation. Psychosom Med 1991 Jan-Feb; 53(1):80-9. 24 Marazziti D, Michelini S, Martini C, Giannaccini G. Lucacchini A. Cassano GB. Further investigation on benzodiazepine binding inhibitory activity in patients with major depression or panic disorder and in healthy volunteers. Neuropsychobiology 1989; 21(1):14-6. Margraf J, Ehlers A. Roth WT. Biological models of panic disorder and agoraphobia--a review. Behav Res Ther 1986;24(5):553-67. Martin NG, Jardine R, Andrews G, Heath AC. Anxiety disorders and neuroticism: are there genetic factors specific to panic? Acta Psychiatr Scand 1988 Jun; 77(6):698-706. Maser JD, Woods SW. The biological basis of panic: psychological interactions. Psychiatr Med 1990; 8(3):121-47. Matuzas W. Al-Sadir J . Uhlenhuth EH. Glass RM. Mitral valve prolapse and thyroid abnormalities in patients with panic attacks. Am J Psychiatry 1987 Apr;144(4):493-6. Matuzas W, Al—Sadir J, Uhlenhuth EH, Glass RM, Easton C. Correlates of mitral valve prolapse among patients with panic disorder. Psychiatry Res 1989 May;28(2):161-70. Mazza DL, Martin D, Spacavento L, Jacobsen J. Gibbs H. Prevalence of anxiety disorders in patients with rnitral valve prolapse. Am J Psychiatry 1986 Mar; 143(3):349-52. McIntyre IM. Judd FK, Burrows GD. Norman TR. Serotonin in panic disorder: platelet uptake and concentration. Int Clin Psychopharmacol 1989 Jan; 4(1):1-6. MIddleton HC. An enhanced hypotensive response to clonidine can still be found in panic patients despite psychological treatment. J Anxiety Disord 1990; 4(3):213~9. Mutchler K, Crowe RR, Noyes R Jr, Wesner RW. Exclusion of the tyrosine hydroxylase gene in 14 panic disorder pedigrees. Am J Psychiatry 1990 Oct;147(10):1367-9. Norman TR. Acevedo A, McIntyre IM, Judd FK, Burrows GD. A kinetic analysis of platelet monoamine oxidase activity in patients with panic attacks. J Affective Disord 1988 Sep-Oct;15(2): 127—30. Norman TR, Burrows GD, Judd. FK, McIntyre IM. Serotonin and panic disorders: a review of clinical studies. Int J Clin Pharmacol Res 1989;9(2):151-7. Norman TR, Gregory MS, Judd FK, Burrows GD, McIntyre IM. Platelet serotonin uptake in panic disorder: comparison with normal controls and the effect of treatment. Aust N Z J Psychiatry 1988 Dec;22(4):390-5. Norman TR. Judd FK, Burrows GD. McIntyre IM. Platelet serotonin uptake in panic disorder patients: a replication study. Psychiatry Res 1989 Oct;30(l): 63-8. Norman TR, Judd FK. Gregory M, James RH, Kimber NM, McIntyre IM. Burrows GD. Platelet serotonin uptake in panic disorder. J Affective Disord 1986 Jul-Aug;1 1(1):69-72. Norman TR, Judd FK, Staikos V. Burrows GD, McIntyre IM. High—affinity platelet [3H]LSD binding is decreased in panic disorder. J Affective Disord 1990 Jun;19(2):119-23. Norman TR. Sartor DM, Judd FK, Burrows GD, Gregory MS. McIntyre IM. Platelet serotonin uptake and 3H-imipramine binding in panic disorder. J Affective Disord 1989 Jul-Aug; 17(1):77-81. Nutt DJ. Altered central alpha 2-adrenoceptor sensitivity in panic disorder. Arch Gen Psychiatry 1989 Feb;46(2):165-9. Nutt DJ. Endocrine response to syncope in panic disorder. Psychiatry Res 1989 Jun;28(3):351-3. Nutt DJ. Increased central alpha 2—adrenoceptor sensitivity in panic disorder. Psychopharrnacology (Berlin) 1986;90(2):268-9. Nutt DJ. The pharmacology of human anxiety. Pharmacol Ther 1990;47(2):233—66. Nutt DJ, Fraser S. Platelet binding studies in panic disorder. J Affective Disord 1987 Jan-Feb;12(1): 7-11. Nutt DJ, Glue P, Lawson C. Wilson S. Flumazenil provocation of panic attacks. Evidence for altered benzodiazepine receptor sensitivity in panic disorder. Arch Gen Psychiatry 1990 Oct;47(10):917-25. Pauli P, Marquardt C, Hart] L, Nutzinger DO, H:olzl R, Strian F. Anxiety induced by cardiac perceptions in patients with panic attacks: a field study. Behav Res Ther 1991;29(2):137—45. Pohl R, Ettedgui E, Bridges M, Lycaki H, Jimerson D, Kopin I, Rainey JM. Plasma MHPG levels in lactate and isoproterenol anxiety states. Biol Psychiatry 1987 Sep;22(9):1127-36. Pols H, Griez E. Serotonin in panic anxiety. Acta Psychiatr Belg 1988 Mar-Apr;88(2):162-72. Price RA. Kidd KK, Weissman MM. Early onset (under age 30 years) and panic disorder as markers for etiologic homogeneity in major depression. Arch Gen Psychiatry 1987 May;44(5):434—40. Rachman S. Levitt K, Lopatka C. Panic: the links between cognitions and bodily symptoms-J. Behav Res Ther 1987;25(5):411-23. Rainey JM Jr. Nesse RM. Psychobiology of anxiety and anxiety disorders. Psychiatr Clin North Am 1985 Mar;8(l):l33-44. Rapaport MH, Risch SC. Golshan S, Gillin JC. Neuroendocrine effects of ovine corticotropin- releasing hormone in panic disorder patients. Biol Psychiatry 1989 Aug;26(4):344-8. Rapee RM. Litwin EM. Barlow DH. Impact of life events on subjects with panic disorder and on comparison subjects. Am J Psychiatry 1990 May; 147(5):640-4. Rapee R, Mattick R, Murrell E. Cognitive mediation in the affective component of spontaneous panic attacks. J Behav Ther Exp Psychiatry 1986 Dec; l7(4):245-53. Reiman EM, Raichle ME. Robins E, Butler FK. Herscovitch P, Fox P, Perlmutter J. The application of positron emission tomography to the study of panic disorder. Am J Psychiatry 1986 Apr; 143(4):469-77. Reiss S. Expectancy model of fear, anxiety. and panic. Clin Psychol Rev l991;11(2):14l-53. Rosenbaum IF. A psychopharmacologist’s perspective on panic disorder. Bull Menninger Clin 1990 Spring;54(2):l84-98. Rosenbaurn JF. Biederman J, Gersten M, Hirshfeld DR. Meminger SR, Herman JB, Kagan J, Reznick JS. Snidman N. Behavioral inhibition in children of parents with panic disorder and agoraphobia. A controlled study. Arch Gen Psychiatry 1988 May; 45(5):463-70. Rosenbaurn JF. Biederman I. Hirshfeld DR. Bolduc EA. Faraone SV. Kagan J. Snidman N, Remick 18. Further evidence of an association between behavioral inhibition and anxiety disorders: results from a family study of children from a non—clinical sample. J Psychiatr Res l991;25(1-2):49-65. Roth M. Some recent developments in relation to agoraphobia and related disorders and their bearing upon theories of their causation. First Gerald J. Sarwer-Foner Clinical Symposium: Current trends in psychiatry (1986. Ottawa, Canada). Psychiatr I Univ Ottawa 1987 Sep;12(3):150-5. 25 Roy-Byme P, Geraci M. Uhde TW. Life events obtained via interview: the effect of time of recall on data obtained in controls and patients with panic disorder. J Affective Disord 1987 Ian-Feb;12(1): 57-62. Roy-Byme PP. Geraci M. Uhde TW. Life events and course of illness in patients with panic disorder. Am J Psychiatry 1986 Aug;l43(8):1033-5. Roy-Byme PP. Geraci M, Uhde TW. Life events and the onset of panic disorder. Am J Psychiatry 1986 Nov; 143(1 1): 1424-7. Roy-Byme PP. Uhde TW. Exogenous factors in panic disorder: clinical and research implications. J Clin Psychiatry 1988 Feb;49(2):56-61. Salkovskis PM. The importance of behaviour in the maintenance of anxiety and panic: A cognitive account. Behav Psychother 1991;l9(1):6-19. Salkovskis PM, Clark DM. Affective responses to hyperventilation: a test of the cognitive model of panic. Behav Res Ther 1990;28(l):51-61. Sanderson WC. Beck AT. Classical conditioning model of panic disorder: response to Wolpe and Rowan. Behav Res Ther 1989;27(5):58l-4. Sanderson WC. Rapee RM. Barlow DH. The influence of an illusion of control on panic attacks induced via inhalation of 5.5% carbon dioxide-enriched air. Arch Gen Psychiatry 1989 Feb;46(2):157-62. Sevin BH. Mitral valve prolapse, panic states, and anxiety. A dilemma in perspective. Psychiatr Clin North Am 1987 Mar;10(l):l41-50. Shean GD. Interpersonal aspects of agoraphobia: Therapeutic implications. 96th Annual Convention of the American Psychological Association: The Adopted Child Syndrome: What therapists should know (1988. Atlanta, Georgia). Psychother Priv Pract 1990;8(3):101-22. Shear MK. Pathophysiology of panic: a review of pharmacologic provocative tests and naturalistic monitoring data. J Clin Psychiatry 1986 Jun;47 Suppl:18-26. Silove D. Severe threat in the genesis of panic disorder. Aust N Z J Psychiatry 1987 Dec; 21(4):59l-600. Smeraldi E. Orsini A. Gasperini M, Sciuto G. Battaglia M. Cassano GB. Perugi G, Migani W. Faravelli C. Pallanti S, Bressa G. Familial analysis of panic disorder and agoraphobia. J Affect Disord 1989; l7(1):1-8. 26 Starkman MN. Cameron 0G. Nesse RM. Zelnik T. Peripheral eatecholarnine levels and the symptoms of anxiety: studies in patients with and without pheochromocytoma. Psychosom Med 1990 Mar- Apr;52(2):129-42. Stein MB. Uhde TW. Cortisol response to clonidine in panic disorder: comparison with depressed patients and normal controls. Biol Psychiatry 1988 Jul; 24(3):322-30. Stein MB. Uhde TW. Infrequent occurrence of EEG abnormalities in panic disorder. Am J Psychiau'y 1989 Apr. l46(4):517-20. Targum SD. Marshall LE. Fenfluramine provocation of anxiety in patients with panic disorder. Psychiatry Res 1989 Jun;28(3): 295-306. Teicher MH. Biology of anxiety. Med Clin North Am 1988 Jul;72(4):791-814. Telch MJ. Brouillard M. Telch CF. Agras WS. Taylor CB. Role of cognitive appraisal in panic-related avoidance. Behav Res Ther 1989;27(4):373-83. Thyer BA. Hirnle J. Fischer D. Is parental death a selective precursor to either panic disorder or agoraphobia? A test of the separation anxiety hypothesis. J Anxiety Disord 1988;2(4):333-8. Thyer BA, Nesse RM, Curtis GC. Cameron 00. Case histories and shorter communications. Panic disorder: A test of the separation anxiety hypothesis. Behav Res Ther 1986;24(2):209-11. Torgersen S. Childhood and family characteristics in panic and generalized anxiety disorders. Am J Psychiatry 1986 May;143(5):630-2. Torgersen S. Comorbidity of major depression and anxiety disorders in twin pairs. Am J Psychiatry 1990 Sep;l47(9):ll99—202. Tweed JL. Schoenbach VJ. George LK, Blazer DG. The effects of childhood parental death and divorce on six-month history of anxiety disorders. Br J Psychiatry 1989 Jun;154:823-8. van den Hout MA. van der Molen GM. Griez E, Lousberg H. Nansen A. Reduction of COZ-induced anxiety in patients with panic attacks after repeated C02 exposure. Am J Psychiatry 1987 Jun; 144(6): 788-91. van der Molen GM, van den Hout MA. van Dieren AC. Griez E. Childhood separation anxiety and adult- onset panic disorders. J Anxiety Disord 1989; 3(2):97-106. Vitaliano PP. Katon W. Russo J. Maiuro RD. Anderson K, Jones M. Coping as an index of illness behavior in panic disorder. J Nerv Ment Dis 1987 Feb:l75(2):78-84. Wall M. Tuchman M. Mielke D. Panic attacks and temporal lobe seizures associated with a right temporal lobe arteriovenous malformation: case report. J Clin Psychiatry 1985 Apr;46(4):143-5. Warren R. Zgourides G. Englert M. Relationships between catastrophic cognitions and body sensations in anxiety disordered. mixed diagnosis. and normal subjects. Behav Res Ther 1990;28(4):355-7. Warren R. Zgourides G, Jones A. Cognitive bias and irrational belief as predictors of avoidance. Behav Res Ther 1989;27(2):181-8. Watkins PL. Clum GA. Borden JW. Broyles S. Hayes J. Imagery-induced arousal in individuals with panic disorder. Cogn Ther Res 1990;14(1):37-46. Weilburg JB. Bear DM, Sachs G. Three patients with concomitant panic attacks and seizure disorder: possible clues to the neurology of anxiety. Am J Psychiatry 1987 Aug;144(8):1053-6. Westenberg HG. den Boer JA. Serotonin function in panic disorder: effect of l-S-hydroxytryptophan in patients and controls. Psychopharmacology (Berlin) 1989;98(2):283-5. Wolpe J. Rowan VC. Classical conditioning and panic disorder: Reply to Sanderson and Beck. Behav Res Ther 1989;27(5):5834. Wolpe J. Rowan VC. Panic disorder: A product of classical conditioning. Behav Res Ther 1988; 26(6):441-50. Woods SW. Charney DS. Silver JM, Krystal JH. Heninger GR. Behavioral. biochemical. and cardiovascular responses to the benzodiazepine receptor antagonist flumazenil in panic disorder. Psychiatry Res 1991 Feb;36(2):115-27. Yeragani VK, Meir-i PC. Balon R. Patel H. Pohl R. History of separation anxiety in patients with panic disorder and depression and normal controls. Acta Psychiatr Scand 1989 Jun;79(6):550-6. Yeragani VK. Rainey JM, Pohl R. Ortiz A. Weinberg P. Gershon S. Thyroid hormone levels in panic disorder. Can J Psychiatry 1987 Aug;32(6):467-9. Zandbergen J. Lousberg HH. Pols H. de Loof C, Griez EJ. Hypercarbia versus hypocarbia in panic disorder. J Affective Disord 1990 Feb;18(2):75-81. Zandbergen J, Pols H. De Loof C. Lousberg H. Griez E. Effect of hypercapnia and other disturbances in the acid-base-balance on panic disorder. Hillside J Clin Psychiatry 1989;11(2):185-97. Zeanah CH. Atypical panic attacks and lack of resolution of mounting. Gen Hosp Psychiatry 1988 Sep;10(5):373-7. Zucker D, Taylor CB, Brouillard M, Ehlers A. Margraf J. Telch M. Roth WT, Agras WS. Cognitive aspects of panic attacks. Content, course and relationship to laboratory stressors. Br J Psychiatry 1989 Jul;155:86-91. 27 PRIMARY CARE, FAMILY PRACTICE, AND SERVICES Anixter WL. Panic disorder and agoraphobia. An update for primary care physicians. N C Med J 1988 Oct;49(10):507-11. Aronson TA, Craig TJ. Thomason SI Logue C. Health care utilization patterns in panic disorder and agoraphobia: A naturalistic study in secondary prevention. J Anxiety Disord 1987;1(4):283-93. Ballenger JC. Unrecognized prevalence of panic disorder in primary care. internal medicine and cardiology. Am J Cardiol 1987 Dec 28;60(l8): 391-471 . Bernstein JA. Sheridan E. Patterson R. Asthmatic patients with panic disorders: report of three cases with management and outcome. Ann Allergy 1991 Apr;66(4):311-4. Boyd 11-]. Use of mental health services for the treatment of panic disorder. Am J Psychiatry 1986 Dec;143(12):1569-74. Braverman BG. Calming a patient with panic disorder. Nursing 1990 Jan;20(1):32C, 32F. Drug treatment of panic disorder: Discussion III. Hosp Pract 1990;25 Suppl 2:40-2. Edlund MJ. Swarm AC. The economic and social costs of panic disorder. Hosp Community Psychiatry 1987 Dec;38(12):1277-9. 1288. Enright MF. Blue BA. Collaborative treatment of panic disorders by psychologists and family physicians. Psychother Priv Pract 1989;7(2):85-90. Ferentz KS. Panic disorder and agoraphobia. Nondrug treatment options for primary care physicians. Postgrad Med 1990 Aug;88(2):185-92. Giesecke ME. Panic disorder in university students: A review. J Am Coll Health 1987;36(3):149-57. Hudson CJ. Anxiety disorders and substance abuse. Special Issue: Managing the dually diagnosed patient: Current issues and clinical approaches. J Chem Depend Treat 1990;3(2):119-38. Katemdahl DA. Factors associated with persons with panic attacks seeking medical care. Fam Med 1990 Nov-Dec;22(6):4626. Katerndahl DA. Panic disorder in primary care settings: research agenda for the '90s [editorial]. Fam Pract Res J 1991 Mar;ll(l):3-7. 28 Katemdahl DA. Patients’ willingness to discuss phobic avoidance symptoms. Fam Pract Res J 1991 Mar; 11(1):91-7. Linnoila MI. Approaches to the treatment of alcoholism and anxiety. Drug ther 1990;20 Supplz27-34. Marshall JR. Diagnosis and management of panic disorder in the emergency department. Emerg Care Q 1991;7(1):1-8. Muskin PR. Panics. prolapse. and PVCs. Gen Hosp Psychiatry 1985 Jul;7(3):219-23. Pollard CA. Lewis LM. Managing panic attacks in emergency patients. J Emerg Med 1989 Sep-Oct; 7(5):547-52. Pollard CA, Obermeier HJ. Cox GL. Inpatient treatment of complicated agoraphobia and panic disorder. Hosp Community Psychiatry 1987 Sep; 38(9):951-8. Raj A. Sheehan DV. Medical evaluation of panic attacks. J Clin Psychiatry 1987 Aug;48(8):309—l3. Rifkin A. Solving panic disorder problems. When your patients' fears thwart their lives. Postgrad Med 1990 Nov l;88(6):133-8. Rosenbaum JF. Drug treatment of panic disorder. Hosp Pract [Off] 1990 Jun;25 Suppl 2:31-9; discussion 40-2. Ross CA, Walker IR. Norton GR, Neufeld K. Management of anxiety and panic attacks in immediate care facilities. Gen Hosp Psychiatry 1988 Mar;10(2)1129-31. Roundtable discussion: "Panic disorder: Epidemiology, diagnosis, and treatment in primary care." Symposium: New directions in biological psychiatry (1986. Coronado. California). J Clin Psychiatry 1986 Oct;47 Suppl:28-30. Schatzberg AF. Ballenger JC. Decisions for the clinician in the treatment of panic disorder: when to treat, which treatment to use, and how long to treat. J Clin Psychiatry 1991 Feb;52 Supplz26-3l; discussion 32. Shear MK, Frances A]. Clinical presentation and evaluation. Psychiatr Ann 1988 Aug;18(8):448-S6. Shelton RC. Diagnosis and management of panic disorder. Compr Ther 1990 Dec;16(12):11-7. Tobe EH. Pitfalls in the management of panic disorder. J Am Osteopath Assoc 1988;88(4):507-9. Wood WG. The diagnosis and management of panic disorder. Psychiatr Med 1990;8(3):197-209. Wulsin LR. Hillard JR. Geier P. Hissa D, Rouan GW. Screening emergency room patients with atypical chest pain for depression and panic disorder. Int J Psychiatry Med 1988;18(4):315-23. TREATMENTS: Pharmacological - Tricyclic Antidepressants Albus M. becrubier Y. Maier W. Buller R. Rosenberg R. Hippius H. Drug treatment of panic disorder: early response to treatment as a predictor of final outcome. Acta Psychiatr Scand 1990 Nov;82(5): 359-65. Albus M, Maier W, Shera D. Bech P. Consistencies and discrepancies in self- and observer-rated anxiety scales. A comparison between the self- and observer-rated Marks-Sheehan scales. Eur Arch Psychiatry Clin Neurosci 1990;240(2):96-102. Andersch S. Rosenberg NK. Kullingsjo H. Ottosson J-O. Bech P. Bruun-Hansen J. Hanson L. Lorentzen K. Mellergard M. Rasmussen S. Rosenberg R. Efficacy and safety of alprazolam. irnipramine and placebo in treating panic disorder. A Scandinavian multicenter study. Acta Psychiatr Scand Suppl 1991;83(365):18-27. Aronson TA. A naturalistic study of irnipramine in panic disorder and agoraphobia. Am J Psychiatry 1987 Aug;144(8):1014-9. Aronson TA. Treatment-emergent depression with antidepressants in panic disorder. Compr Psychiatry 1989 May-Jun;30(3):267-71. Austin LS. Lydiard RB. Fossey MD. Zealberg JJ. Laraia MT. Ballenger JC. Panic and phobic disorders in patients with obsessive compulsive disorder. J Clin Psychiatry 1990 Nov;51(ll):456-8. Balestrieri M. Ruggeri M. Bellantuono C. Drug treatment of panic disorder--a critical review of controlled clinical trials. Psychiatr Dev 1989 Winter;7(4):337-50. Ballenger JC. Pharmacotherapy of the panic disorders. J Clin Psychiatry 1986 Jun;47 Supplz27-32. Beardslee SL. Papadakis E. Fontana DJ. Commissaris RL. Antipanic drug treatments: failure to exhibit anxiolytic-like effects on defensive burying behavior. Pharmacol Biochem Behav 1990 Feb; 35(2):451-5. Brady KT. Zarzar M. Lydiard RB. Fluoxetine in panic disorder patients with imipramine-associated weight gain. J Clin Psychopharmacol 1989 Feb;9(1):66-7. Buller R, Maier W. Goldenberg 1M. Lavori PW, Benkert O. Chronology of panic and avoidance. age of onset in panic disorder. and prediction of treatment 29 response. A report from the Cross-National Collaborative Panic Study. Eur Arch Psychiatry Clin Neurosci 1991;240(3):163-8. Burrows GD. Managing long-term therapy for panic disorder. J Clin Psychiatry 1990 Nov;51 Suppl: 9-12. Cassano GB. Petracca A. Perugi G. Nisita C. Musetti L. Mengali F, McNair DM. Clomiprarnine for panic disorder: I. The first 10 weeks of a long-term comparison with imipramine. J Affective Disord 1988 Mar-Apr;l4(2):123-7. Chamey DS. Heninger GR. Noradrenergic function and the mechanism of action of antianxiety treatment. II. The effect of long-term imipramine treatment. Arch Gen Psychiatry 1985 May;42(5): 473-81. Charney DS. Woods SW. Goodman WK. Riflrin B. Kinch M. Aiken B. Quadrino 1M. Heninger GR. Drug treatment of panic disorder: the comparative efficacy of irniprarnine. alprazolam. and trazodone. J Clin Psychiatry 1986 Dec;47(12):580-6. Clark DB. Taylor CB. Roth WT, Hayward C. Ehlers A. Margraf J. Agras WS. Surreptitious drug use by patients in a panic disorder study. Am J Psychiatry 1990 Apr;l47(4):507-9. Cox BJ. Swinson RP. Endler NS. A review of the psychopharmacology of panic disorder: Individual differences and non specific factors. Can J Psychiatry 1991 ;36(2):130-8. Crowe RR. Noyes R Jr. Panic disorder and agoraphobia. Dis Mon 1986 Jul;32(7):389—444. Davis DM. Update on the treatment of panic attacks. J Med Assoc Ga 1988 Nov;77(ll):831-2. Deltito IA. Argyle N. Klerman GL. Patients with panic disorder unaccompanied by depression improve with alprazolam and imipramine treatment. J Clin Psychiatry 1991 Mar;52(3):121-7. Deltito JA. Argyle N, Bullet R. Nutzinger D. Ottosson JO. Brandon S, Mellergard M, Shera D. The sequence of improvement of the symptoms encountered in patients with panic disorder. Compr Psychiatry 1991 Mar-Apr;32(2):120-9. Den Boer IA. Westenberg HG. Effect of a serotonin and noradrenaline uptake inhibitor in panic disorder; a double-blind comparative study with fluvoxamine and maprotiline. Int Clin Psychopharmacol 1988 Jan;3(l):59—74. 30 Den Boer JA, Westenberg HG, Kamerbeek WD, Verhoeven WM, Kahn RS. Effect of serotonin uptake inhibitors in anxiety disorders; a double-blind comparison of clomipramine and fluvoxamine. Int Clin Psychopharmacol 1987 Jan;2(l):21-32. Dilsaver SC. Panic disorder. Am Fam Physician 1989 Jun;39(6):167-72. Eriksson E, Westberg P, Ailing C, Thuresson K. Modigh K. Cerebrospinal fluid levels of monoamine metabolites in panic disorder. Psychiatry Res 1991;36(3):243-51. Eriksson E, Westberg P. Thuresson K, Modigh K, Ekman R, Widerl:ov E. Increased cerebrospinai fluid levels of endorphin immunoreactivity in panic disorder. Neuropsychopharmacology 1989 Sep; 2(3):225-8. Faiudi G. Kecskemety P. Melipramine treatment of panic disease. Ther Hung 1987;35(3):129-35. Fava GA, Grandi S, Saviotti FM, Conti S. Hypochondriasis with panic attacks. Psychosomatics 1990 Summer;3l(3):351—3. Fava M, Anderson K, Rosenbaum IF. "Anger attacks": possible variants of panic and major depressive disorders. Am J Psychiatry 1990 Jul;147(7):867-70. Fishman SM, Sheehan DV, Carr DB. Thyroid indices in panic disorder. J Clin Psychiatry 1985 Oct; 46(10):432-3. Fontana DJ, Carbary TJ, Commissaris RL. Effects of acute and chronic anti-panic drug administration on conflict behavior in the rat. Psychopharmacology (Berlin) 1989;98(2):157-62. Fontana DJ, Commissaris RL. Effects of acute and chronic irniprarnine administration on conflict behavior in the rat: a potential "animal model" for the study of panic disorder? Psychopharmacology (Berlin) 1988;95(2):147-50. Friedman S, Sunderland GS, Rosenblum LA. A nonhuman primate model of panic disorder. Psychiatry Res 1988 Jan;23(1):65-75. Fyer AJ. Agoraphobia. Mod Prob] Pharmacopsychiatry 1987;22:91-126. Fyer AJ. Liebowitz MR, Gorman JM, Davies SO, Klein DF. Lactate vulnerability of remitted panic patients. Psychiatry Res 1985 Feb;14(2):l43-8. George DT. Anderson P. Nutt DJ, Linnoila M. Aggressive thoughts and behavior: another symptom of panic disorder? Acta Psychiatr Scand 1989 May; 79(5):500-2. Giesecke ME. Panic disorder in university students: A review. J Am Coll Health 1987;36(3):149-57. Gold DD Jr. Management of panic disorder: Case reports support a potential role for amoxapine. Hosp Formul 1990;25(11):1178-79. 1182—4. Gold DD Jr. Panic Attacks: Diagnosis and management. Cardiovasc Rev Rep 1988;9(1):35-7, 40. Goodman WK. Chamey DS. Therapeutic applications and mechanisms of action of monoamine oxidase inhibitor and heterocyclic antidepressant drugs. J Clin Psychiatry 1985 Oct;46(10 Pt 2):6-24. Gorman JM, Liebowitz MR, Dillon D. Fyer A], Cohen BS, Klein DF. Antipanic drug effects during lactate infusion in lactate-refractory panic patients. Psychiatry Res 1987 Jul;21(3):205-12. Green MA, Curtis GC. Personality disorders in panic patients: Response to termination of antipanic medication. J Pers Disord 1988;2(4):303-14. Grunhaus L, Harel Y, Krugler T, Pande AC, Haskett RF. Major depressive disorder and panic disorder. Effects of comorbidity on treatment outcome with antidepressant medications. Clin Neuropharmacol 1988 0ct;11(5):454-61. Grunhaus L, Rabin D, Greden IF. Simultaneous panic and depressive disorder: response to antidepressant treatments. J Clin Psychiatry 1986 Jan;47(1):4-7. Heninger GR, Chamey DS, Price LH. Noradrenergic and serotonergic receptor system function in panic disorder and depression. Acta Psychiatr Scand Suppl 1988;341:138-50. Hudson JI, Pope HG Jr. Affective spectrum disorder: does antidepressant response identify a family of disorders with a common pathophysiology? Am J Psychiatry 1990 May;l47(5):552-64. Jann MW. Kunz NM. Treatment of panic and phobic disorders. Clin Pharm 1987 Dec;6(12):947-62. Judd FK, Burrows GD, Marriott PF, Fambach P, Blair- West S, Normal TR. A short-term open trial of clomipramine in the treatment of patients with panic attacks. Hum Psychopharmacol 1991;6(1):53-60. Judd FK, Norman TR, Burrows GD. Pharmacological treatment of panic disorder. Int Clin Psychopharmacol 1986 Jan;1(1):3-16. Judd FK, Norman TR, Burrows GD. Pharmacotherapy of panic disorder. Int Rev Psychiatry 1990; 2(3-4):399—409. Kalus 0. Asnis GM. Rubinson E. Kalm R, Harkavy Friedman JM. Iqbal N, Grosz D. Van Praag H. Cahn W. Desiprarnine treatment in panic disorder. J Affect Disord l991;21(4):239—44. Katon W. Panic disorder: epidemiology. diagnosis, and treatment in primary care. J Clin Psychiatry 1986 0ct;47 Suppl:21-30. Katon W. Vitaliano PP. Russo J. Corrnier L, Anderson K. Jones M. Panic disorder: epidemiology in primary care. J Fam Pract 1986 Sep;23(3):233-9. King D, Nicolini H. de la Fuente JR. Abuse and withdrawal of panic treatment drugs. Psychiatr Ann 1990 Sep;20(9):525-8. Klein DF. Psychopharmacologic treatment of panic disorder. Psychosomatics 1984:2500 Suppl):32-6. Klein DF, Gar-man JM. A model of panic and agoraphobic development. Acta Psychiatr Scand Suppl 1987;335:87-95. Klein DF. Klein HM. The status of panic disorder. Curr Opin Psychiatry 1988;1(2):177-83. Klerman GL. Depression and panic anxiety: the effect of depressive co—morbidity on response to drug treatment of patients with panic disorder and agoraphobia. J Psychiatr Res 1990;24 Suppl 2: 27-41. Klerman GL. Overview of the Cross—National Collaborative Panic Study. Arch Gen Psychiatry 1988 May;45(5):407-12. Kupfer DJ. Lessons to be learned from long-term treatment of affective disorders: potential utility in panic disorder. J Clin Psychiatry 1991 Feb;52 Suppl:12-6; discussion 17. Lepola U. Recognition of panic disorder. Nord Psykiatr Tidsskr 1989;43(6):511-3. Lepola U. Heikkinen H. Rimon R, Riekkinen P. Clinical evaluation of alprazolam in patients with panic disorder: A double-blind comparison with irnipramine. Hum Psychopharmacol 1990;5(2): 159-63. Lepola U. Jolkkonen J. Rim:on R, Riekkinen P. Long- term effects of alprazolam and imipramine on cerebrospinal fluid monoamine metabolites and neuropeptides in panic disorder. Neuropsychobiology 1989;21(4):182-6. Liebowitz MR. Antidepressants in panic disorders. Br J Psychiatry Suppl 1989 Oct;(6):46-52. 31 Liebowitz MR. Imipramine in the treatment of panic disorder and its complications. Psychiatr Clin North Am 1985 Mar;8(1):37-47. Liebowitz MR. Tricyclic antidepressants and monoamine oxidase inhibitors in the treatment of panic disorder: brief review. Psychopharmacol Bull 1989;25(1):17-20. Liebowitz MR. Fyer AJ. Gorman JM. Carnpeas RB. Sandberg DP. Hollander E. Papp LA. Klein DF. Tricyclic therapy of the DSM-III anxiety disorders: a review with implications for further research. J Psychiatr Res 1988;22 Suppl 1:7-31. Lingjaerde 0. Lactate—induced panic attacks: possible involvement of serotonin reuptake stimulation. Acta Psychiatr Scand 1985 Aug;72(2):206-8. Linnoila MI. Anxiety and alcoholism. J Clin Psychiatry 1989 Nov;50 Supplz26-9. Lydiard RB. Preliminary results of an open. fixed-dose study of desipramine in panic disorder. Psychopharmacol Bull 1987;23(1):139-40. Lydiard RB. Ballenger JC. Antidepressants in panic disorder and agoraphobia. J Affective Disord 1987 Sep-Oct;13(2):153-68. Lydiard RB. Ballenger JC. Panic-related disorders: Evidence for efficacy of the antidepressants. Special Issue: Perspectives on panic-related disorders. J Anxiety Disord 1988;2(1):77o94. Lydiard RB. Laraia MT. Ballenger JC. Howell EF. Emergence of depressive symptoms in patients receiving alprazolam for panic disorder. Am J Psychiatry 1987 May;l44(5):664-5. Lydiard RB, Roy-Byme PP. Ballenger JC. Recent advances in the psychopharmacological treatment of anxiety disorders. Hosp Community Psychiatry 1988 Nov;39(11):1157-65. Margraf J. Ehlers A. Roth WT. Clark DB, Sheikh J. Agras WS, Taylor CB. How "blind" are double- blind studies? J Consult Clin Psychol 1991 Feb; 59(1):184-7. Mattick RP. Andrews G. Hadzi-Pavlovic D. Christensen H. Treatment of panic and agoraphobia. An integrative review. J Nerv Ment Dis 1990 Sep; 178(9):567-76. Mavissakalian M. Differential effects of irnipramine and behavior therapy on panic disorder with agoraphobia. Psychopharmacol Bull 1989;25(1): 27-9. 32 Mavissakalian M. Sequential combination of imipramine and self-directed exposure in the treatment of panic disorder with agoraphobia. J Clin Psychiatry 1990 May;51(5):184-8. Mavissakalian MR. Perel JM. Imipramine dose- response relationship in panic disorder with agoraphobia. Preliminary findings. Arch Gen Psychiatry 1989 Feb;46(2):127-31. McTavish D, Benfield P. Clomipramine. An overview of its pharmacological properties and a review of its therapeutic use in obsessive compulsive disorder and panic disorder. Drugs 1990 Jan;39(1):136-53. Mellergard M. Lorentzen K, Bech P, Ottosson J-O, Rosenberg R. A trend analysis of changes during treatment of panic disorder with alprazolam and imipramine. Acta Psychiatr Scand Suppl 1991; 83(365):28-32. Mellergard M. Rosenberg NK. Patterns of response during placebo treatment of panic disorder. Acta Psychiatr Scand 1990 Apr;81(4):340—4. Mellman TA. Uhde TW. Patients with frequent sleep panic: clinical findings and response to medication treatment. J Clin Psychiatry 1990 Dec;51(12): 513-6. Middleton HC, Nutt DJ. Heart rate response to standing as an index of adaptation to imipramine during treatment of panic disorder. Hum Psychopharmacol 1988;3(3):191-4. Modigh K. Antidepressant drugs in anxiety disorders. Acta Psychiatr Scand Suppl 1987;335:57-74. Modigh K. Eriksson Elias, Lisjo P. Westburg P. Follow—up study of clorimipramine in the treatment of panic disorder. Proceedings of the World Psychiatric Association on the Psychopathology of Panic Disorders: Many faces of panic disorder (1988. Fspoo. Finland). Psychiatr Fenn 1989; Suppl:145-53. Munjack DJ. Reba] R, Shaner R, et a1. Imipramine versus propranolol for the treatment of panic attacks: A pilot study. Compr Psychiatry 1985;26(1):80-9. Munjack DJ, Usigli R. Zulueta A. Crocker B, Adatia N, Buckwalter JG, Baltazar P. Kurvink W, Inglove H, Kelly R, et al. Nortriptyline in the treatment of panic disorder and agoraphobia with panic attacks. J Clin Psychopharmacol 1988 Jun;8(3):204-7. Murphy DL, Pigott TA. A comparative examination of a role for serotonin in obsessive compulsive disorder, panic disorder. and anxiety. J Clin Psychiatry 1990 Apr;51 Suppl:53-8; discussion 59-60. Murphy DL, Siever LI, Insel TR. Therapeutic responses to tricyclic antidepressants and related drugs in non-affective disorder patient populations. Prog Neuropsychopharmacol Biol Psychiatry 1985; 9(1):3-13. Muskin PR. Panics, prolapse, and PVCs. Gen Hosp Psychiatry 1985 Ju1;7(3):219-23. Noyes R Jr. Garvey M], Cook BL. Follow—up study of patients with panic disorder and agoraphobia with panic attacks treated with tricyclic antidepressants. J Affective Disord 1989 Mar-Jun;16(2-3):249-57. Noyes R Jr. Garvey M], Cook BL, Samuelson L. Problems with tricyclic antidepressant use in patients with panic disorder or agoraphobia: results of a naturalistic follow-up study. J Clin Psychiatry 1989 May;50(5):163-9. Noyes R Jr. Perry P. Maintenance treatment with antidepressants in panic disorder. J Clin Psychiatry 1990 Dec;51 Suppl A:24-30. Nutt DJ, Glue P. Imipramine in panic disorder. 1. Clinical response and pharmacological changes. I Psychopharmacol 1991;5(1):56-64. Nutt DJ . Glue P. Irritability in panic disorder: Effects of imipramine treatment. Hum Psychopharmacol 1991;6(1):49-52. O'Boyle M. Panic disorder: diagnosis and treatment. Tex Med 1989 Aug;85(8):46—9. Otakpor AN. A prospective study of panic disorder in a Nigerian psychiatric out-patient population. Acta Psychiatr Scand 1987 Nov;76(5):541-4. Overall JE, Sheehan DV. Multivariate analysis of changes in panic frequency counts. Clin Neuropharmacol l986;9 Suppl 42155-7. Pecknold JC. Behavioural and combined therapy in panic states. Prog Neuropsychophannacol Biol Psychiatry l987;11(2-3):97-104. Philipp M, Maier W, Bullet R. Pharmacotherapy of panic attacks. Pharmacopsychiatry 1988 Nov; 21(6):281-2. Pohl R. Balon R, Yeragani VK, Gershon S. Serotonergic anxiolytics in the treatment of panic disorder: a controlled study with buspirone. Psychopathology 1989;22 Suppl 1:60-7. Pohl R, Yeragani VK. Balon R. Effects of isoproterenol in panic disorder patients after antidepressant treatment. Biol Psychiatry 1990 Aug 1;28(3):203-14. Pohl R. Yeragani VK. Balon R. Lycaki H. The jitteriness syndrome in panic disorder patients treated with antidepressants. J Clin Psychiatry 1988 Mar;49(3):100-4. Pohl R. Yeragani VK, Ortiz A, Rainey JM Jr, Gershon S. Response of tricyclic-induced jitteriness to a phenothiazine in two patients. J Clin Psychiatry 1986 Aug;47(8):427. Rickels K. Antianxiety therapy: potential value of long-term treatment. J Clin Psychiatry 1987 Dec;48 Supplz7-1 1 . Rickels K. Case WG. Downing RW. Fridman R. One- year follow-up of anxious patients treated with diazepam. J Clin Psychopharmacol 1986;6(1):32-6. Ritkin A. Siris SG. Panic disorder: response to sodium lactate and treatment with antidepressants. Prog Neuropsychopharmacol Biol Psychiatry 1985;9(1): 33-8. Rizley R, Kahn RJ. McNair DM, Frankenthaler LM. A comparison of alprazolam and irniprarnine in the treatment of agoraphobia and panic disorder. Psychopharmacol Bull 1986;22(1):167-72. Rosenberg R. Bech P. Mellergard M. Ottosson J-O. Alprazolam, irniprarnine and placebo treatment of panic disorder: Predicting therapeutic response. Acta Psychiatr Scand Suppl 1991;83(365):46~52. Rosenberg R, Bech P, Mellergard M. Ottosson J-O. Secondary depression in panic disorder: An indicator of severity with a weak effect on outcome in alprazolam and imipramine treatment. Acta Psychiatr Scand Suppl 1991;83(365):39-45. Rosenberg NK, Mellergard M, Rosenberg R. Beck P, Ottosson J-O. Characteristics of panic disorder patients responding to placebo. Acta Psychiatr Scand Suppl 1991;83(365):33-8. Sargent M. Panic disorder. Hosp Community Psychiatry 1990 Jun;41(6):621-3. Schatzberg AF. Ballenger JC. Decisions for the clinician in the treatment of panic disorder: when to treat. which treatment to use. and how long to treat. J Clin Psychiatry 1991 Feb;52 Supp1:26-31; discussion 32. Schifano F. Magni G. Panic attacks and major depression after discontinuation of long-term diazepam abuse. DICP 1989 Dec;23(12):989-90. Schittecatte M. Charles G. Depauw Y. Mesters P, Wilrnotte J. Growth hormone response to clonidine in panic disorder patients. Psychiatry Res 1988 Feb;23(2):147-51. 33 Schneier FR. Liebowitz MR. Davies SO, Fairbanks J, Hollander E, Carnpeas R. Klein DF. Fluoxetine in panic disorder. J Clin Psychopharmacol 1990 Apr; 10(2):119-21. Scrignar CB. Postpanic anxiety disorder: diagnosis and treatment. South Med J 1986 Apr;79(4):400-4. Sheehan DV. Tricyclic antidepressants in the treatment of panic and anxiety disorders. 139th Annual Meeting of the American Psychiatric Association: Beyond depression: New uses of antidepressants (1986, Washington, DC). Psychosomatics 1986 Nov;27(11 Suppl):10-6. Sheehan DV. Raj AB, Sheehan KH. Soto S. Is buspirone effective for panic disorder? J Clin Psychopharmacol 1990 Feb;10(1):3-11. Sheehan DV. Raj AB. Sheehan KH. Soto S. The relative efficacy of buspirone. imipramine and placebo in panic disorder: a preliminary report. Pharmacol Biochem Behav 1988 Apr;29(4):815-7. Sheehan DV. Sheehan KH. Pharmacological treatment of panic and anxiety disorders. ISI Atlas Sci Pharrnacol 1987;1(3):254-6. Sheehan DV. Soto S. Recent developments in the treatment of panic disorder. Acta Psychiatr Scand Suppl 1987;335:75-85. Stein MB. Uhde TW. Triiodothyronine potentiation of tricycfic antidepressant treatment in patients with panic disorder. Biol Psychiatry 1990 Dec 15; 28(12):1061-4. Stewart RS. Pharmacologic treatment of panic disorder and agoraphobia. Hosp Formul 1990;25(4):416-22. Sunderland G. Friedman S, Rosenblurn LA. Imipramine and alprazolam treatment of lactate- induced acute endogenous distress in nonhuman primates. Am J Psychiatry 1989 Aug;146(8): 1044-7. Svebak S, Cameron A. Levander S. Clonazepam and irnipramine in the treatment of panic attacks: a double—blind comparison of efficacy and side effects. J Clin Psychiatry 1990 May;51 Supp1:14-7; discussion 50-3. Sverd J. Imipramine treatment of panic disorder in a boy with Tourette‘s syndrome. J Clin Psychiatry 1988 Jan;49(1):31—2. Swinson RP. The acute treatment of anxiety and depression. Psychiatr J Univ Ott 1989 Jun; 14(2):375—8; discussion 379-80. 34 Swinson RP. Pecknold JC. Kuch K. Psychophannacological treatment of panic disorder and related states: a placebo controlled study of alprazolarn. Prog Neuropsychophannacol Biol Psychiatry 1987;11(2-3):105-13. Taylor CB. Hayward C. King R. Ehlers A. Margraf J, Maddock R. Clark D. Roth WT. Agras WS. Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind. placebo— controlled trial. J Clin Psychopharmacol 1990 Apr; 10(2):112-8. Taylor CB. King R. Margraf J. Ehlers A, Telch M, Roth WT. Agras WS. Use of medication and in vivo exposure in volunteers for panic disorder research. Am J Psychiatry 1989 Nov;146(11):1423-6. Tesar GE. Rosenbaum JF. Successful use of clonazepam in patients with treatment-resistant panic disorder. J Nerv Ment Dis 1986 Aug;174(8): 477-82. Tobe EH. Pitfalls in the management of panic disorder. J Am Osteopath Assoc l988;88(4):507-9. Treatment outlines for the management of anxiety states. Aust N Z J Psychiatry 1985;19(2):138-51. Tyrer P. Seivewright N. Ferguson B. Murphy S. Darling C. Brothwell J. Kingdon D. Johnson AL. The Nottingham Study of Neurotic Disorder: relationship between personality status and symptoms. Psychol Med 1990 May;20(2):423-31. Tyrer P. Seivewright N. Murphy S. Ferguson B. Kingdon D. Barczak P. Brothwell J. Darling C. Gregory S. Johnson AL. The Nottingham study of neurotic disorder: comparison of drug and psychological treatments. Lancet 1988 Jul 30; 2(8605):235-40. Tyrer P. Shawcross C. Monoamine oxidase inhibitors in anxiety disorders. J Psychiatr Res 1988;22 Suppl 1:87-98. Uhlenhuth EH. Matuzas W. Glass RM. Easton C. Response of panic disorder to fixed doses of alprazolam or imipramine. J Affective Disord 1989 Nov-Dec;l7(3):261-70. Wall M. 'I‘uchman M, Mielke D. Panic attacks and temporal lobe seizures associated with a right temporal lobe arteriovenous malformation: case report. J Clin Psychiatry 1985 Apr;46(4):143-5. Ware MR. DeVane CL. Imipramine treatment of panic disorder during pregnancy. J Clin Psychiatry 1990 Nov;51(11):482-4. Westenberg HG. den Boer JA. Serotonin-influencing drugs in the treatment of panic disorder. Psychopathology 1989;22 Suppl 1:68-77. Whiteford HA. Evans L. Agoraphobia and the dexamethasone suppression test: Atypical depression? Aust N Z J Psychiatry 1984; 18(4):374-7. Wood WG. The diagnosis and management of panic disorder. Psychiatr Med 1990;8(3):197-209. Woods SW. Chamey DS, Delgado PL. Heninger GR. The effect of long-term imipramine treatment on carbon dioxide-induced anxiety in panic disorder patients. J Clin Psychiatry 1990 Dec;51(12):505-7. Yeragani VK. Balon R. Pohl R. Schizophrenia, panic attacks. and antidepressants. Am J Psychiatry 1989 Feb;146(2):279. Yeragani VK. Meiri P. Balon R, Pohl R. Golec S. Effect of irnipramine treatment on changes in heart rate and blood pressure during postural and isometric handgrip tests. Eur J Clin Pharmacol 1990;38(2):139—44. Yeragani VK. Pohl R. Balon R. Rainey JM. Berchou R. Ortiz A. Sodium lactate infusions after treatment with tricyclic antidepressants: behavioral and physiological findings. Biol Psychiatry 1988 Nov; 24(7):767-74. Yeragani VK, Rainey JM. Balon R, Berchou R. Lycaki H. Pohl R. The effect of tricyclic antidepressants on stress-induced heart rate changes in panic disorder patients. Acta Psychiatr Scand 1987 Sep; 76(3):324-7. - Alprazolam Albus M. Lecrubier Y. Maier W. Buller R. Rosenberg R. Hippius H. Drug treatment of panic disorder: early response to treatment as a predictor of final outcome. Acta Psychiatr Scand 1990 Nov;82(5): 359-65. Albus M. Maier W, Shera D. Bech P. Consistencies and discrepancies in self- and observer-rated anxiety scales. A comparison between the self- and observer-rated Marks-Sheehan scales. Eur Arch Psychiatry Clin Neurosci 1990;240(2):96-102. Alexander PE. Alexander DD. Alprazolam treatment for panic disorders. J Clin Psychiatry 1986 Jun; 47(6):301-4. Andersch S. Rosenberg NK. Kullingsjo H. Ottosson J~O. Bech P. Bruun-Hansen J, Hanson L, Lorentzen K. Mellergard M. Rasmussen S. Rosenberg R. Efficacy and safety of alprazolam. imipramine and placebo in treating panic disorder. A Scandinavian multicenter study. Acta Psychiatr Scand Suppl 1991;83(365):18-27. Ballenger JC. Efficacy of benzodiazepines in panic disorder and agoraphobia. J Psychiatr Res 1990;24 Suppl 2:15-25. Ballenger JC. Burrows GD. DuPont RL Jr. Lesser IM, Noyes R Jr. Pecknold JC. Riflrin A. Swinson RP. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short- term treatment. Arch Gen Psychiatry 1988 May; 45(5):413-22. Beitman BD. Basha IM, Trombka LH. Jayaratna MA. Russell B. Flaker G. Anderson S. Pharmacotherapeutic treatment of panic disorder in patients presenting with chest pain. J Fam Pract 1989 Feb;28(2):177-80. Beitman BD. Basha IM, Trombka LH. Jayaratna MA. Russell BD, Tarr SK. Alprazolam in the treatment of cardiology patients with atypical chest pain and panic disorder. J Clin Psychopharrnacol 1988 Apr; 8(2):127-30. Buller' R. Maier W. Goldenberg IM, Lavori PW. Benkert 0. Chronology of panic and avoidance. age of onset in panic disorder. and prediction of treatment response. A report from the Cross-National Collaborative Panic Study. Eur Arch Psychiatry Clin Neurosci 1991 ;240(3):l63—8. Burrows GD. Managing long-term therapy for panic disorder. J Clin Psychiatry 1990 Nov;51 Suppl: 9-12. 35 Burrows GD. Norman TR. Judd FK, Marriott PF. Short-acting versus long-acting benzodiazepines: discontinuation effects in panic disorders. J Psychiatr Res 1990;24 Suppl 2:65-72. Carr DB. Fishman SM. Kasting NW. Sheehan DV. Vasopressin response to lactate infusion in normals and patients with panic disorder. Funct Neurol 1986 Apr-Jun;1(2):123-7. Carr DB, Sheehan DV. Surman OS. Coleman JH. Greenblatt DJ. Heninger GR. Jones K]. Levine PH. Watkins WD. Neuroendocrine correlates of lactate- induced anxiety and their response to chronic alprazolam therapy. Am J Psychiatry 1986 Apr; 143(4):483-94. Chamey DS. Heninger GR. Noradrenergic function and the mechanism of action of antianxiety treatment. I. The effect of long-term alprazolam treatment. Arch Gen Psychiatry 1985 May;42(5): 458-67. Chamey DS. Heninger GR. Serotonin function in panic disorders. The effect of intravenous tryptophan in healthy subjects and patients with panic disorder before and during alprazolam treatment. Arch Gen Psychiatry 1986 Nov;43(11):1059-65. Chamey DS. Woods SW. Benzodiazepine treatment of panic disorder: a comparison of alprazolam and lorazepam. J Clin Psychiatry 1989 Nov;50(11): 418-23. Chamey DS. Woods SW. Goodman WK. Rifldn B. Kinch M, Aiken B. Quadrino LM. Heninger GR. Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam. and trazodone. J Clin Psychiatry 1986 Dec;47(12):580-6. Ciraulo DA. Antal at, Smith RB. Olson DR, Goldberg DA. Rand EH. Raskin RB. Phillips JP. Shader RI, Greenblatt DJ. The relationship of alprazolam dose to steady-state plasma concentrations. J Clin Psychopharrnacol 1990 Feb;10(1):27-32. Ciraulo DA. Bamhill JG. Boxenbaum HG. Greenblatt DJ. Smith RB. Pharmacokinetics and clinical effects of alprazolam following single and multiple oral doses in patients with panic disorder. J Clin Pharmacol 1986 Apr;26(4):292-8. Clark DB. Taylor CB. Roth WT. Hayward C. Ehlers A. Margraf J. Agras WS. Surreptitious drug use by patients in a panic disorder study. Am J Psychiatry 1990 Apr",147(4):507-9. Coryell W. Noyes R Jr. Clancy J. Crowe R, Chaudhry D. Abnormal escape from dexamethasone suppression in agoraphobia with panic attacks. Psychiatry Res 1985 Aug;15(4):301-11. 36 Coryell W. Noyes R. HPA axis disturbance and treatment outcome in panic disorder. Biol Psychiatry 1988 Nov;24(7):762-6. Coryell W. Noyes R. Placebo response in panic disorder. Am J Psychiatry 1988 Sep;145(9): 1138—40. Coryell W. Noyes R Jr, Schlechte J. The significance of HPA axis disturbance in panic disorder. Biol Psychiatry 1989 Apr 15;25(8):989-1002. Cox BJ, Swinson RP, Endler NS. A review of the psychopharmacology of panic disorder: Individual differences and non specific factors. Can J Psychiatry 1991 ;36(2): 130-8. Dager SR, Khan A. Cowley D, Avery DH, Elder J. Roy-Byme P, Dunner DL. Characteristics of placebo response during long-term treatment of panic disorder. Psychopharmacol Bull 1990; 26(3):273-8. Davidson JR. Continuation treatment of panic disorder with high-potency benzodiazepines. J Clin Psychiatry 1990 Dec;51 Suppl A:3l-7. Deltito JA, Argyle N. Buller R, Nutzinger D, Ottosson JO, Brandon S. Mellergard M. Shera D. The sequence of improvement of the symptoms encountered in patients with panic disorder. Compr Psychiatry 1991 Mar-Apr;32(2):120—9. Deltito JA, Argyle N, Klerrnan GL. Patients with panic disorder unaccompanied by depression improve with alprazolam and imipramine treatment. J Clin Psychiatry 1991 Mar;52(3):121-7. Dilsaver SC. Panic disorder. Am Fam Physician 1989 Jun;39(6):167-72. Drug treatment of panic disorder: Discussion III. Hosp Pract 1990;25 Suppl 2240-2. Durmer DL, Ishiki D, Avery DH, Wilson LG, Hyde TS. Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study. J Clin Psychiatry 1986 Sep;47(9):458-60. Edlund MJ. Swann AC. Low MHPG and continuing treatment in panic disorder. Prog Neuropsychopharmacol Biol Psychiatry 1989; 13(5):701-7. Edlund MJ. Swarm AC, Clothier J. Patients with panic attacks and abnormal EEG results. Am J Psychiatry 1987 Apr;144(4):508-9. Eriksson E. Brain neurotransmission in panic disorder. Acta Psychiatr Scand Suppl 1987;335:31-7. Eriksson E, Carlsson M, Nilsson C, Soderpalm B. Does alprazolam. in contrast to diazepam, activate alpha 2-adrenoceptors involved in the regulation of rat growth hormone secretion? Life Sci 1986 Apr 21;38(16):1491-8. Fava GA. Fading of therapeutic effects of alprazolam in agoraphobia. Case reports. Prog Neuropsychopharmacol Biol Psychiatry 1988; 12(1):]09-12. Fava GA, Grandi S, Saviotti FM, Conti S. Hypochondriasis with panic attacks. Psychosomatics 1990 Summer;31(3):351-3. Fava M, Rosenbaum JF, MacLaughlin RA, Tesar GE, Pollack MH, Cohen LS, Hirsch M. Dehydroepiandrosterone-sulfate/cortisol ratio in panic disorder. Psychiatry Res 1989 Jun;28(3): 345-50. Fishman SM, Sheehan DV. Carr DB. Thyroid indices in panic disorder. J Clin Psychiatry 1985 Oct; 46(10):432-3. Fyer AJ. Liebowitz MR, Gonnan JM, Campeas R, Levin A. Davies SO, Goetz D, Klein DF. Discontinuation of alprazolam treatment in panic patients. Am J Psychiatry 1987 Mar; 144(3):303-8. Fyer AJ, Liebowitz MR. Got-man JM, Campeas R, Levin A. Sandberg D, Fyer M. Hollander E, Papp L. Goetz D. et al. Effects of clonidine on alprazolam discontinuation in panic patients: a pilot study. J Clin Psychopharrnacol 1988 Aug;8(4)5270—4. Garvey M. Noyes R Jr. Cook B. Tollefson G. The relationship of panic disorder and its treatment outcome to 24-hour urinary MHPG levels. Psychiatry Res 1989 Oct;30(1):53-61. Gastfriend DR. Rosenbaum JF. Adjunctive buspirone in benzodiazepine treatment of four patients with panic disorder. Am J Psychiatry 1989 Jul;l46(7): 914-6. Giesecke ME. Panic disorder in university students: A review. J Am Coll Health 1987;36(3):149-57. Gorman JM, Liebowitz MR. Dillon D. Fyer A]. Cohen BS. Klein DF. Antipanic drug effects during lactate infusion in lactate-refractory panic patients. Psychiatry Res 1987 Jul;21(3):205-12. Green MA, Curtis GC. Personality disorders in panic patients: Response to termination of antipanic medication. J Pers Disord 1988;2(4):303-14. Hauri PJ. Friedman M, Ravaris CL. Sleep in patients with spontaneous panic attacks. Sleep 1989 Aug; 12(4):323-37. Herman JB. Brotman AW. Rosenbaum JF. Rebound anxiety in panic disorder patients treated with shorter-acting benzodiazepines. J Clin Psychiatry 1987 Oct;48 Suppl:22-8. Herman JB. Rosenbaum JF, Brotman AW. The alprazolam to clonazepam switch for the treatment of panic disorder. J Clin Psychopharmacol 1987 Jun;7(3):175-8. Huybrechts I. The pharmacology of alprazolam: a review. Clin 'l'her 1991 Jan-Feb;13(1):100-17. J arm MW. Kurtz NM. Treatment of panic and phobic disorders. Clin Pharm 1987 Dec;6(12):947-62. Johnston AL. File SE. Profiles of the antipanic compounds, triazolobenZodiazepines and phenelzine. in two animal tests of anxiety. Psychiatry Res 1988 Jul;25(1):81}90. Katon W. Panic disorder: epidemiology. diagnosis. and treatment .in primary care. J Clin Psychiatry 1986 0ct:47 Suppl:21-30. Katon W. Vitaliano PP. Russo J. Connier L, Anderson K. Jones M. Panic disorder: epidemiology in primary care. J Fam Pract 1986 Sep;23(3):233-9. King D. Nicolini H. de la Fuente JR. Abuse and withdrawal of panic treatment drugs. Psychiau Ann 1990 Sep;20(9):525-8. Klein DF. Psychopharmacologic treatment of panic disorder. Psychosomatics 1984:2500 Suppl):32-6. Klerman GL. Depression and panic anxiety: the effect of depressive co—morbidity on response to drug treatment of patients with panic disorder and agoraphobia. J Psychiatr Res 1990;24 Suppl 2: 27-41. Klerman GL. Overview of the Cross-National Collaborative Panic Study. Arch Gen Psychiatry 1988 May;45(5):407-12. Klerman GL. Panic disorder: strategies for long-term treatment. J Clin Psychiatry 1991 Feb:52 Supplz3-5. Klerman GL. Ballenger JC. Burrows GD, DuPont RL. et al. "The ‘efficacy' of alprazolam in panic disorder and agoraphobia: A critique of recent reports": Reply. Arch Gen Psychiatry 1989 Jul;46(7):670-2. Klerman GL. Freedman DX. Shader RI. The separation of panic and agoraphobia from other anxiety disorders: Introduction of the conference proceedings. J Psychiatr Res 1988;22 Suppl 1:3-5. Klosko JS. Barlow DH. Tassinari R. Cemy JA. A comparison of alprazolam and behavior therapy in 37 treatment of panic disorder. J Consult Clin Psychol 1990 Feb;58(1):77-84. Lepola U. Recognition of panic disorder. Nord Psykiatr Tidsskr 1989;43(6):511-3. Lepola U. Heikkinen H. Rimon R, Riekkinen P. Clinical evaluation of alprazolam in patients with panic disorder: A double-blind comparison with imipramine. Hum Psychopharmacol 1990;5(2): 159-63. Lepola U. Jolkkonen J . Rim:on R. Riekkinen P. Long- term effects of alprazolam and imipramine on cerebrospinal fluid monoamine metabolites and neuropeptides in panic disorder. Neuropsychobiology 1989;21(4):182-6. Lesser IM. Rubin RT. Pecknold JC. Rifldn A. Swinson RP. Lydiard RB, Burrows GD. Noyes R Jr. DuPont RL Jr. Secondary depression in panic disorder and agoraphobia. 1. Frequency, severity. and response to treatment. Arch Gen Psychiatry 1988 May;45(5): 437-43. Lesser IM. Rubin RT. Rifkin A. Swinson RP. Ballenger JC. Burrows GD. Dupont RL. Noyes R. Pecknold JC. Secondary depression in panic disorder and agoraphobia. 11. Dimensions of depressive symptomatology and their response to treatment. J Affective Disord 1989 Jan-Feb;16(l):49-58. Liebowitz MR, Fyer AJ. Gorman JM. Carnpeas R, Levin A, Davies SR, Goetz D. Klein DF. Alprazolam in the treatment of panic disorders. J Clin Psychopharmacol 1986 Feb;6(1):13-20. Linnoila MI. Anxiety and alcoholism. J Clin Psychiatry 1989 Nov;50 Suppl:26-9. Lopez AL, Kathol RG. Noyes R Jr. Reduction in urinary free cortisol during benzodiazepine treatment of panic disorder. Psychoneuroendocrinology 1990; 15(1):23-8. Lydiard RB. Laraia MT. Ballenger JC. Howell EF. Emergence of depressive symptoms in patients receiving alprazolam for panic disorder. Am J Psychiatry 1987 May;144(5):664-S. Lydiard RB. Roy-Byrne PP. Ballenger JC. Recent advances in the psychopharmacological treatment of anxiety disorders. Hosp Community Psychiatry 1988 Nov;39(l 1):1157-65. Margraf J. Ehlers A. Roth WT. Clark DB. Sheikh J. Agras WS, Taylor CB. How "blind" are double- blind studies? J Consult Clin Psychol 1991 Feb; 59(1):184-7. 38 Marks IM. de Albuquerque A. Cottraux J . Gentil V. et al. The "efficacy" of alprazolam in panic disorder and agoraphobia: A critique of recent reports. Arch Gen Psychiatry 1989 Jul;46(7):668-72. Marshall JR. Diagnosis and management of panic disorder in the emergency department. Emerg Care Q 1991;7(1):1-8. Mattick RP. Andrews G. Hadzi-Pavlovic D, Christensen H. Treatment of panic and agoraphobia. An integrative review. J Nerv Ment Dis 1990 Sep; l78(9):567-76. McIntyre IM. Judd FK. Burrows GD. Armstrong SM, Norman TR. Plasma concentrations of melatonin in panic disorder. Am J Psychiatry 1990 Apr; 147(4):462-4. Meco G. Capriani C. Bonifati U. Ecari U. Etizolam: A new therapeutic possibility in the treatment of panic disorder. Adv Ther l989;6(4):l96-206. . Mellergard M, Lorentzen K. Bech P. Ottosson J-O. Rosenberg R. A trend analysis of changes during treatment of panic disorder with alprazolam and irnipramine. Acta Psychiatr Scand Suppl 1991; 83(365):28-32. ‘ Mellergard M. Rosenberg NK. Patterns of response during placebo treatment of panic disorder. Acta Psychiatr Scand 1990 Apr;81(4):340~4. Mohns EB. Discontinuation and withdrawal problems of alprazolam. West J Med 1989;151(3):312. Munjack DJ. Crocker B. Cabe D. Brown R. Usigli R. Zulueta A. McManus M. McDowell D. Palmer R. Leonard M. Alprazolam. propranolol. and placebo in the treatment of panic disorder and agoraphobia with panic attacks. J Clin Psychopharmacol 1989 Feb;9(1):22—7. Nagy 1M. Krystal JH. Woods SW. Charney DS. Clinical and medication outcome after short-term alprazolam and behavioral group treatment in panic disorder. 2.5 year naturalistic follow-up study. Arch Gen Psychiatry 1989 Nov;46(11):993-9. Noyes R. Reich J . Clancy J. O'Gorman TW. Reduction in hypochondriasis with treatment of panic disorder [published erratum appears in Br J Psychiatry 1987 Feb;150:273]. Br J Psychiatry 1986 Nov;l49:631-5. Noyes R Jr. Cook B. Garvey M. Summers R. Reduction of gastrointestinal symptoms following treatment for panic disorder. Psychosomatics 1990 Winter;31(l):75-9. Noyes R Jr. DuPont RL Jr. Pecknold JC. Rifldn A. Rubin RT. Swinson RP. Ballenger JC, Burrows GD. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. 11. Patient acceptance. side effects, and safety. Arch Gen Psychiatry 1988 May;45(5):423-8. Noyes R Jr. Garvey MJ. Cook B. Suelzer M. Controlled discontinuation of benzodiazepine treatment for patients with panic disorder. Am J Psychiatry 1991 Apt;l48(4):517-23. Noyes R Jr. Perry PJ. Crowe RR. Coryell WH. Clancy J. Yamada T, Gabel J. Seizures following the withdrawal of alprazolam. J Nerv Ment Dis 1986 Jan;174(1):50-2. O'Boyle M. Panic disorder: diagnosis and treatment. Tex Med 1989 Aug;85(8):46-9. Overall JE. Sheehan DV. Multivariate analysis of changes in panic frequency counts. Clin Neuropharmacol 1986;9 Suppl 4:155-7. Pecknold JC. Behavioural and combined therapy in panic states. Prog Neuropsychopharmacol Biol Psychiatry l987;11(2-3):97-104. Pecknold JC. Fleury D. Alprazolam-induced manic episode in two patients with panic disorder. Am J Psychiatry 1986 May;143(5):652-3. Pecknold JC. Swinson RP, Kuch K, Lewis CP. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. III. Discontinuation effects. Arch Gen Psychiatry 1988 May;45(5): 429-36. Pecknold JC. Swinson RP. Taper withdrawal studies with alprazolam in patients with panic disorder and agoraphobia. Psychopharmacol Bull 1986;22(1): 173-6. Pollack MH. Long-term management of panic disorder. J Clin Psychiatry 1990 May;51 Supplzll-3; discussion 50-3. Pollack MH. Otto MW. Rosenbaum JF. Sachs GS. O'Neil C. Asher R. Meltzer-Brody S. Longitudinal course of panic disorder: findings from the Massachusetts General Hospital Naturalistic Study. J Clin Psychiatry 1990 Dec;51 Suppl A:12—6. Pollack MH. Rosenbaum JF. Benzodiazepines in panic-related disorders. Special Issue: Perspectives on panic-related disorders. J Anxiety Disord 1988; 2(1):95-107. Pollack MH. Rosenbaum JF. Tesar GE. Herman JB. Sachs GS. Clonazepam in the treatment of panic disorder and agoraphobia. Psychopharrnacol Bull 1987;23(1):l4l-4. Pyke RE. Greenberg HS. Double-blind comparison of alprazolam and adinazolam for panic and phobic disorders. J Clin Psychopharmacol 1989 Feb; 9(1):15-21. Pyke RE. Kraus M. Alprazolam in the treatment of panic attack patients with and without major depression. J Clin Psychiatry 1988 Feb;49(2):66-8. Raj A. Sheehan DV. Panic anxiety: diagnosis. etiology. and treatment. Compr Ther 1986 Oct; 12(10):7-15. Rickels K, Case WG, Schweizer E. The drug treatment of anxiety and panic disorder. Stress Med 1988; 4(4):231-9. Rizley R. Kahn RJ, McNair DM, Frankenthaler LM. A comparison of alprazolam and imipramine in the treatment of agoraphobia and panic disorder. Psychopharmacol Bull l986;22(1):167-72. Rosenberg NK. Mellergard M, Rosenberg R. Beck P. Ottosson J-O. Characteristics of panic disorder patients responding to placebo. Acta Psychiatr Scand Suppl 1991;83(365):33-8. Rosenberg R. Bech P, Mellergard M. Ottosson J-O. Alprazolam. imipramine and placebo treatment of panic disorder: Predicting therapeutic response. Acta Psychiatr Scand Suppl l991;83(365):46—52. Rosenberg R. Bech P, Mellergard M, Ottosson J-O. Secondary depression in panic disorder: An indicator of severity with a weak effect on outcome in alprazolam and imipramine treatment. Acta Psychiatr Scand Suppl 1991;83(365):39—45. Roy-Byme PP. Dager SR, Cowley DS, Vitaliano P. Dunner DL. Relapse and rebound following discontinuation of benzodiazepine treatment of panic attacks: alprazolam versus diazepam. Am J Psychiatry 1989 Ju1;146(7):860-S. Schweizer E, Fox I, Case G, Rickels K. Lorazepam vs. alprazolam in the treatment of panic disorder. Psychopharmacol Bull 1988;24(2):224-7. Schweizer E. Pohl R. Balon R. Fox I, Rickels K. Yeragani VK. Lorazepam vs. alprazolam in the treatment of panic disorder. Pharmacopsychiatry 1990 Mar;23(2):90-3. Scrignar CB. Postpanic anxiety disorder: diagnosis and treatment. South Med J 1986 Apr;79(4):400-4. Sheehan DV. Benzodiazepines in panic disorder and agoraphobia. J Affective Disord 1987 Sep- Oct;13(2):169—81. Sheehan DV. Monoamine oxidase inhibitors and alprazolam in the treatment of panic disorder and 39 agoraphobia. Psychiatr Clin North Am 1985 Mar; 8(1):49-62. Sheehan DV, Sheehan KH. Pharmacological treatment of panic and anxiety disorders. ISI Atlas Sci Pharmacol 1987;1(3):254-6. Sheehan DV. Soto S. Recent developments in the treatment of panic disorder. Acta Psychiatr Scand Suppl 1987;335:75-85. Smith GR. O'Rourke DF, Parker PE, Ford CV. et al. Panic and nausea instead of grief in an adolescent. J Am Acad Child Adolesc Psychiatry 1988 Jul; 27(4):509-l3. Stewart RS. Pharmacologic treatment of panic disorder and agoraphobia. Hosp Formul 1990;25(4):416-22. Sunderland G. Friedman S, Rosenblum LA. Imipramine and alprazolam treatment of lactate- induced acute endogenous distress in nonhuman primates. Am J Psychiatry 1989 Aug;146(8): 1044—7. Swinson RP, Pecknold JC. Kuch K. Psychopharmacological treatment of panic disorder and related states: a placebo controlled study of alprazolam. Prog Neuropsychopharmacol Biol Psychiatry 1987;11(2-3):105-13. Taylor CB, Hayward C, King R, Ehlers A. Margraf J. Maddock R. Clark D. Roth WT, Agras WS. Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double—blind. placebo- controlled trial. J Clin Psychopharmacol 1990 Apr; 10(2):1 12-8. Tesar GE. High-potency benzodiazepines for short- term management of panic disorder: the US. experience. J Clin Psychiatry 1990 May;51 Suppl: 4-10; discussion 50-3. Tesar GE. Rosenbaum JF, Pollack MH. Herman JB. Sachs GS, Mahoney EM, Cohen LS. McNamara M. Goldstein S. Clonazepam versus alprazolam in the treatment of panic disorder: interim analysis of data from a prospective, double-blind, placebo-controlled trial. J Clin Psychiatry 1987 Oct;48 Suppl:16-21. Tesar GE, Rosenbaum JF. Pollack MH. Otto MW, Sachs GS, Herman JB, Cohen LS, Spier SA. Double- blind. placebo-controlled comparison of clonazepam and alprazolam for panic disorder. J Clin Psychiatry 1991 Feb;52(2):69-76. Tiller JW. The new and newer antianxiety agents. Med J Aust 1989 Dec 4-18;151(11-12):697-701. Tobe EH. Pitfalls in the management of panic disorder. J Am Osteopath Assoc 1988;88(4):507-9. 40 Tobena A. Sanchez R. Pose R. Masana J, et a1. Brief treatment with alprazolam and behavioral guidance in panic disorder. Anxiety Res 1990 Nov;3(3): 163-74. Uhlenhuth EH. Matuzas W, Glass RM, Easton C. Response of panic disorder to fixed doses of alprazolarn or imipramine. J Affech've Disord 1989 Nov-Dec;17(3):261-70. Warner MD. Peabody CA. Boutros NN. Whiteford HA. Alprazolam and withdrawal seizures. J Nerv Ment Dis 1990;178(3):208-9. Wincor MZ. Munjack DJ. Palmer R. Alprazolarn levels and response in panic disorder: preliminary results. J Clin Psychopharmacol 1991 Feb;ll(l): 48-51. Wood WG. The diagnosis and management of panic disorder. Psychiatr Med 1990;8(3):l97-209. - Other Benzodiazepines Andersch S. Rosenberg NK. Kullingsjo H. Ottosson J-O. Bech P. Bruun-Hansen J. Hanson L, Lorentzen K, Mellergard M. Rasmussen S. Rosenberg R. Efficacy and safety of alprazolam. imipramine and placebo in treating panic disorder. A Scandinavian multicenter study. Acta Psychiatr Scand Suppl 1991;83(365):18-27. Aronson TA. Treatment-emergent depression with antidepressants in panic disorder. Compr Psychiatry 1989 May-Jun;30(3):267-71. Aronson TA. Carasiti I. McBane D. Whitaker-Amitia P. Biological correlates of lactate sensitivity in panic disorder. Biol Psychiatry 1989 Sep;26(5): 463-77. Balestrieri M, Ruggeri M. Bellantuono C. Drug treatment of panic disorder--a critical review of controlled clinical trials. Psychiatr Dev 1989 Winter;7(4):337-50. Ballenger JC. Efficacy of benzodiazepines in panic disorder and agoraphobia. J Psychiatr Res 1990;24 Suppl 2:15-25. Ballenger JC. Long-term pharrnacologic treatment of panic disorder. J Clin Psychiatry 1991 Feb;52 Suppl:l8-23; discussion 24-5. Ballenger JC. Pharmacotherapy of the panic disorders. J Clin Psychiatry 1986 Jun;47 Supplz27-32. Beardslee SL, Papadakis E. Fontana DJ . Commissaris RL. Antipanic drug treatments: failure to exhibit anxiolytic-like effects on defensive burying behavior. Pharrnacol Biochem Behav 1990 Feb; 35(2):451-5. Beaudry P, Fontaine R. Chouinard G. Annable L. An open clinical trial of clonazeparn in the treatment of patients with recurrent panic attacks. Prog Neuropsychopharrnacol Biol Psychiatry 1985 .9(5- 6): 589- 92. Beaudry P. Fontaine R. Chouinard G. Annable L. Clonazepam in the treatment of patients with recurrent panic attacks. J Clin Psychiatry 1986 Feb; 47(2):83-5. Beckett A. Fishman SM. Rosenbaum JF. Clonazepam blockade of spontaneous and C02 inhalation- provoked panic in a patient with panic disorder. J Clin Psychiatry 1986 Sep;47(9):475-6. Bogdonoff MD. Benzodiazepine sensitivity in panic disorder. Drug Ther 1990;20(9):33. Breier A. Chamey DS, Heninger GR. The diagnostic validity of anxiety disorders and their relationship to depressive illness. Am J Psychiatry 1985 Jul; 142(7):787-97. Burrows GD. Managing long-term therapy for panic disorder. J Clin Psychiatry 1990 Nov;51 Suppl: 9-12. Burrows GD. Norman TR, Judd FK, Marriott PF. Short—acting versus long-acting benzodiazepines: discontinuation effects in panic disorders. J Psychiatr Res 1990;24 Suppl 2:65-72. Chamey DS, Woods SW. Benzodiazepine treatment of panic disorder: a comparison of alprazolam and lorazepam. J Clin Psychiatry 1989 Nov;50(ll): 418-23. Coryell W. Noyes R. Placebo response in panic disorder. Am J Psychiatry 1988 Sep;l45(9): 1138—40. Coryell W, Noyes R Jr, Reich J. The prognostic significance of HPA-axis disturbance in panic disorder: a three-year follow-up. Biol Psychiatry 1991 Jan 15;29(2):96-102. Coryell W, Noyes R Jr, Schlechte J. The significance of HPA axis disturbance in panic disorder. Biol Psychiatry 1989 Apr 15:25(8):989-1002. Cowley DS. Roy-Byme PP. Hyperventilation and panic disorder. Am J Med 1987 Nov;83(5):929—37. Crowe RR. Noyes R Jr. Panic disorder and agoraphobia. Dis Mon 1986 Jul;32(7):389-444. Dajas F, Nin A. Barbeito L. Urinary norepinephrine excretion in panic and phobic disorders. J Neural Transm 1986;65(1):75-81. Davidson JR. Continuation treatment of panic disorder with high-potency benzodiazepines. J Clin Psychiatry 1990 Dec;51 Suppl A:31—7. de Montigny C. Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers. Preliminary findings. Arch Gen Psychiatry 1989 Jun;46(6): 51 1-7. Drug treatment of panic disorder: Discussion 111. Hosp Pract 1990;25 Suppl 2:40-2. Dunner DL, Ishiki D. Avery DH, Wilson LG, Hyde TS. Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study. J Clin Psychiatry 1986 Sep;47(9):458—60. DuPont RL. Thinking about stopping treatment for panic disorder. J Clin Psychiatry 1990 Dec;51 Suppl A:38-45. 41 Eriksson E, Carlsson M, Nilsson C, Soderpalm B. Does alprazolam, in contrast to diazepam, activate alpha 2-adrenoceptors involved in the regulation of rat growth hormone secretion? Life Sci 1986 Apr 21;38(16):1491-8. Evans L. Panic disorder. A new definition to anxiety. Curr Ther 1987;28(11):19-21. Fava M, Anderson K, Rosenbaum JF. "Anger attacks": possible variants of panic and major depressive disorders. Am J Psychiatry 1990 Jul;147(7):867-70. Fava M, Rosenbaum JF. MacLaughlin RA, Tesar GE. Pollack MH. Cohen LS, Hirsch M. Dehydroepiandrosterone-sulfate/cortisol ratio in panic disorder. Psychiatry Res 1989 Jun;28(3): 345-50. Fontaine R. Clonazepam for panic disorders and agitation. Psychosomatics 1985 Dec;26(12 Suppl): 13-8. Freedman DX. Benzodiazepines: therapeutic. biological and psychosocial issues. Symposium summary. J Psychiatr Res 1990;24 Suppl 2:169-74. Garvey M, Noyes R Jr, Cook B, Tollefson G. The relationship of panic disorder and its treatment outcome to 24-hour urinary MHPG levels. Psychiatry Res 1989 Oct;30(1):53-61. Gastfriend DR, Rosenbaum JF. Adjunctive buspirone in benzodiazepine treatment of four patients with panic disorder. Am J Psychiatry 1989 Ju1;146(7): 914-6. Giesecke ME. Panic disorder in university students: A review. J Am Coll Health 1987;36(3):l49-57. Gold DD Jr. Panic Attacks: Diagnosis and management. Cardiovasc Rev Rep 1988;9(1):35-7. 40. Goodman WK, Chamey DS. Price LH, Woods SW, Heninger GR. Ineffectiveness of clonidine in the treatment of the benzodiazepine withdrawal syndrome: report of three cases. Am J Psychiatry 1986 Jul;143(7):900-3. Hayes PE, Schulz SC. Beta-blockers in anxiety disorders. J Affective Disord 1987 Sep—Oct; 13(2):119-30. Herman JB, Brotrnan AW. Rosenbaum JF. Rebound anxiety in panic disorder patients treated with shorter-acting benzodiazepines. J Clin Psychiatry 1987 Oct;48 Suppl:22-8. 42 Herman JB. Rosenbaum IF. Brotrnan AW. The alprazolam to clonazepam switch for the treatment of panic disorder. J Clin Psychopharmacol 1987 Jun;7(3):l75-8. Hollister LE. Anxiety: drug treatments for biologically determined disorders. Ration Drug Ther 1986 Apr; 20(4):1-6. Jann MW. Kurtz NM. Treatment of panic and phobic disorders. Clin Pharm 1987 Dec;6(12):947-62. Johnston AL. File SE. Profiles of the antipanic compounds, triazolobenzodiazepines and phenelzine. in two animal tests of anxiety. Psychiatry Res 1988 Jul;25(1):81—90. Judd FK. Burrows GD. Marriott PF. Norman TR. A short term open clinical trial of clobazam in the treatment of patients with panic attacks. Int Clin Psychopharmacol 1989 Oct:4(4):285-93. Judd FK. Norman TR, Burrows GD. Pharmacological treatment of panic disorder. Int Clin Psychopharmacol 1986 Jan;l(1):3-16. Judd FK. Norman TR. Burrows GD. Pharmacotherapy of panic disorder. Int Rev Psychiatry 1990; 2(3-4):399-409. Klein DF. Psychopharmacologic treatment of panic disorder. Psychosomatics 1984;25(10 Suppl):32-6. Klennan GL. Panic disorder: strategies for long-term treatment. J Clin Psychiatry 1991 Feb;52 Supplz3-5. Klerman GL. Coleman JH. Purpura RP. The design and conduct of the Upjohn Cross-National Collaborative Panic Study. Psychopharmacol Bull 1986;22(1):59-64. Kutcher SP. MacKenzie S. Successful clonazepam treatment of adolescents with panic disorder. J Clin Psychopharmacol 1988 Aug;8(4):299-301. Lilienfeld SO. Jacob RG. Funnan JM. Vestibular dysfunction followed by panic disorder with agoraphobia. J Nerv Ment Dis 1989 Nov; 177(11):700-1. Linnoila MI. Approaches to the treatment of alcoholism and anxiety. Drug ther 1990;20 Suppl: 27-34. Lopez AL. Kathol RG, Noyes R Jr. Reduction in urinary free cortisol during benzodiazepine treatment of panic disorder. Psychoneuroendocrinology 1990; 15(1):23-8. Lydiard RB. Pharmacological treatment. Psychiatr Ann 1988 Aug;18(8):468-72. Lydiard RB, Howell EF. Laraia MT, Fossey MD. et a1. Depression in patients receiving lorazepam for panic. Am J Psychiatry 1989 Sep;146(9):1230—1. Lydiard RB, Laraia MT, Howell EF, Ballenger JC. Can panic disorder present as irritable bowel syndrome? J Clin Psychiatry 1986 Sep;47(9):470-3. Lydiard RB. Laraia MT. Howell EF. Fossey MD. Reynolds RD. Ballenger JC. Phenelzine treatment of panic disorder: lack of effect on pyridoxal phosphate levels. J Clin Psychopharmacol 1989 Dec;9(6):428-31 . Lydiard RB, Roy-Byme PP, Ballenger JC. Recent advances in the psychopharmacological treatment of anxiety disorders. Hosp Community Psychiatry 1988 Nov;39(11):1157-65. Marks 1. Behavioural and drug treatments of phobic and obsessive-compulsive disorders. Psychother Psychosom 1986;46(1-2):35-44. Marshall JR. Diagnosis and management of panic disorder in the emergency department. Emerg Care Q 1991;7(1):l-8. Mattick RP, Andrews G. Hadzi-Pavlovic D. Christensen H. Treatment of panic and agoraphobia. An integrative review. J Nerv Ment Dis 1990 Sep; 178(9):567-76. Meco G. Capriani C, Bonifati U. Ecari U. Etizolam: A new therapeutic possibility in the treatment of panic disorder. Adv Ther 1989;6(4):196-206. Murray JB. Psychopharmacological investigation of panic disorder by means of lactate infusion. J Gen Psychol 1987 Jul;114(3):297-311. Muskin PR. Panics. prolapse, and PVCs. Gen Hosp Psychiatry 1985 Jul;7(3):219—23. Nasdahl CS. Johnston IA, Coleman JH. May CN. Druff JH. Protocols for the use of psychoactive drugs-- Part IV: Protocol for the treatment of anxiety disorders. J Clin Psychiatry 1985 Apr;46(4):128-32. Norman TR, Gregory MS. Judd PK, Burrows GD. McIntyre 1M. Platelet serotonin uptake in panic disorder: comparison with normal controls and the effect of treatment. Aust N Z J Psychiatry 1988 Dec;22(4):390-5. Noyes R Jr. Cook B. Garvey M. Summers R. Reduction of gastrointestinal symptoms following treatment for panic disorder. Psychosomatics 1990 Winter;31(l):75-9. Noyes R Jr, Garvey M]. Cook B. Suelzer M. Controlled discontinuation of benzodiazepine treatment for patients with panic disorder. Am J Psychiatry 1991 Apr;l48(4):517-23. Nutt DJ , Glue P. Lawson C, Wilson S. Flumazenil provocation of panic attacks. Evidence for altered benzodiazepine receptor sensitivity in panic disorder. Arch Gen Psychiatry 1990 Oct;47(10):917-25. Ontiveros A. Fontaine R. Panic attacks and multiple sclerosis. Biol Psychiatry 1990 Mar;27(6):672-3. Pollack MH. Clonazepam: a review of open clinical trials. J Clin Psychiatry 1987 0ct;48 Suppl:12-5. Pollack MH. Long-term management of panic disorder. J Clin Psychiatry 1990 May;51 Supplzll-S; discussion 50-3. Pollack MH. Otto MW, Rosenbaum JF, Sachs GS. O'Neil C. Asher R. Meltzer-Brody S. Longitudinal course of panic disorder: findings from the Massachusetts General Hospital Naturalistic Study. J Clin Psychiatry 1990 Dec;51 Suppl A:12-6. Pollack MH. Rosenbaum JF. Benzodiazepines in panic-related disorders. Special Issue: Perspectives on panic-related disorders. J Anxiety Disord 1988; 2(1):95-107. Pollack MH. Rosenbaum JF, Tesar GE, Herman JB. Sachs GS. Clonazepam in the treatment of panic disorder and agoraphobia. Psychopharmacol Bull 1987;23(1):141—4. Pollack MH. Tesar GE. Rosenbaum JF, Spier SA. Clonazepam in the treatment of panic disorder and agoraphobia: a one-year follow-up. J Clin Psychopharmacol 1986 Oct;6(5):302—4. Pyke RE, Greenberg HS. Double-blind comparison of alprazolam and adinazolam for panic and phobic disorders. J Clin Psychopharmacol 1989 Feb; 9(1):15-21. Reich JH. DSM-III personality disorders and the outcome of treated panic disorder. Am J Psychiatry 1988 Sep;145(9):1149-52. Rickels K. Antianxiety therapy: potential value of long-term treatment. J Clin Psychiatry 1987 Dec;48 Suppl:7-1 1. Rickels K. Clinical studies of "specific" anxiolytics as therapeutic agents. Psychopharrnacol Ser 1987;3: 88-95. Rickels K. Case WG, Downing RW. Fridman R. One- year follow-up of anxious patients treated with diazepam. J Clin Psychopharmacol 1986;6(1):32-6. 43 Rickels K. Case WG, Schweizer E. The drug treatment of anxiety and panic disorder. Stress Med 1988; 4(4):231-9. Rickels K, Schweizer EE. Benzodiazepines for treatment of panic attacks: a new look. Psychopharmacol Bull 1986;22(1):93-9. Rickels K, Schweizer E. Case WG, Greenblatt DJ. Long-term therapeutic use of benzodiazepines. I. Effects of abrupt discontinuation [published erratum appears in Arch Gen Psychiatry 1991 Jan;48(1):51]. Arch Gen Psychiatry 1990 0ct;47(10):899-907. Rifldn A. Benzodiazepines for anxiety disorders. Are the concerns justified? Postgrad Med 1990 Jan; 87(1):209-11, 215-6, 219. Rosenbaum IF. A psychopharmacologist's perspective on panic disorder. Bull Menninger Clin 1990 Spring;54(2):184-98. Rosenbaum JF. Drug treatment of panic disorder. Hosp Pract [Off] 1990 Jun:25 Suppl 2:31-9; discussion 40-2. Rosenbaum JF. Panic disorder: Diathesis and treatment issues. J Clin Psychiatry 1990;51(12 Suppl A):3-4. Rosenblat H. Panic attacks triggered by photic stimulation. Am J Psychiatry 1989 Jun;146(6): 801-2. Roy-Byme PP, Dager SR. Cowley DS. Vitaliano P, Dunner DL. Relapse and rebound following discontinuation of benzodiazepine treatment of panic attacks: alprazolam versus diazepam. Am J Psychiatry 1989 Ju1;l46(7):860-5. Roy-Byme PP, Lewis N, Villacres E, Diem H, Greenblatt DJ . Shader RI, Veith R. Preliminary evidence of benzodiazepine subsensitivity in panic disorder. Biol Psychiatry 1989 Nov;26(7):744-8. Sargent M. Panic disorder. Hosp Community Psychiatry 1990 Jun;4l(6):621-3. Savoldi F, Somenzini G, Ecari ~U. Etizolam versus placebo in the treatment of panic disorder with agoraphobia: a double-blind study. Curr Med Res Opin 1990;12(3):185-90. Schatzberg AF, Ballenger JC. Decisions for the clinician in the treatment of panic disorder: when to treat, which treatment to use, and how long to treat. J Clin Psychiatry 1991 Feb;52 Suppl:26-31; discussion 32. Schifano F, Magni G. Panic attacks and major depression after discontinuation of long-term diazepam abuse. DICP 1989 Dec:23(12):989-90. 44 Schweizer E. Fox 1, Case G. Rickels K. Lorazepam vs. alprazolam in the treatment of panic disorder. Psychopharmacol Bull 1988;24(2):224-7. Schweizer E, Pohl R. Balon R. Fox I, Rickels K. Yeragani VK. Lorazepam vs. alprazolam in the treatment of panic disorder. Pharmacopsychiatry 1990 Mar;23(2):90-3. Schweizer E. Rickels K. Buspirone in the treatment of panic disorder: A controlled pilot comparison with clorazepate. J Clin Psychopharmacol 1988 Aug; 8(4):303. Sheehan DV. Benzodiazepines in panic disorder and agoraphobia. J Affective Disord 1987 Sep—Oct; 13(2):169-81. Sheehan DV. Raj AB, Harnett-Sheehan K. Soto S. etal. Adinazolam sustained release formulation in the treatrnent of panic disorder: A pilot study. Ir J psychol Med 1990 Sep;7(2):124—8. Sheehan DV. Sheehan KH. Pharmacological treatment of panic and anxiety disorders. ISI Atlas Sci Pharmacol 1987;1(3):254-6. Shelton RC. Diagnosis and management of panic disorder. Compr 'l'her 1990 Dec;16(12):11-7. Spier SA. Tesar GE. Rosenbaum JF. Woods SW. Treatment of panic disorder and agoraphobia with clonazepam. J Clin Psychiatry 1986 May;47(5): 238-42. Stewart RS. Pharmacologic treatment of panic disorder and agoraphobia. Hosp Formul 1990;25(4):416—22. Svebak S. Cameron A. Levander S. Clonazepam and imiprarnine in the treatment of panic attacks: a double-blind comparison of efficacy and side effects. J Clin Psychiatry 1990 May;51 Supplzl4-7; discussion 50-3. Swartz M. Landerman R. George LK. Melville ML. Blazer D, Smith K. Benzodiazepine anti-anxiety agents: prevalence and correlates of use in a southern community. Am J Public Health 1991 May;81(5):592-6. Swinson RP. The acute treatment of anxiety and depression. Psychiatr J Univ Ott 1989 Jun; l4(2):375—8; discussion 379—80. Taylor DP. Serotonin agents in anxiety. Ann New York Acad Sci 1990;600:545-57. Taylor CB. Hayward C. Cardiovascular considerations in selection of anti-panic pharmacotherapy. J Psychiatr Res 1990;24 Suppl 2:43-9. Taylor CB. King R. Margraf J. Ehlers A. Telch M. Roth WT. Agras WS. Use of medication and in vivo exposure in volunteers for panic disorder research. Am J Psychiatry 1989 Nov;l46(ll):1423-6. Tesar GE. High-potency benzodiazepines for short- terrn management of panic disorder: the U.S. experience. J Clin Psychiatry 1990 May;51 Suppl: 4-10; discussion 50-3. Tesar GE. Rosenbaum IF. Successful use of clonazepam in patients with treatment-resistant panic disorder. J Nerv Ment Dis 1986 Aug;174(8): 477—82. Tesar GE. Rosenbaum JF. Pollack MH, Herman IB. Sachs GS. Mahoney EM. Cohen LS. McNamara M. Goldstein S. Clonazepam versus alprazolam in the treatment of panic disorder: interim analysis of data from a prospective. double—blind. placebo-controlled trial. J Clin Psychiatry 1987 0ct;48 Supplzlo-Zl. Tesar GE, Rosenbaum JF. Pollack MH. Otto MW. Sachs GS. Herman JB, Cohen LS. Spier SA. Double- blind. placebo-controlled comparison of clonazepam and alprazolam for panic disorder. J Clin Psychiatry 1991 Feb;52(2):69-76. Tiller JW. The new and newer antianxiety agents. Med J Aust 1989 Dec 4—18;151(11-12):697-701. Treatment of syndromes or of symptoms in psychiatry? Lancet 1988;2(8607):373—4. Treatment outlines for the management of anxiety states. Aust N Z J Psychiatry 1985;19(2):138-51. Tyrer P, Seivewright N, Ferguson B. Murphy S. Darling C. Brothwell J. Kingdon D. Johnson AL. The Nottingham Study of Neurotic Disorder: relationship between personality status and symptoms. Psychol Med 1990 May;20(2):423-31. Tyrer P. Seivewright N. Murphy S. Ferguson B. Kingdon D. Barezak P. Brothwell J. Darling C. Gregory S. Johnson AL. The Nottingham study of neurotic disorder: comparison of drug and psychological treatments. Lancet 1988 Jul 30; 2(8605):235-40. Uhde TW. Kellner CH. Cerebral ventricular size in panic disorder. J Affective Disord 1987 Mar-Apr; 12(2):175—8. Wameke LB. Benzodiazepines: abuse and new use. Can J Psychiatry 1991 Apr;36(3):194-205. Williams RB Jr. Do benzodiazepines have a role in the prevention or treatment of coronary heart disease and other major medical disorders? .J Psychiatr Res 1990;24 Suppl 2:51-6. Wood WG. The diagnosis and management of panic disorder. Psychiatr Med 1990;8(3):197-209. Woods SW. Chamey DS. Silver JM. Krystal JH, Heninger GR. Behavioral. biochemical. and cardiovascular responses to the benzodiazepine receptor antagonist flumazenil in panic disorder. Psychiatry Res 1991 Feb;36(2):115-27. 45 - Monoamine Oxidase Inhibitors Balestrien' M. Ruggeri M, Bellantuono C. Drug treatment of panic disorder--a critical review of controlled clinical trials. Psychiatr Dev 1989 Winter;7(4):337-50. Ballenger JC. Long-term pharmacologic treatment of panic disorder. J Clin Psychiatry 1991 Feb;52 Suppl:18-23; discussion 24-5. Ballenger JC. Pharmacotherapy of the panic disorders. J Clin Psychiatry 1986 Jun;47 Supplz27-32. Beardslee SL. Papadakis E, Fontana DJ, Commissaris RL. Antipanic drug treatments: failure to exhibit anxiolytic-like effects on defensive burying behavior. Phannacol Biochem Behav 1990 Feb; 35(2):451-5. Buigues J. Vallejo J. Therapeutic response to phenelzine in patients with panic disorder and agoraphobia with panic attacks. J Clin Psychiatry 1987 Feb;48(2):55-9. Davis DM. Update on the treatment of panic attacks. J Med Assoc Ga 1988 Nov;77(11):83l-2. Dilsaver SC. Panic disorder. Am Fam Physician 1989 Jun;39(6):167-72. Fishman SM, Sheehan DV, Carr DB. Thyroid indices in panic disorder. J Clin Psychiatry 1985 Oct; 46(10):432-3. Fontana DJ , Carbary TJ, Commissaris RL. Effects of acute and chronic anti-panic drug administration on conflict behavior in the rat. Psychopharmacology (Berlin) l989;98(2):157-62. Giesecke ME. Panic disorder in university students: A review. J Am Coll Health 1987;36(3):l49—57. Gold DD It. Management of panic disorder: Case reports support a potential role for amoxapine. Hosp Formul 1990;25(11):1178-79. 1182-4. Gold DD Jr. Panic Attacks: Diagnosis and management. Cardiovasc Rev Rep l988;9(1):35-7, 40. Goodman WK, Chamey DS. Therapeutic applications and mechanisms of action of monoamine oxidase inhibitor and heterocyclic antidepressant drugs. J Clin Psychiatry 1985 Oct;46(10 Pt 2):6-24. Gorman JM. Panic disorders. Mod Probl Pharmacopsychiatry 1987;22:36-90. 46 Hudson 11. Pope HG Jr. Affective spectrum disorder: does antidepressant response identify a family of disorders with a common pathophysiology? Am J Psychiatry 1990 May;l47(5):552-64. Jann MW. Kurtz NM. Treatment of panic and phobic disorders. Clin Pharm 1987 Dec;6(12):947-62. Johnston AL. File SE. Profiles of the antipam'c compounds. triazolobenzodiazepines and phenelzine, in two animal tests of anxiety. Psychiatry Res 1988 Jul;25(l):81-90. Judd FK, Norman TR. Burrows GD. Pharmacological treatment of panic disorder. Int Clin Psychopharmacol 1986 Jan;1(1):3-16. Judd FK. Norman TR. Burrows GD. Pharmacotherapy of panic disorder. Int Rev Psychiatry 1990; 2(3-4):399—409. Katon W. Panic disorder: epidemiology. diagnosis. and treatment in primary care. J Clin Psychiatry 1986 Oct;47 Supp1:21-30. Katon W. Vitaliano PP. Russo J. Corrnier L, Anderson K, Jones M. Panic disorder: epidemiology in primary care. J Fam Pract 1986 Sep;23(3):233—9. King D. Nicolini H. de la Fuente JR. Abuse and withdrawal of panic treatment drugs. Psychiatr Ann 1990 Sep;20(9):525-8. Klein DF. Psychopharmacologic treatment of panic disorder. Psychosomatics 1984:2500 Suppl):32-6. Klein DF. Klein HM. The utility of the panic disorder concept. Eur Arch Psychiatry Neurol Sci 1989; 238(5-6):268—79. Liebowitz MR. Antidepressants in panic disorders. Br J Psychiatry Suppl 1989 Oct;(6):46-52. Liebowitz MR. 'l‘ricyclic antidepressants and monoarnine oxidase inhibitors in the treatment of panic disorder: brief review. Psychopharmacol Bull 1989;25(1):17-20. Liebowitz MR. Ballenger J. Barlow DH. Davidson J, Foa EB. Fyer A. New perspectives on anxiety disorders in DSM-IV and ICD-lO. Drug Ther 1990;20 Suppl:129-36. Linnoila MI. Anxiety and alcoholism. J Clin Psychiatry 1989 Nov;50 Supplz26-9. Lydiard RB. - Pharmacological treatment. Psychiatr Ann 1988 Aug;18(8):468-72. Lydiard RB. Ballenger JC. Antidepressants in panic disorder and agoraphobia. J Affective Disord 1987 Sep-Oct;13(2):153-68. Lydiard RB. Laraia MT, Howell EF, Ballenger JC. Can panic disorder present as irritable bowel syndrome? J Clin Psychiatry 1986 Sep;47(9):470—3. Lydiard RB. Laraia MT, Howell EF. Fossey MD. Reynolds RD. Ballenger JC. Phenelzine treatment of panic disorder: lack of effect on pyridoxal phosphate levels. J Clin Psychopharmacol 1989 Dec;9(6):428-31. Mattick RP. Andrews G. Hadzi—Pavlovic D. Christensen H. Treatment of panic and agoraphobia. An integrative review. J Nerv Ment Dis 1990 Sep; 178(9):567-76. Modigh K. Antidepressant drugs in anxiety disorders. Acta Psychiatr Scand Suppl 1987;335:57-74. Murphy DL, Siever LJ, Insel TR. Therapeutic responses to tricyclic antidepressants and related drugs in non-affective disorder patient populations. Prog Neuropsychopharmacol Biol Psychiatry 1985; 9(1):3-13. Muskin PR. Panics. prolapse. and PVCs. Gen Hosp Psychiatry 1985 Jul;7(3):219-23. Norman TR. Burrows GD. Monoamine oxidase, monoamine oxidase inhibitors. and panic disorder. J Neural Transm Suppl 1989;28:53-63. Noyes R Jr. Perry P. Maintenance treatment with antidepressants in panic disorder. J Clin' Psychiatry 1990 Dec;51 Suppl A:24-30. O'Boyle M. Panic disorder. diagnosis and treatment. Tex Med 1989 Aug;85(8):46—9. Overall JE. Sheehan DV. Multivariate analysis of changes in panic frequency counts. Clin Neuropharmacol 1986;9 Suppl 4:155-7. ' Ozdaglar A. Wiedemann K, Lauer CJ. Krieg JC. Brofarominc (CGP 11305 A) in the treatment of panic disorders. Pharmacopsychiatry 1989; 22(5):211-2. Pecknold JC. Behavioural and combined therapy in panic states. Prog Neuropsychopharmacol Biol Psychiatry 1987;11(2-3):97-104. Raj A. Sheehan DV. Panic anxiety: diagnosis. etiology. and treatment. Compr Ther 1986 Oct; 12(10):7-15. Rickels K. Antianxiety therapy: potential value of long-term treatment. J Clin Psychiatry 1987 Dec;48 Supplz7-11. Sargent M. Panic disorder. Hosp Community Psychiatry 1990 Jun;41(6):621-3. Schatzberg AF, Ballenger JC. Decisions for the clinician in the treatment of panic disorder: when to treat. which treatment to use, and how long to treat. J Clin Psychiatry 1991 Feb;52 Supp1226-31; discussion 32. Scrignar CB. Postpanic anxiety disorder: diagnosis and treatment. South Med J 1986 Apr;79(4):400-4. Sheehan DV. Monoamine oxidase inhibitors and alprazolam in the treatment of panic disorder and agoraphobia. Psychiatr Clin North Am 1985 Mar; 8(1):49-62. Sheehan DV. Sheehan KH. Pharmacological treatment of panic and anxiety disorders. ISI Atlas Sci Pharmacol 1987;1(3):254-6. Sheehan DV. Soto S. Recent developments in the treatment of panic disorder. Acta Psychiatr Scand Suppl 1987;335:75-85. Shelton RC. Diagnosis and management of panic disorder: Compr Ther 1990 Dec;16(12):11-7. Stewart RS. Pharmacologic treatment of panic disorder and agoraphobia. Hosp Formul 1990;25(4):416-22. Swinson RP, Pecknold JC, Kuch K. Psychopharmacological treatment of panic disorder and related states: a placebo controlled study of alprazolam. Prog Neuropsychopharmacol Biol Psychiatry 1987;11(2-3):105-13. Taylor CB, Hayward C. Cardiovascular considerations in selection of anti-panic pharmacotherapy. J Psychiatr Res 1990;24 Suppl 2:43-9. Tesar GE. Rosenbaum JF. Successful use of clonazepam in patients with treatment-resistant panic disorder. J Nerv Ment Dis 1986 Aug;l74(8): 477-82. Treatment outlines for the management of anxiety states. A'ust N Z J Psychiatry 1985;l9(2):138-51. Tyrer P. Shawcross C. Monoamine oxidase inhibitors in anxiety disorders. J Psychiatr Res 1988;22 Suppl 1:87-98. Wesner RB. Noyes R Jr. Tolerance to the therapeutic effect of phenelzine in patients with panic disorder. J Clin Psychiatry 1988 Nov;49(11):450-1. Westenberg HG. den Boer IA. Selective monoamine uptake inhibitors and a serotonin antagonist in the treatment of panic disorder. Psychopharmacol Bull l989;25(1):ll9-23. Westenberg HG. den Boer IA. Selective monoamine uptake inhibitors and a serotonin antagonist in the 47 treatment of panic disorder. Psychopharmacol Bull l989;25(1):124-7. Whiteford HA. Evans L. Agoraphobia and the dexamethasone suppression test: Atypical depression? Aust N Z J Psychiatry 1984;18(4): 374-7. Wood WG. The diagnosis and management of panic disorder. Psychiatr Med 1990;8(3):197-209. 48 - Other Pharmacological Treatments Brady KT, Zarzar M, Lydiard RB. Fluoxetine in panic disorder patients with imipramine-associated weight gain. J Clin Psychopharmacol 1989 Feb;9(1):66-7. Breier A. Chamey DS, Heninger GR. The diagnostic validity of anxiety disorders and their relationship to depr essive illness. Am J Psychiatry 1985 Jul; 142(7):787-97. Chamey DS, Woods SW, Goodman WK, Rifltin B, Kinch M, Aiken B, Quadrino LM, Heninger GR. Drug treatment of panic disorder: the comparative efficacy of irnipramine, alprazolam, and trazodone. J Clin Psychiatry 1986 Dec;47(12):580-6. Clark DB, Taylor CB, Roth WT, Hayward C, Ehlers A. Margraf J, Agras WS. Surreptitious drug use by patients in a panic disorder study. Am J Psychiatry 1990 Apr,147(4):507-9. Coryell W, Noyes R. Placebo response in panic disorder. Am J Psychiatry 1988 Sep;l45(9): 1138-40. Dager SR. Khan A, Cowley D, Avery DH, Elder J, Roy-Byme P, Dunner DL. Characteristics of placebo response during long-tent: treatment of panic disorder. Psychopharmacol Bull 1990; 26(3):273-8. Den Boer JA, Westenberg HG. Effect of a serotonin and noradrenaline uptake inhibitor in panic disorder; a double-blind comparative study with fluvoxamine and maprotiline. Int Clin Psychopharmacol 1988 Jan;3(1):59-74. Den Boer JA. Westenberg HG. Kamerbeek WD, Verhoeven WM, Kahn RS. Effect of serotonin uptake inhibitors in anxiety disorders; a double—blind comparison of clomiprarnine and fluvoxamine. Int Clin Psychopharmacol 1987 Jan;2(1):21-32. Den Boer JA, Westenberg HG, Mastenbroek B, van Ree IM. The ACTH (4-9) analog ORG 2766 in panic disorder: a preliminary study. Psychopharmacol Bull l989;25(2):204-8. Eriksson E, Carlsson M, Nilsson C, Soderpalrn B. Does alprazolatn, in contrast to diazepam, activate alpha 2-adrenoceptors involved in the regulation of rat growth hormone secretion? Life Sci 1986 Apr 21;38(16):1491-8. Fyer AJ, Liebowitz MR, Gortnan JM, Campeas R, Levin A, Sandberg D, Fyer M, Hollander E. Papp L, Goetz D. et al. Effects of clonidine on alprazolam discontinuation in panic patients: a pilot study. J Clin Psychopharmacol 1988 Aug;8(4):270-4. Gastfriend DR, Rosenbaum IF. Adjunctive buspirone in benzodiazepine treatment of four patients with panic disorder. Am J Psychiatry 1989 Jul;146(7): 914-6. Gold DD Jr. Management of panic disorder: Case reports support a potential role for arnoxapine. Hosp Formul 1990;25(11):1178-79, 1182-4. Gold DD Jr. Panic Attacks: Diagnosis and management. Cardiovasc Rev Rep 1988;9(1):35-7, 40. Goodman WK, Chamey DS, Price LH. Woods SW, Heninger GR. Ineffectiveness of clonidine irt the treatment of the benzodiazepine withdrawal syndrome: report of three cases. Am J Psychiatry 1986 Jul;143(7):900-3. Gorman JM, Liebowitz MR, Dillon D, Fyer A], Cohen BS, Klein DF. Antipanic drug effects during lactate infusion in lactate-refractory panic patients. Psychiatry Res 1987 Jul;21(3):205-12. German JM, Liebowitz MR, Fyer AJ, Goetz D, Carnpeas RB. Fyer MR, Davies SO, Klein DF. An open trial of fluoxetine in the treatment of panic attacks [published erratum appears in J Clin Psychopharmacol 1988 Feb;8(1):13]. J Clin Psychopharmacol 1987 Oct;7(5):329-32. Griez E, Pols H, Lousberg H. Serotonin antagonism in panic disorder: an open trial with ritanserin. Acta Psychiatr Belg 1988;88(5—6):372—7. Griez E, van den Hout MA. C02 inhalation in the treatment of panic attacks. Behav Res Ther 1986; 24(2):145—50. Grunhaus LJ, Cameron 0, Pande AC, Haskett RF, Hollingsworth P], Smith CB. Comorbidity of panic disorder and major depressive disorder: effects on platelet alpha 2 adrenergic receptors. Acta Psychiatr- Scand 1990 Mar;81(3):216—9. Hayes PE, Schulz SC. Beta-blockers in anxiety disorders. J Affective Disord 1987 Sep—Oct; 13(2):119-30. Heninger GR. Recent research on the neurobiology of panic. Curr Opin Psychiatry 1989;2(1):112-6. Heninger GR, Chamey DS, Price LH. Noradrenergic and serotonergic receptor system function in panic disorder and depression. Acta Psychiatr Scand Suppl 1988;341:138—50. Jann MW, Kurtz NM. Treatment of panic and phobic disorders. Clin Pharrn 1987 Dec;6(12):947-62. Judd FK. Norman TR. Burrows GD. Pharmacotherapy of panic disorder. Int Rev Psychiatry 1990; 2(3-4):399—409. Klein E, Uhde TW. Controlled study of verapamil for treatment of panic disorder. Am J Psychiatry 1988 Apr;145(4):431-4. Klerman GL. Panic disorder: strategies for long-term treatment. J Clin Psychiatry 1991 Feb;52 Supplz3-5. Levinson DF, Acquaviva J. Exacerbation of panic disorder during propranolol therapy. J Clin Psychopharmacol 1988 Jun;8(3):193-5. Liegghio NE, Yeragani VK, Moore NC. Buspirone- induced jitteriness in three patients with panic disorder and one patient with generalized anxiety disorder. J Clin Psychiatry 1988 Apr;49(4):165-6. Marconi PL, Gismondi R. Valigi R. Pancheri P. ALFA Project: An expert system on pharmacological treatment of panic attack disorder. New Trends Exp Clin Psychiatry 1988 Jan-Mar.4(l):25-36. Mavissakalian M, Perel J, Bowler K. Dealy R. Trazodone in the treatment of panic disorder and agoraphobia with panic attacks. Am J Psychiatry 1987 Jun;l44(6):785-7. McNamara ME, Fogel BS. Anticonvulsant-responsive panic attacks with temporal lobe EEG abnormalities. J Neuropsychiatr Clin Neurosci 1990 SPfin8;2(2):193-6. Mellergard M. Rosenberg NK. Patterns of response during placebo treatment of panic disorder. Acta Psychiatr Scand 1990 Apr;8l(4):340-4. Middleton HC. An enhanced hypotensive response to clonidine can still be found in panic patients despite psychological treatment. J Anxiety Disord 1990; 4(3):213-9. Munjack DJ. Crocker B. Cabe D, Brown R, Usigli R, Zulueta A. McManus M. McDowell D. Palmer R. Leonard M. Alprazolam, propranolol. and placebo in the treatment of panic disorder and agoraphobia With panic attacks. J Clin Psychopharmacol 1989 Feb;9(1):22-7. Munjack DJ, Reba] R. Shancr R. et a1. Imipramine versus propranolol for the treatment of panic attacks: A pilot study. Compr Psychiatry 1985; 26(1):80-9. Murphy DL. Pigott TA. A comparative examination of a role for serotonin in obsessive compulsive disorder, panic disorder. and anxiety. J Clin Psychiatry 1990 Apr;51 Suppl:S3-8; discussion 59-60. 49 Nutt DJ. Altered central alpha 2—adrenoceptor sensitivity in panic disorder. Arch Gen Psychiatry 1989 Feb;46(2):165-9. Nutt DJ. Increased central alpha 2-adrenoceptor sensitivity in panic disorder. Psychopharmacology (Berlin) 1986;90(2):268-9. Ozdaglar A, Wiedemann K, Lauer CJ, Krieg JC. Brofaromine (CGP 11305 A) in the treatment of panic disorders. Pharmacopsychiatry 1989; 22(5):211-2. Pohl R, Balon R. Yeragani VK, Gershon S. Serotonergic anxiolytics in the treatment of panic disorder: a controlled study with buspirone. Psychopathology 1989;22 Suppl 1:60-7. Pohl R. Yeragani VK, Balon R. Effects of isoproterenol in panic disorder patients after antidepressant treatment. Biol Psychiatry 1990 Aug 1;28(3):203-14. Pohl R, Yeragani VK, Ortiz A. Rainey JM Jr, Gershon S. Response of tricyclic-induced jitteriness to a phenothiazine in two patients. J Clin Psychiatry 1986 Aug;47(8):427. Primeau F. Fontaine R. GABAergic agents and panic disorder. Biol Psychiatry 1988 Dec;24(8):942—3. Primeau F, Fontaine R. Beauclair L. Valproic acid and panic disorder. Can J Psychiatry 1990 Apr;35(3): 248-50. Rapaport MH. Risch SC. Gillin JC. Golshan S. Janowsky DS. Blunted growth hormone response to peripheral infusion of human growth hormone- releasing factor in patients with panic disorder. Am J Psychiatry 1989 Jan;146(1):92-5. Reich J. The effect of personality on placebo response in panic patients. J Nerv Ment Dis 1990 Nov; 178(11):699—702. Reid TL. Raj BA, Sheehan DR. Ictal panic/epileptogenic activity: treatment with primidone. Psychosomatics 1988;29(4):431-3. Rickels K, Case WG. Schweizer E. The drug treatment of anxiety and panic disorder. Stress Med 1988; 4(4):231-9. Robinson DS. Shrotriya RC, Alms DR, Messina M, Andary J. Treatment of panic disorder: nonbenzodiazepine anxiolytics. including buspirone. Psychopharmacol Bull 1989;25(l):21-6. Rosenberg NK, Mellergard M. Rosenberg R, Beck P. Ottosson J-O. Characteristics of panic disorder patients responding to placebo. Acta Psychiatr Scand Suppl 1991;83(365):33-8. 50 Roy-Byme PP. Uhde TW. Panic disorder and major depression: Biological relationships. Psychopharmacol Bull 1985;21(3):551-4. Schittecatte M. Charles G. Depauw Y. Mesters P. Wilmotte J. Growth hormone response to clonidine in panic disorder patients. Psychiatry Res 1988 Feb;23(2): 147 -5 1. Schneier FR, Liebowitz MR. Davies SO, Fairbanks J. Hollander E. Campeas R. Klein DF. Fluoxetine in panic disorder. J Clin Psychopharmacol 1990 Apr; 10(2):ll9-21. Schweizer E, Rickels K. Buspirone in the treatment of panic disorder: A controlled pilot comparison with clorazepate. J Clin Psychopharmacol 1988 Aug; 8(4):303. Sheehan DV. Raj AB, Sheehan KH. Soto S. Is buspirone effective for panic disorder? J Clin Psychopharmacol 1990 Feb;10(l):3-11. Sheehan DV. Raj AB. Sheehan KH. Soto S. The relative efficacy of buspirone. imipramine and placebo in panic disorder: a preliminary report. Pharmacol Biochem Behav 1988 Apr;29(4):815-7. Sheehan DV. Zak JP. Miller JA Jr. Fanous BS. Panic disorder: the potential role of serotonin reuptake inhibitors. J Clin Psychiatry 1988 Aug;49 Suppl: 30—6. Stein MB, Uhde TW. Cortisol response to clonidine in panic disorder: comparison with depressed patients and normal controls [see comments]. Biol Psychiatry 1988 Ju1;24(3):322-30. Stewart RS. Pharmacologic treatment of panic disorder and agoraphobia. Hosp Formul 1990;25(4):416-22. Stoudemire A. Ninan PT. Wooten V. Hypnogenic paroxysmal dystonia with panic attacks responsive to drug therapy. Psychosomatics 1987 May;28(5): 280-1. Taylor DP. Serotonin agents in anxiety. Ann New York Acad Sci 1990;600:545-57. Tondo L. Burrai C. Scamonatti L. Toccafondi F, et a1. Carbamazepine in panic disorder. Am J Psychiatry 1989 Apr;146(4):558-9. Tundo A, Minnai G. Agoraphobic-panic disorder and carbamazepine. Med Sci Res 1989 0ct;17(19): 801-2. Uhde TW. Stein MB. Vittone BJ. Siever LI. Boulenger JP. Klein E. Mellman TA. Behavioral and physiologic effects of short-term and long-term administration of clonidine in panic disorder. Arch Gen Psychiatry 1989 Feb;46(2):170-7. Uhde TW. Stein MB. Post RM. Lack of efficacy of carbamazepine in the treatment of panic disorder. Am J Psychiatry 1988 Sep;145(9):1104-9. Uhde TW. Vittone BJ. Siever LJ, Kaye WH, Post RM. Blunted growth hormone response to clonidine in panic disorder patients. Biol Psychiatry 1986 Sep;21(11):1081-5. Westenberg HG. den Boer JA. Selective monoamine uptake inhibitors and a serotonin antagonist in the treatment of panic disorder. Psychopharmacol Bull 1989;25(1):119-23. Westenberg HG. den Boer JA. Selective monoamine uptake inhibitors and a serotonin antagonist in the treatment of panic disorder. Psychopharmacol Bull 1989;25(1):124-7. Westenberg HG, den Boer JA. Serotonin-influencing drugs in the treatment of panic disorder. Psychopathology 1989;22 Suppl 1:68-77. Yeragani VK. Balon R, Pohl R. Schizophrenia, panic attacks. and antidepressants. Am J Psychiatry 1989 Feb;146(2):279. Yeragani VK. Pohl R, Balon R. Lactate-induced panic and beta—adrenergic blockade. Psychiatry Res 1990 Apr;32(1):93-4. - Reviews Balestrieri M. Ruggeri M. Bellantuono C. Drug treatment of panic disorder--a critical review of controlled clinical trials. Psychiatr Dev 1989 Winter;7(4):337-50. Ballenger JC. Long-term pharmacologic treatment of panic disorder. J Clin Psychiatry 1991 Feb;52 Supp1:18-23; discussion 24-5. Ballenger JC. Pharmacotherapy of the panic disorders. J Clin Psychiatry 1986 Jun;47 Suppl:27-32. Burrows GD. Norman TR, Judd FK. Panic disorder: a treatment update. J Clin Psychiatry 1991 Jul;52 (7 Suppl):24-6. Cassano GB, Perugi G. McNair DM. Panic disorder: review of the empirical and rational basis of pharmacological treatment. Pharmacopsychiatry 1988 Jul;21(4):157-65. Davis DM. Update on the treatment of panic attacks. J Med Assoc Ga 1988 Nov;77(11):831-2. Judd FK. Norman TR, Burrows GD. Pharmacological treatment of panic disorder. Int Clin Psychopharmacol 1986 Jan;1(1):3-16. Judd FK, Norman TR. Burrows GD. Pharrnacotherapy of panic disorder. Int Rev Psychiatry 1990; 2(3-4):399-409. Klein DF. Psychopharmacologic treatment of panic disorder. Psychosomatics 1984;25(10 Suppl):32—6. Liebowitz MR. Tricyclic antidepressants and monoamine oxidase inhibitors in the treatment of panic disorder: brief review. Psychopharmacol Bull 1989;25(1):l7-20. Liebowitz MR. Fyer AJ. Gorman J. Klein DF. Recent developments in the understanding and phannacotherapy of panic attacks. Psychopharmacol Bull l986;22(3):792-6. Lydiard RB. Pharmacological treatment. Psychiatr Ann 1988 Aug;18(8):468-72. Lydiard RB, Roy-Byme PP. Ballenger JC. Recent advances in the psychopharmacological treatment of anxiety disorders. Hosp Community Psychiatry 1988 Nov;39(11):1157-65. Philipp M. Maier W. Buller R. Pharmacotherapy of panic attacks. Pharrnacopsychiatry 1988 Nov; 21 (6):281-2. 51 Sheehan DV. Monoamine oxidase inhibitors and alprazolam in the treatment of panic disorder and agoraphobia. Psychiatr Clin North Am 1985 Mar;8(1):49v62. Sheehan DV. Sheehan KH. Pharmacological treatment of panic and anxiety disorders. ISI Atlas Sci Pharrnacol l987;1(3):254-6. Stewart RS. Pharmacologic treatment of panic disorder and agoraphobia. Hosp Formul 1990;25(4):416-22. Tiller JW. The new and newer antianxiety agents. Med J Aust 1989 Dec 4-18;151(11-12):697-701. Treatment of syndromes or of symptoms in psychiatry? Lancet 1988;2(8607):373-4. 52 TREATMENTS: Psychosocial - Cognitive/Behavioral Therapies Barlow DH. Behavioral conception and treatment of panic. Psychopharmacol Bull 1986;22(3):802-6. Barlow DH. In defense of panic disorder with agoraphobia and the behavioral treatment of panic: A comment on Kleiner. Behavior Ther 1986 May; 9(5):99-100. Barlow DH. Long-term outcome for patients with panic disorder treated with cognitive-behavioral therapy. J Clin Psychiatry 1990 Dec;51 Suppl A: 17-23. Barlow DH. Craske MG. Cemy JA. Klosko JS. . Behavioral treatment of panic disorder. Behav Ther 1989;20(2):261-82. Borden JW, Clum GA. Broyles SE, Watkins PL. Coping strategies and panic. I Anxiety Disord 1988;2(4):339-52. Clark DM. A cognitive approach to panic. Behav Res Ther l986;24(4):46l-70. Clark DM. Salkovskis PM. Chalkley AJ. Respiratory conlrol as a treatment for panic attacks. J Behav Ther Exp Psychiatry 1985 Mar;16(1):23-30. Clum GA, Borden JW. Etiology and treatment of panic disorders. Prog Behav Modif 1989;24:192-222. Craske MG, Street L. Barlow DH. Instructions to focus upon or distract from internal cues during exposure treatment of agoraphobic avoidance. Behav Res Ther 1989;27(6):663-72. Dattilio FM. Symptom induction and de-escalation in the treatment of panic attacks. J Ment Health Courts 1990 Oct;12(4):515-9. Dattilio FM. The use of paradoxical intention in the treatment of panic attacks. I Couns Dev 1987 Oct; 66(2):102-3. de Ruiter C, Ryken H, Garssen B. Kraaimaat F. Breathing retraining. exposure and a combination of both, in the treatment of panic disorder with agoraphobia. Behav Res Ther 1989;27(6):637-55. Frances A. Shear MK, Fyer MR. "Relaxation-induced panic (RIP): When resting isn't peaceful": Commentary. Integr Psychiatry 1987 Dec;5(4): 295-6. Gelder MG. Psychological treatment of panic anxiety. Psychiatr Ann 1990 Sep;20(9):529—32. Gilbert C. Skin conductance feedback and panic attacks. Biofeedback Self Regul 1986 Sep; 1 1(3):251-4. Gitlin B, Martin J. Shear MK. Frances A. Ball G. Josephson S. Behavior therapy for panic disorder. J Nerv Ment Dis 1985 Dec;173(12):742-3. Hegel MT. Abel GG, Etscheidt M. Cohen-Cole S, Wilmer CI. Behavioral treatment of angina-like chest pain in patients with hyperventilation syndrome. J Behav Ther Exp Psychiatry 1989 Mar; 20(1):31-9. Hibbert GA, Chan M. Respiratory control: its contribution to the treatment of panic attacks. A controlled study. Br J Psychiatry 1989 Feb; 154:232-6. Klosko JS. Barlow DH. Cognitive-behavioral treatment of panic attacks. J Integr Eclectic Psychother 1987 Winter;6(4):462-9. Laraia MT, Stuart GW. Best CL. Behavioral treatment of panic-related disorders: a review. Arch Psychiatr Nurs 1989 Jun;3(3):125-33. Levis DJ. Treating anxiety and panic attacks: The conflict model of Irnplosive Therapy. J Integr Eclectic Psychother 1987 Winter;6(4):450-6l. Lindemann C. "Relaxation-induced panic (RIP): When resting isn’t peaceful": Commentary. A. Integr Psychiatry 1987 Jun;5(2):109-10. Marchione KE, Michelson L. Greenwald M. Dancu C. Cognitive behavioral treatment of agoraphobia. Behav Res Ther 1987 25(5):319-28. Marks 1M. Behavioral aspects of panic disorder. Am J Psychiatry 1987 Sep;144(9):1160-5. Marriott P. Panic and phobic disorders. Current cognitive behavioural strategies. Aust Fam Physician 1990 Sep;19(9):l357. 1360-2, 1365-70. McNamee G. O'Sullivan G. Lelliott P. Marks 1. Telephone—guided treatment for housebound agoraphobics with panic disorder: Exposure vs. relaxation. Behav Ther l989;20(4):491-7. Michelson L. Marchione K. Greenwald M. Glanz L. Testa S. Marchione N. Panic disorder: cognitive- behavioral treatment. Behav Res Ther 1990;28(2): 141-51. 0st LG. A maintenance program for behavioral treatment of anxiety disorders. Behav Res Ther 1989;27(2):123—30. Ost LG. Applied relaxation in the treatment of panic ' disorder. Special Issue: Applied relaxation: Method and applications. Scand J Behav Ther 1988;17(2): 1 1 1-24. Ost LG. Applied relaxation vs progressive relaxation in the treatment of panic disorder. Behav Res Ther 1988;26(1):13-22. 0st LG. Coping techniques in the treatment of anxiety disorders: Two controlled case studies. Behav Psychother 1985; 13(2): 154-61 . Putkonen AR. Behavior therapy of panic disorders. Proceedings of the World Psychiatric Association on the Psychopathology of Panic Disorders: Many faces of panic disorder (1988. Espoo. Finland). Psychiatr Fenn 1989;Suppl:127-32. Rapee RM. A case of panic disorder treated with breathing retraining. J Behav Ther Exp Psychiatry 1985 Mar;16(l):63-5. Rapee RM. Barlow DH. Cognitive-behavioral treatment. Psychiatr Ann 1988 Aug;18(8):473-7. Salkovskis PM. Clark DM. Hackmann A. Treatment of panic attacks using cognitive therapy without exposure or breathing retraining. Behav Res Ther l991;29(2):161-6. Salkovskis PM. Jones DR, Clark DM. Respiratory control in the treatment of panic attacks: replication and extension with concurrent measurement of behaviour and pC02. Br J Psychiatry 1986 May; 148:526-32. Schwartz RM, Michelson L. States-of—mind model: Cognitive balance in the treatment of agoraphobia. J Consult Clin Psychol 1987 Aug;55(4):557-65. Shear MK, Ball G. Josephson S. An empirically developed cognitive-behavioral treatment of panic. J Integr Eclectic Psychother 1987 Winter;6(4): 421-33. Sokol L, Beck AT, Greenberg RL, Wright FD. Berchick RJ. Cognitive therapy of panic disorder. A nonpharmacological alternative. J Nerv Ment Dis 1989 Dec;177(12):711-6. Swinson RP, Kuch K. Behavioural psychotherapy of agoraphobia/panic disorder. Special Issue: Behavioural psychotherapy into the 1990's. Int Rev Psychiatry l989;1(3):l95-205. Tarrier N. Main CJ. Applied relaxation training for generalised anxiety and panic attacks: the efficacy of a learnt coping strategy on subjective reports. Br J Psychiatry 1986 Sep;149:330-6. 53 Watkins PL, Sturgis ET, Clum GA. Guided imaginal coping: an integrative treatment for panic disorder. J Behav Ther Exp Psychiatry 1988 Jun;19(2): 147-55. Wells A. Panic disorder in association with relaxation induced anxiety: An attentional training approach to treatment. Behav Ther 1990;21(3):273—80. 54 - Other Psychotherapies Borkovec TD, Mathews AM. Treatment of nonphobic anxiety disorders: A comparison of nondirective. cognitive. and coping desensitization therapy. J Consult Clin Psychol 1988 Dec;56(6):877-84. Boume S. Panic attacks: New approaches to an old problem. Br J Psychiatry 1987 Feb;150:265—6. Craske MG. Burton T. Barlow DH. Relationships among measures of communication. marital satisfaction and exposure during couples treatment of agoraphobia. Behav Res Ther l989;27(2):31-140. Der DF. Lewington P. Rational self-directed hypnotherapy: a treatment for panic attacks. Am J Clin Hypn 1990 Jan;32(3):160-7. Feist E. An innovative programme for the treatment of panic attacks: A case study. Aust J Clin Hypnother Hypnosis 1986 Sep;7(2):122-6. Katschnig H. Strategies for treating primary and secondary symptoms of panic disorder: A conceptual framework. Proceedings of the World Psychiatric Association on the Psychopathology of Panic Disorders: Many faces of panic disorder (1988, Espoo. Finland). Psychiatr Fenn 1989; Suppl:l 12-9. Leistikow D. Panic disorder: An in utero problem. Med Hypnoanal J 1987 Mar;2(1):25—31. Martinsen EW, Hoffart A, Solberg OY. Aerobic and non-aerobic forms of exercise in the treatment of anxiety disorders. Stress Med 1989;5(2):115-20. Matez A. The rapid treatment of fear. panic and phobia disorders using hypnoanalysis . . . with illustrative case history summaries. J Am Acad Med Hypnoanal 1986 Dec;1(2):68-87. Milrod B, Shear MK. Psychodynamic treatment of panic: three case histories. Hosp Community Psychiatry 1991 Mar;42(3):311-2. SartOry G, Olajide D. Vagal innervation techniques in the treatment of panic disorder. Behav Res Ther 1988;26(5):431-4. Silber A. Panic attacks facilitating recall and mastery: implications for psychoanalytic technique. J Am Psychoanal Assoc 1989;37(2):337-64. Stoeri JH. Psychoanalytic psychotherapy with panic states: A case presentation. Psychoanal Psychol 1987;4(2):101-13. Straub JH. An eclectic counseling approach to the treatment of panics. J Integr Eclectic Psychother 1987 Winter;6(4):434-49. Wolfe BE. Phobias, panic and psychotherapy integration. J Integr Eclectic Psychother 1989 Fall;8(3):264-76. - Reviews McNally RJ. Psychological approaches to panic disorder: a review. Psychol Bull 1990 Nov; 108(3):403-19. 55 Combined Treatments Beitrnan BD, Basha IM. Trombka LH. Panic attacks and their treatrnmt: An introduction. J Integr Eclect Psychother 1987 Winter;6(4):412-20. Burrows GD. Managing long-term therapy for panic disorder. J Clin Psychiatry 1990 Nov;51 Suppl: 9-12. Clum GA. Psychological interventions vs. drugs in the treatment of panic. Behav Ther l989;20(3):429—57. Hamett DS. Panic disorder: integrating psychotherapy and psychophannacology. Psychiatr Med 1990;8(3): 21 1-22. Judd FK, Burrows GD. Panic and phobic disorders-- are psychological or pharmacological treatments effective? Aust N Z J Psychiatry 1986 Sep;20(3): 342-8. Klosko JS. Barlow DH. Tassinari R. Cemy JA. A comparison of alprazolam and behavior therapy in treatment of panic disorder. J Consult Clin Psychol 1990 Feb;58(1):77-84. Kupfer DJ. Lessons to be learned from long-term treatment of affective disorders: potential utility in panic disorder. J Clin Psychiatry 1991 Feb;52 Suppl:12—6; discussion 17. Marks 1. Behavioural and drug treatments of phobic and obsessive-compulsive disorders. Psychother Psychosom 1986;46(1-2):35-44. Mattick RP, Andrews G. Hadzi-Pavlovic D. Christensen H. Treatment of panic and agoraphobia. An integrative review. J Nerv Ment Dis 1990 Sep; 178(9):567-76. Mavissakalian M. Differential effects of irnipramine and behavior therapy on panic disorder with agoraphobia. Psychopharmacol Bull 1989;25(l): 27-9. Mavissakalian M. Sequential combination of imipramine and self-directed exposure in the treatment of panic disorder with agoraphobia. J Clin Psychiatry 1990 May;51(5):184-8. Mavissakalian MR. Jones BA. Antidepressant drugs plus exposure treatment of agoraphobia/panic and obsessive-compulsive disorders. Special Issue: Behavioural psychotherapy into the 1990's. Int Rev Psychiatry l989;1(3):275-81. Michelson LK, Marchione K. Behavioral. cognitive. and pharmacological treatments of panic disorder with agoraphobia: critique and synthesis. J Consult Clin Psychol 1991 Feb;59(l):100-14. 56 Nagy LM. Krystal JH. Woods SW. Chamey DS. Clinical and medication outcome after short-term alprazolam and behavioral group treatment in panic disorder. 2.5 year naturalistic follow-up study. Arch Gen Psychiatry 1989 Nov;46(11):993-9. Pecknold JC. Behavioural and combined therapy in panic states. Prog Neuropsychopharmacol Biol Psychiatry 1987;11(2-3):97-104. Sheehan DV. Soto S. Recent developments in the treatment of panic disorder. Acta Psychiatr Scand Suppl 1987;335:75—85. Smith GR. O’Rourke DF. Parker PE, Ford CV, et a1. Panic and nausea instead of grief in an adolescent. J Am Acad Child Adolesc Psychiatry 1988 Jul; 27(4):509-13. Taylor CB. King R. Margraf J. Ehlers A. Telch M. Roth WT. Agras WS. Use of medication and in vivo exposure in volunteers for panic disorder research. Am J Psychiatry 1989 Nov;146(11):l423-6. Tobena A. Sanchez R. Pose R, Masana J. et a1. Brief treatment with alprazolam and behavioral guidance in panic disorder. Anxiety Res 1990 Nov;3(3): 163-74. Treatment outlines for the management of anxiety states. Aust N Z J Psychiatry 1985;19(2):138-51. Tyrer P, Seivewn'ght N. Murphy S. Ferguson B. Kingdon D. Barczak P, Brothwell J, Darling C. Gregory S. Johnson AL. The Nottingham study of neurotic disorder: comparison of drug and psychological treatments. Lancet 1988 Jul 30; 2(8605):235-40. Mechanism of Action of Treatments Adler CM. Craske MG, Kirshenbaum S. Barlow DH. ‘Fear of panic': an investigation of its role in panic occurrence. phobic avoidance. and treatment outcome. Behav Res Ther 1989;27(4):391-6. Argyle N. The nature of cognitions in panic disorder. Behav Res Ther 1988;26(3):261-4. Breslow MF, Fankhauser MP. Potter RL. Meredith KE. Misiaszek J. Hope DG Jr. Role of gamma- arninobutyric acid in antipanic drug efficacy. Am J Psychiatry 1989 Mar;146(3):353-6. Carr DB. Sheehan DV. Surman OS. Coleman JH. Greenblatt DJ. Heninger GR. Jones K]. Levine PH. Watkins WD. Neuroendocrine correlates of lactate- induced anxiety and their response to chronic alprazolam therapy. Am J Psychiatry 1986 Apr; 143(4):483-94. Chamey DS. Heninger GR. Noradrenergic function and the mechanism of action of antianxiety treatment. I. The effect of long-term alprazolam treatment. Arch Gen Psychiatry 1985 May;42(5): 458-67. Chamey DS. Heninger GR. Noradrenergic function and the mechanism of action of antianxiety treatment. 11. The effect of long-term imipramine treatment. Arch Gen Psychiatry 1985 May;42(5): 473-81. Chamey DS. Heninger GR. Serotonin function in panic disorders. The effect of intravenous tryptophan in healthy subjects and patients with panic disorder before and during alprazolam treatment. Arch Gen Psychiatry 1986 Nov;43(11):1059-65. Clum GA. Pendrey D. Depression symptomatology as a non-requisite for successful treatment of panic with antidepressant medications. J Anxiety Disord 1987;1(4):337-44. Coryell W, Noyes R Jr. Schlechte J. The significance of HPA axis disturbance in panic disorder. Biol Psychiatry 1989 Apr 15:25(8):989-1002. Den Boer JA. Westenberg HG. Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin. Psychopharmacology (Berl) 1990;102(1):85-94. Edlund MJ, Swann AC. Low MHPG and continuing treatment in panic disorder. Prog Neuropsychopharmacol Biol Psychiatry 1989;13(5): 701-7. Eriksson E. Brain neurotransmission in panic disorder. Acta Psychiatr Scand Suppl 1987;335:31-7. Eriksson E. Carlsson M. Nilsson C. Soderpalrn B. Does alprazolam. in contrast to diazeparn. activate alpha 2-adrenoceptors involved in the regulation of rat growth hormone secretion? Life Sci 1986 Apr 21;38(16):149l-8. Eriksson E. Westberg P. Thuresson K. Modigh K. Ekrnan R. Widerlzov E. Increased cerebrospinal fluid levels of endorphin irnmunoreactivity in panic disorder. Neuropsychopharmacology 1989 Sep; 2(3):225-8. Friedman S. Assessing the marital environment of agoraphobics. J Anxiety Disord 1990;4(4):335—40. Fyer AJ. Gorman JM, Liebowitz MR. et a1. Sodium lactate infusion. panic attacks. and ionized calcium. Biol Psychiatry 1984;19(10):1437-47. George DT. Ladenheim J A. Nutt DJ. Effect of pregnancy on panic attacks. Am J Psychiatry 1987 Aug;144(8):1078-9. Goodman WK. Charney DS. Therapeutic applications and mechanisms of action of monoamine oxidase inhibitor and heterocyclic antidepressant drugs. J Clin Psychiatry 1985 Oct;46(10 Pt 2):6-24. Gorman JM, Fyer AI. Ross DC. Cohen BS. Martinez JM, Liebowitz MR. Klein DF. Normalization of venous pH. pC02. and bicarbonate levels after blockade of panic attacks. Psychiatry Res 1985 Jan;14(1):57-65. Klein DF. The pathophysiology of panic anxiety. J Clin Psychialry 1991;52(2 Suppl):10-l. Lepola U, Jolkkonen J. Rirnzon R. Riekkinen P. Long- term effects of alprazolarn and imipramine on cerebrospinal fluid monoamine metabolites and neuropeptides in panic disorder. Neuropsychobiology 1989;21 (4): 182-6. Ley R. Dyspneic-fear and catastrophic cognitions in hyperventilatory panic attacks. Behav Res Ther 1989;27(5):S49-54. Lingjaerde O. Lactate-induced panic attacks: possible involvement of serotonin reuptake stimulation. Acta Psychiatr Scand 1985 Aug;72(2):206-8. Lopez AL. Kathol RG. Noyes R Jr. Reduction in urinary free cortisol during benzodiazepine treatment of panic disorder. Psychoneuroendocrinology 1990; 15(1):23-8. Louie AK, Lannon RA. Ketter TA. Treatment of cocaine-induced panic disorder. Am J Psychiatry 1989 Jan;146(1):40-4. 57 Marazziti D. Imipramine binding in panic disorder. Pharmacopsychiatry 1989 May;22(3):128-9. Marazziti D. Rotondo A. Placidi GF. Perugi G, Cassano GB. Pacifici GM. Binding of imipramine to platelet membranes is reduced in panic attacks. Fundarn Clin Pharmacol l988;2(2):69-75. Marazziti D, Rotondo A. Placidi GF. Perugi G. Cassano GB. Pacifici GM. Imiprarnine binding in platelets of patients with panic disorder. Pharmacopsychialry 1988 Jan;21(1):47-9. Redmond DE Jr. The possible role of locus coeruleus noradrenergic activity in anxiety-panic. Clin Neuropharmacol 1986;9 Suppl 4:40-2. Shear MK. Fyer A]. Ball G, Josephson S. Fitzpatrick M, Gitlin B, Frances A. Gorman J, Liebowitz M. Klein DF. Vulnerability to sodium lactate in panic disorder patients given cognitive-behavioral therapy. Am J Psychiatry 1991 Jun;148(6):795-7. Yeragani VK. Balon R. Pohl R. Berchou R. Merlos B, Weinberg P. Lactate induced panic and beta-2 adrenergic activation. Pharmacopsychiatry 1990 Ju1;23(4):198. 58 AGORAPHOBIA Agoraphobia. Lancet 1988 Oct 15;2(8616):881-2. Alfin PL. Agoraphobia: A study of family of origin characteristics and relationship patterns. Smith Coll Stud Soc Work 1987 Mar;57(2):134-54. Ambrosini P. Imipramine binding in agoraphobia. Psychiatry Res 1986 Jun;l8(2):l89-90. Anton RF. Ballenger JC. Lydiard RB. Laraia MT. Howell EF. Gold PW. CSF prostaglandin—E in agoraphobia with panic attacks. Biol Psychiatry 1989 Jul;26(3):257-64. Amow BA, Taylor CB. Agras WS, Telch MJ. Enhancing agoraphobic treatment outcome by changing couple communication patterns. Behav Ther 1985;16(5):452-67. Amtz A. Van den Hout MA, Lousberg R, Schouten B. Is the match/mismatch model based on a statisu'cal artefact? Behaviour Res Therapy l990;28(3): 249-53. Arrindell WA, Emmelkamp PM. Sanderman R. Marital quality and general life adjustment in relation to treatment outcome in agoraphobia. Adv Behav Res Ther 1986;8(3):139-85. Arrindell WA. Sanderman R. Van der Molen H, Van der Ende J. et al. The structure of assertiveness: A confirmatory approach. Behav Res Ther 1988; 26(4):337-9. Ascher LM, Schotte DE, Grayson IB. Enhancing effectiveness of paradoxical intention in treating travel restriction in agoraphobia. Behav Ther 1986 Mar;l7(2):124-30. Badalamenti AF. Psychopharmacology of agoraphobia and a hypothesis of Sigmund Freud. Dyn Psychother 1985 Fall-Winter;3(2):lS9-68. Barlow DH. R.S. Hallam: Anxiety: Psychological perspectives on panic and agoraphobia. Behav Res Ther 1986;24(6):693-6. Baum M. An animal model for agoraphobia using a safety-signal analysis. Behav Res Ther 1986; 24(1):87-9. Beckfield DF. Importance of altering global response style in the treatment of agoraphobia. Psychother Theory Res Pract Train l987;24(4):752-8. Bennun I. A composite formulation of agoraphobia. Am J Psychother 1986 Apr;40(2):177-88. Biran M. Cognitive and exposure treatment for agoraphobia: Reexamination of the outcome research. I Cogn Psychother 1988 Fa11;2(3):165-78. Biran MW. Two-stage therapy for agoraphobia. Am J Psychother 1987 Jan;41(1):127-36. Blanco IM. Comments on "From Symmetry to Asymmetry" by Klaus Fink. Int J Psychoanal 1989;70 (Pt 3):491-8. Bowen RC. D'Arcy C. South MN. Hawkes JE. The effects of a nurse therapist conducted behavioral agoraphobia treatment program on medical utilization. J Anxiety Disord 1990;4(4):341-9. Brown R, Munjack D. McDowell D. Agoraphobia with and without current panic attacks. Psychol Rep 1989 Apr;64(2):503-6. Burgess PM. Toward resolution of conceptual issues in the assessment of belief systems in rational-emotive therapy. J Cogn Psychother 1990 Summer;4(2 Spec Iss):l71-84. Burns LE. Thorpe GL. Cavallaro LA. Agoraphobia 8 years after behavioral treatment: A follow-up study with interview, self-report. and behavioral data. Behav Ther 1986 Nov;17(5):580-91. Butler G, Gelder M. Problem-solving: Not a treatment for agoraphobia: A reply to D'Zurilla (1985). Behav Ther 1985 Nov;16(5):548-50. Cemy JA. Barlow DH, Craske MG, Himadi WG. Couples treatment of agoraphobia: A two-year follow-up. Behav Ther 1987 Fall;l8(4):401-15. Chambless DL. Measurement effects on outcome of treatment for agoraphobia. Behav Ther 1989 Summer;20(3):465-6. Chambless DL. Spacing of exposure sessions in treatment of agoraphobia and simple phobia. Behav Therapy 1990 Spring;21(2):217—29. Chambless DL. Caputo GC. Jasin SE. Gracely E], Williams C. The Mobility Inventory for Agoraphobia. Behav Res Ther 1985;23(1):35—44. Chambless DL. Goldstein AJ. Gallagher R, Bright P. Integrating behavior therapy and psychotherapy in the treatment of agoraphobia. Psychotherapy 1986;23(1):150-9. Chambless DL, Mason J. Sex, sex—role stereotyping and agoraphobia. Behav Res Ther 1986;24(2): 231-5. Chambless DL. Woody SR. Is agoraphobia harder to treat? A comparison of agoraphobics’ and simple phobics' response to treatment. Behav Res Ther l990;28(4):305-12. Comings DE. Comings BG. Hereditary agoraphobia and obsessive-compulsive behaviour in relatives of patients with Gilles de la Tourette's syndrome. Br J Psychiatry 1987 Aug;l51:l95-9. Cottraux J. Mollard E. Duinat—Pascal A. Agoraphobia with panic attacks and social phobia: A comparative clinical and psychometric study. Psychiatr Psychobiol l988;3(l):49-56. Covelli V, Maffione AB. Jirillo E. Effects of in vivo administration of timostimolina (TP-l) on the immune system from patients with phobic disorders. New Trends Exp Clin Psychiatry 1988 0ct-Dec;4(4):213-21. Cox DJ, Ballenger JC. Laraia M. Hobbs WR, Peterson GA, Hucek A. Different rates of improvement of different symptoms in combined pharmacological and behavioral treatment of agoraphobia. J Behav Ther Exp Psychiatry 1988 Jun;19(2):ll9-26. Craske MG. Sanderson WC, Barlow DH. How do desynchronous response systems relate to the treatment of agoraphobia: A follow-up evaluation. Behav Res Ther l987;25(2):117-22. D'Zurilla TJ. Problem-solving: Still a promising treatment strategy for agoraphobia. Behav Ther 1985 Nov;l6(5):545-8. de Moor W. The topography of agoraphobia. Am J Psychotherapy 1985 Jul;39(3):371-88. Dewey D. Hunsley J. The effects of marital adjustment and spouse involvement on the behavioral treatment of agoraphobia: A meta-analytic review. Anxiety Res l990;2(2):69-83. Diamond DB. Panic attacks. hypochondriasis, and agoraphobia: a self-psychology formulation. Am J Psychother 1985 Jan;39(l):114-25. Diamond DB. Psychotherapeutic approaches to the treatment of panic attacks. hypochondriasis and agoraphobia. Br J Med Psychol 1987 Mar;60(Pt l):79—84. Eaton WW. Key] PM. Risk factors for the onset of Diagnostic Interview Schedule/DSM-III agoraphobia in a prospective. population-based study. Arch Gen Psychiatry 1990 Sep;47(9):819-24. Elsenga S. Emmelkamp PM. Behavioral treatment of an incest-related trauma in an agoraphobic client. I Anxiety Disord 1990;4(2):151-62. 59 Emanuele MA. Brooks MH. Gordon DL. Braithwaite SS. Agoraphobia and hyperthyroidism. Am J Med 1989 Apr;86(4):484-6. Emmelkamp PM. Brilman E, Kuiper H, Mersch PP. The treatment of agoraphobia: A comparison of self- instructional training, rational emotive therapy. and exposure in vivo. Behav Modif 1986 Jan;10(l): 37-53. Emmelkamp PM. Mersch PP. Vissia E. The external validity of analogue outcome research: evaluation of cognitive and behavioral interventions. Behav Res Ther 1985;23(1):83-6. Evans L. et al. Plasma serotonin levels in agoraphobia. Am J Psychiatry 1985 Feb;142(2):267. Evans L. Kenardy J . Schneider P, Hoey H. Effect of a selective serotonin uptake inhibitor in agoraphobia with panic attacks. A double-blind comparison of zimeldine, irnipramine and placebo. Acta Psychiatr Scand 1986 Jan;73(1):49—53. Evans LE. Oei TP. Hoey H. Prescribing patterns in agoraphobia with panic attacks. Med J Aust 1988 Jan 18;l48(2):74-7. Faravelli C, Webb T. Ambonetti A, Fonnesu F. Sessarego A. Prevalence of traumatic early life events in 31 agoraphobic patients with panic attacks. Am J Psychiatry 1985 Dec;142(12):1493-4. Fava GA. Kellner R. Zielezny M, Grandi S. Hypochondriacal fears and beliefs in agoraphobia. J Affective Disord 1988 May-Jun;14(3):239-44. Fava GA. Zielezny M. Luria E. Canestrari R. Obsessive—compulsive symptoms in agoraphobia: changes with treatment. Psychiatry Res 1988 Jan; 23(1):57-63. Filewich RJ. Treatment of the agoraphobic dental patient. Dent Clin North Am 1988 0ct;32(4): 723-33. ‘ Fink K. From symmetry to asymmetry. Int J Psychoanal 1989;70(Pt 3):481-9. Finkel JA. Diazepam in a patient with chronic schizophrenia complicated by agoraphobia. J Clin Psychiatry 1987 Jan;48(l):33-4. Fodor IG. Cognitive/behavior therapy for agoraphobic women: Toward utilizing psychodynamic understanding to address family belief systems and enhance behavior change. Special Issue: Women, power. and therapy: Issues for women. Women Ther 1987 Spring-Summer;6(l-2):103-23. 60 Franklin JA. A 6-year follow-up of the effectiveness of respiratory retraining, in-situ isometric relaxation. and cOgnitive modification in the treatment of agoraphobia. Behav Modif 1989 Apr;13(2):139-67. Franklin IA. The changing nature of agoraphobic fears. Br J Clin Psychol 1987 May;26(Pt 2):127-33. Friedman S. Implications of object—relations theory for the behavioral treatment of agoraphobia. Am J Psychother 1985 Oct;39(4):525-40. Friedman S. Technical considerations in the behavioral-marital treatment of agoraphobia. Am J Farn Ther 1987 Summer;15(2):lll-22. Frustaci J. A survey of agoraphobics in self-help groups. Smith Coll Stud Social Work 1988 Jun; 58(3): 193-21 1. Gerew AB, Romney DM. Leboeuf A. Synchrony and desynchrony in high and low arousal subjects undergoing therapeutic exposure. J Behav Ther Exp Psychiatry 1989 Mar;20(1):41-8. Ghosh A. Marks IM. Self-treatment of agoraphobia by exposure. Behav Ther 1987 Winter;18(1):3-16. Gloger S. Grunhaus L. Gladic D. O'Ryan F. Cohen L. Codner S. Panic attacks and agoraphobia: low dose clomiprarnine treatment. J Clin Psychopharrnacol 1989 Feb;9(1):28-32. Goldberg C. Agoraphobia: Contributing factors. phobic situations. and exposure in vivo. Psychol Rep 1986 Aug;59(1):143-60. Goldberg C. Biological model of agoraphobia: a comment. Psychol Rep 1988 Oct;63(2):571-8. Gournay KJ. The base for exposure treatment in agoraphobia: some indicators for nurse therapists and community psychiatric nurses. J Adv Nurs 1991 Jan;l6(1):82—91. Greenberg D. Belrnaker RH. DDAVP as a possible method to enhance positive benefit of behaviour therapy. Br J Psychiatry 1985 Dec;147:7l3-5. Gustavson B. Jansson L. Jerremalm A. 0st LG. Therapist behavior during exposure treatment of agoraphobia. Behav Modif 1985 Oct;9(4):491-504. Haimo S. Blitman F. The effects of assertive training on sex role concept in female agoraphobics. Women Ther 1985 Summer;4(2):S3-6l. Hamann MS. Mavissakalian M. Discrete dimensions in agoraphobia: a factor analytic study. Br J Clin Psychol 1988 May;27(Pt 2):137-44. Hazell J. Wilkins A]. A contribution of fluorescent lighting to agoraphobia. Psychol Med 1990 Aug; 20(3):591-6. Herod EL. An agoraphobic patient with dental anxiety: report of case. J Am Dent Assoc 1988 Jun;116(7): 860-1. Hirnadi WG. Safety signals and agoraphobia. J Anxiety Disord 1987;1(4):345-60. Hirnadi WG. Boice R. Barlow DH. Assessment of agoraphobia: 11. Measurement of clinical change. Behav Res Ther 1986;24(3):321-32. Himadi WG. Boice R, Barlow DH. Assessment of agoraphobia: Triple response measurement. Behav Res Titer 1985;23(3):311-23. Hirnadi WG. et al. The relationship of marital adjustment to agoraphobia treatment outcome. Behav Res Ther 1986;24(2):107-15. Hoffart A. Matinsen EW. Exposure-based integrated vs. pure psychodynamic treatment of agoraphobic inpatients. Psychotherapy 1990 Summer;27(2): 210-8. Holden AE. Barlow DH. Heart rate and heart rate variability recorded in vivo in agoraphobics and nonphobics. Behav Ther 1986 Jan;17(1):26—42. Horn TL. Agoraphobia. Am Fam Physician 1985 Jul; 32(1):165-73. Jackson HJ. Elton V. A multimodal approach to the treatment of agoraphobia: four case studies. Can J Psychiatry 1985 Nov;30(7):539—43. Jacobson NS, Holtzworth-Munroe A. Schmaling KB. Marital therapy and spouse involvement in the treatment of depression. agoraphobia. and alcoholism. J Consult Clin Psychol 1989 Feb; 57(1):5-10. Jacobson NS. Wilson L. Tupper C. The clinical significance of treatment gains resulting from exposure-based interventions for agoraphobia: A reanalysis of outcome data. Behav Ther 1988 Fall; 19(4):539-54. James JE. Desertsitization treatment of agoraphobia. Br J Clin Psychol 1985 May;24(Pt 2):133—4. Jansson L. Jerremalm A. 0st LG. Applied relaxation in the treatment of agoraphobia: Two experimental case studies. Scand J Behav Ther 1985;14(4): 169-76. Jansson L, Jerremalm A, Cat LG. Follow-up of agoraphobic patients treated with exposure in vivo or applied relaxation. Br J Psychiatry 1986 Oct; 149:486-90. Jansson L. 0st LG, Jerremalm A. Prognostic factors in the behavioral treatment of agoraphobia. Behav Psychother 1987 Jan;15(1):31-44. Johnston DG, Troyer IE, Whitsett SF. Clomipramine treatment of agoraphobic women. An eight-week controlled trial. Arch Gen Psychiatry 1988 May; 45(5):453—9. Kaplan SP. Agoraphobia in a rehabilitation medicine setting: A case report. J Courts Psychology 1987 Apr;34(2):132~5. Katemdahl DA. Factors in the panic-agoraphobia transition. I Am Board Farn Pract 1989 Jan-Mar; 2(1):10-6. Kay G. Mental health. Joyful strategies. Nurs Times 1990 Mar l4-20;86(11):69-71. Kenardy J, Evans L, Oei TPS. The importance of cognitions in panic attacks. Behav Ther 1988; l9(3):471-83. Kenardy J, Oei TP. Evans L. Neuroticism and age of onset for agoraphobia with panic attacks. J Behav Ther Exp Psychiatry 1990 Sep;21(3):193-7. Klein DF, Klein HM. The substantive effect of variations in panic measurement and agoraphobia definition. J Anxiety Disord 1989;3(1):45-56. Klein DF, Ross DC, Cohen P. Panic and avoidance in agoraphobia. Application of path analysis to treatment studies. Arch Gen Psychiatry 1987 Apr; 44(4):377-8S. Kleiner L, Marshall WL. Relationship difficulties and agoraphobia. Clin Psychol Rev 1985;5(6):581-95. Kleiner L, Marshall WL. Spevack M. Training in problem-solving and exposure treatment for agoraphobics with panic attacks. I Anxiety Disord 1987;1(3):219-38. Kleman GL. Current trends in clinical research on panic attacks, agoraphobia, and related anxiety disorders. J Clin Psychiatry 1986 Jun;47 Suppl: 37 -9. Koehler K, Vanzopoulos D, Ebel H. Agoraphobia and depression: relationships and severity in hospitalized women. Compr Psychiatry 1986 Nov-Dec;27(6): 533-9. Koksal F, Power KG. Four Systems Anxiety Questionnaire (FSAQ): A self-report measure of 61 somatic, cognitive, behavioral, and feeling components. J Pers Assess 1990 Summer;54(3—4): 534-45. Kopp M, Gruzelier J. Electrodetrnally differentiated subgroups of anxiety patients and controls. II: Relationships with auditory, somatosensory and pain thresholds, agoraphobic fear, depression and cerebral laterality. Int J Psychophysiol 1989 Mar;7(1):65-75. Kopp MS. Psychophysiological characteristics of anxiety patients and controls. Psychother Psychosom 1989;52(1-3):74-9. Kopp MS. Mihaly K, Linka E. Bitter I. Electrodennally differentiated subgroups of anxiety patients. I. Automatic and vigilance characteristics. Int J Psychophysiol 1987 May;5(1):43—5 1. Last CG, Barlow DH, O'Brien GT. Assessing cognitive aspects of anxiety. Stability over time and agreement between several methods. Behav Modif 1985 Jan;9(1):72-93. Layboume PC Jr, Redding JG. Agoraphobia. Is fear the basis of symptoms? Postgrad Med 1985 Oct; 78(5):109-12, 114, 117-8. Lazarus AA. Treating agoraphobia: Behavioral/multimodal perspectives. Psychother Priv Pract 1986 Fall;4(3):11-23. Lazarus AA, Messer SB. Clinical choice points: Behavioral versus psychoanalytic interventions. Psychotherapy 1988 Spring;25(1):59-70. LeBoeuf A. Relaxation-induced anxiety in an agoraphobic population. Perceptual Motor Skills 1986 Jun;62(3):910. Lelliott PT, Marks 1M, Monteiro W0, et a1. Agoraphobics 5 years after imipramine and exposure. Outcome and predictors. J Nerv Ment Dis 1987;175(10):599~605. ' Lewis DA. "Imipramine binding in agoraphobia": Reply. Psychiatry Res 1986 Jun;18(2):191-2. Lewis DA, Noyes R Jr, Coryell W, Clancy J. Tritiated imipramine binding to platelets is decreased in patients with agoraphobia. Psychiatry Res 1985 Sep;16(1):1-9. Ley R. Agoraphobia, the panic attack and the hyperventilation syndrome. Behav Res Ther 1985; 23(1):79-81. Ley R. Blood, breath, and fears: A hyperventilation theory of panic attacks and agoraphobia. Clin Psychol Rev 1985 ;5(4):27 1 ~85. 62 Liddell A, Acton B. Agoraphobics’ understanding of the development and maintenance of their symptoms. J Behav Ther Exp Psychiatry 1988 Dec;l9(4):261-6. Liddell A, Bilsbury CD. Rattenbury C. Concordance and discordance of cognitive, behavioural and somatic self-ratings as a function of exposure: A Discan analysis. Behav Res Ther 1987;25(5):425-8. Liddell A, et a1. Compliance as a factor in outcome with agoraphobic clients. Behav Res Ther 1986; 24(2):217-20. Lydiard RB. Desipramine in agoraphobia with panic attacks: an open. fixed-dose study. J Clin Psychopharmacol 1987 Aug;7(4):258-60. Mackay W, Liddell A. An investigation into the matching of specific agoraphobic anxiety response characteristics with specific types of treatment. Behav Res'Ther 1986;24(3):361—4. Mali D, Hudson KJ. A note on waiting list attrition. Behav Change 1988;5(4):l71-4. Marcus HP, Range CM. Community—based services for agoraphobics. Families Society 1990 Dec; 71(10):602-6. Margraf J. Ehlers A. Taylor CB. Amow B. Roth WT. Guttman scaling in agoraphobia: cross-cultural replication and prediction of treatment response patterns. Br J Clirt Psychol 1990 Feb;29(Pt 1): 37-41. Marks I. O'Suilivan G. Drugs and psychological treatments for agoraphobia/panic and obsessive— compulsive disorders: a review. Br J Psychiatry 1988 Nov;153:650-8. Matte Blanco 1. Comments on "From symmetry to asymmetry" by Klaus Fink. Int J Psychoanal l989;70(3):491-8. Mattimore-Knudson RS. Reality Therapy via proxy for paranoia and agoraphobia. Clin Gerontol 1986 Feb; 4(3):58-61. Mavissakalian M. Clinically significant improvement in agoraphobia research. Behav Res Ther 1986; 24(3):369-70. Mavissakalian M. Imipramine in agoraphobia. Compr Psychiatry 1986 Jul-Aug;27(4):401-6. Mavissakalian M. Initial depression and response to irnipramine in agoraphobia. J Nerv Ment Dis 1987 Jun;175(6):358-61. Mavissakalian M. Male and female agoraphobia: are they different? Behav Res Ther 1985;23(4):469-71. Mavissakalian M. The placebo effect in agoraphobia-- II. J Nerv Ment Dis 1988 Jul;176(7):446-8. Mavissakalian M. The placebo effect in agoraphobia. J Nerv Ment Dis 1987 Feb;l75(2):95-9. Mavissakalian M. The relationship between panic, phobic and anticipatory anxiety in agoraphobia. Behav Res Ther 1988;26(3):235-40. Mavissakalian M. Trimodal assessment in agoraphobia research: Further observations on heart rate and synchrony/desynchrony. J Psychopathol Behav Asses 1987 Mar;9(l):89-98. Mavissakalian M. Hamann MS. Assessment and significance of behavioral avoidance in agoraphobia. J Psychopathol Behav Assess 1986 Dec;8(4):317-27. Mavissakalian M. Hamann MS. DSM-III personality disorder in agoraphobia. Compr Psychiatry 1986 Sep-Oct;27(5):471-9. Mavissakalian M, Michelson L. Agoraphobia: relative and combined effectiveness of therapist-assisted in vivo exposure and imipratnine. J Clin Psychiatry 1986 Mar;47(3):117-22. Mavissakalian M, Michelson L. Two-year follow-up of exposure and irnipramine treatment of agoraphobia. Am J Psychiatry 1986 Sep;143(9):1106-12. Mavissakalian M. Perel J. Imipramine in the treatment of agoraphobia: dose-response relationships. Am J Psychiatry 1985 Sep;142(9):1032-6. Mayerhoff D. Vital—Heme J, Lesser M, Brenner R. Alprazolam-induced manic reaction. N Y State J Med 1986 Jun;86(6):320. McConaghy N, Silove D. Hall W. Behaviour completion mechanisms. anxiety and agoraphobia. Aust N Z J Psychiatry 1989 Sep;23(3):373-8. McNally RJ. Foa EB. Cognition and agoraphobia: Bias in the interpretation of threat. Special Issue: Anxiety: Cognitive factors and the anxiety disorders. Cogn Ther Res 1987 Oct;11(5):567-81. McNally RJ. Lorenz M. Anxiety sensitivity in agoraphobics. J Behav Ther Exp Psychiatry 1987 Mar;18(1):3-11. Michelson L. Treatment consonance and response profiles in agoraphobia: The role of individual differences in cognitive, behavioral and physiological treatments. Behav Res Ther 1986; 24(3):263-75. Michelson L, et al. The role of self-directed in vivo exposure in cognitive, behavioral, and psychophysiological treatments of agoraphobia. Behav Ther 1986 Mar;17(2):91-108. Michelson L, Marchione K. Marchione N, Tesla S. Mavissakalian M. Cognitive correlates and outcome of cognitive, behavioral and physiological treatments of agoraphobia. Psychol Rep 1988 Dec; 63(3):999—1004. Michelson L, Mavissakalian M. Psychophysiological outcome of behavioral and pharmacological treatments of agoraphobia. J Consult Clin Psychol 1985 Apr;53(2):229.36. Michelson L. Mavissakalian M. Marchione K. Cognitive, behavioral, and psychophysiological treatments of agoraphobia: A comparative outcome investigation. Behav Ther l988;l9(2):97—120. Michelson L. Mavissakalian M. Marchione K. Cognitive and behavioral treatments of agoraphobia: Clinical, behavioral, and psychophysiological outcomes. J Consult Clin Psychol 1985;53(6): 913-25. Michelson L. Mavissakalian M. Marchione K, Ulrich RF, Marchione N, Testa S. Psychophysiological outcome of cognitive. behavioral and psychophysiologically-based treatments of agoraphobia. Behav Res Ther l990;28(2):127-39. Milne G. Hypnosis in the treatment of single phobia and complex agoraphobia: A series of case studies. Aust J Clin Exp Hypnosis 1988 May;l6(1):53-65. Miranda D. Doctor RM. Agoraphobia: A review of research and treatment. Phobia Pract Res J 1989 Spring-Summer;2(1):37-55. Monteiro W, Marks 1M, Ramm E. Marital adjustment and treaUnent outcome in agoraphobia. Br J Psychiatry 1985 Apr;146:383-90. Moran C. Depersonalization and agoraphobia associated with marijuana use. Br J Med Psychol 1986 Jun;59(Pt 2):l87-96. Moran C, Andrews G. A familial occurrence of agoraphobia. Br J Psychiatry 1985;146:262-7. Nicholson RC. How the significant other can help an agoraphobic patient. Emphasis Nurs 1985;1(2): 57-65. Norton GR, Allen GE, Walker JR. Predicting lreatment preferences for agoraphobia. Behav Res Ther 1985; 23(6):699-701. 63 Noyes R, Chaudry DR, Domingo DV. Pharmacologic treatment of phobic disorders. J Clin Psychiatry 1986 Sep;47(9):445-52. Oatley K, Hodgson D. Influence of husbands on the outcome of their agoraphobic wives‘ therapy. Br J Psychiatry 1987 Mar;150:380-6. Ogles BM, Lambert MI, Weight DG, Payne IR. Agoraphobia outcome measurement: A review and meta-analysis. Psychol Assess 1990 Sep;2(3): 317-25. 0st LG. Psychophysiological assessment of agoraphobia. J Psychophysiol 1990;4(4):315-9. 0st LG. The Agoraphobia Scale: An evaluation of its reliability and validity. Behav Res Ther 1990; 28(4):323-9. 0st LG. Ways of acquiring phobias and outcome of behavioral treatments. Behav Res Ther 1985; 23(6):683-9. Perlrnutter RA. Psychopharmacology of attachment: Effects of successful agoraphobia treatment on marital relationships. Fam Syst Med 1990 Fall; 8(3):279-84. Persson G, Nordlund CL. Agoraphobics and social phobics: differences in background factors, syndrome profiles and therapeutic response. Acta Psychiatr Scand 1985 Feb;71(2):148-59. Peterson GA. Ballenger JC, Cox DP. Hucek A, Lydiard RB, Laraia MT. Trockman C. The dexamethasone suppression test in agoraphobia. J Clin Psychopharmacol 1985 Apr;5(2):100-2. Phillipson H. The use of O.R.T. as a facilitator of maturational processes: Some implications for a range of applications with special reference to subliminal activation of preconscious processing. Special Issue: Object Relations Technique. Br J Proj Psychol 1988 Jun;33(1):84-105. Pollack MH. Sachs GS. Tesar GE, Shushtari J, Herman JB. Otto MW . Rosenbaum JF. Pilot outreach services to homebound agdraphobic patients. Hosp Community Psychiatry 1991 Mar;42(3):315-7. Pollard CA. Respiratory distress during panic attacks associated with agoraphobia. Psychol Rep 1986 Feb;58(1):61-2. Pollard CA, Henderson JG, Frank M, Margolis RB. Help-seeking patterns of anxiety-disordered individuals in the general population. J Anxiety Disord 1989;3(3):131-8. 64 Pollard CA. Pollard HJ. Corn KJ. Panic onset and major events in the lives of agoraphobics: a test of contiguity. J Abnorm Psychol 1989 Aug;98(3): 318-21. Pyke JM. Longdon M. Agoraphobia. Can Nurse 1985 Jun;81(6):18-21. Pyke RE. Greenberg HS. Norepinephrine challenges in panic patients. J Clin Psychopharmacol 1986 Oct; 6(5):279—85. Rachman S, Craske M. Tallman K, Solyom C. Does escape behavior strengthen agoraphobic avoidance? A replication. Behav 'Iher 1986;l7(4):366-84. Rifldn A. Pecknold JC, Swinson RP. Ballenger JC. Burrows GD. Noyes R. Dupont RL, Lesser 1. Sequence of improvement in agoraphobia with panic attacks. J Psychiatr Res 1990;24(1):l-8. Rohrbaugh M. Shean GD. Anxiety disorders: An interactional view of agoraphobia. J Psychother Fm 1987 Fall;3(3):65-85. Rose SD. Group exposure: A method of treating agoraphobia. Special Issue: Group work with the emotionally disabled. Soc Work Groups 1990; 13(1):37-51. Roth WT. Telch M]. Taylor CB, Agras WS. Autonomic changes after treatment of agoraphobia with panic attacks. Psychiatry Res 1988 Apr, 24(1):95-107. Roth WT. Telch M]. Taylor CB, Sachitano JA. Gallen CC. Kopell ML. McClenahan KL. Agras WS. Pfefferbaum A. Autonomic characteristics of agoraphobia with panic attacks. Biol Psychiatry 1986 Oct;21(12):1133-54. Sakol MS. Power KG. The effects of long-term benzodiazepine treatment and graded withdrawal on psychometric performance. Psychopharmacology 1988 May;95(l):l35-8. Sanory G. Master D. Rachman S. Safety-signal therapy in agoraphobics: a preliminary test. Behav Res Ther 1989;27(2):205-9. Schneider P. Evans L, Ross-Lee L. Wiltshire B. Eadie M. Kenardy J. Hoey H. Plasma biogenic amine levels in agoraphobia with panic attacks. Pharmacopsychiatry 1987 May;20(3):102-4. Shean G. Uchenwa U. Interpersonal style and anxiety. J Psychol 1990 Jul;124(4):403-8. Southworth S, Kirsch I. The role of expectancy in exposure-generated fear reduction in agoraphobia. Behav Res Ther 1988;26(2):ll3-20. Stanton HE. Treating phobias rapidly with Bandler's theatre technique. Aust J Clin Exp Hypnosis 1988 Nov;16(2):153—60. Surman OS, Williams J, Sheehan DV. Strom TB. Jones K]. Coleman J. Immunological response to stress in agoraphobia and panic attacks. Biol Psychiatry 1986 Jul;21(8-9):768-74. Taylor IL. The reactive effect of self—monitoring of target activities in agoraphobics: A pilot study. Scand J Behav 'Iher 1985;14(l):17-22. Telch MJ, et a1. Combined pharmacological and behavioral treatment for agoraphobia. Behav Res Therapy 1985;23(3):325-35. Thomson G. Agoraphobia: The etiology and treatment of an attachment/separation disorder. Trans Anal I 1986 Jan;16(1):11-7. Thorpe GL. Freedman EG. Lazar JD. Assertiveness training and exposure in vivo for agoraphobics. Behav Psychother 1985 Apr;l3(2):132-41. Thorpe GL, Hecker JE. Cavallaro LA, Kulberg GE. Insight versus rehearsal in cognitive-behaviour therapy: A crossover study with sixteen phobics. Behav Psychother 1987 0ct;15(4):319-36. Thyer BA. Agoraphobia: a superstitious conditioning perspective. Psychol Rep-1986 Feb;58(1):95-100. Thyer BA. Community-based self-help groups for the treatment of agoraphobia. J Soc Soc Welf 1987 Sep;14(3):135-41. Thyer BA, Himle J. Temporal relationship between panic attack onset and phobic avoidance in agoraphobia. Behav Res Ther 1985;23(5):607-8. Trull TI. Nietzel MT. Main A. The use of meta- analysis to assess the clinical significance of behavior therapy for agoraphobia. Behav Ther 1988 Fa11;19(4):527—38. Turner SM. Stanley MA. Beidel DC. Bond L. The Social Phobia and Anxiety Inventory: Construct validity. J Psychopathol Behav Assess 1989 Sep; 11(3):221-34. Viswanathan R, Kachur EK. Development of agoraphobia after surviving cancer. Gen Hosp Psychiatry 1986 Mar;8(2):127-32. Vital-Heme J, Brenner R, Lesser M. Another case of alprazolam withdrawal syndrome. Am J Psychiatry 1985 Dec;142(12):1515. Wardle J. Behaviour therapy and benzodiazepines: Allies or antagonists? World Congress of Behaviour Therapy (1988. Edinburgh. Scotland). Br J Psychiatry 1990 Feb;156:163-8. Wardle J, Ahmad T. Hayward P. Anxiety sensitivity in agoraphobia. J Anxiety Disord 1990;4(4):325-33. Watts FN. Attentional strategies and agoraphobic anxiety. Behav Psychother 1989 Jan;17(1):15-26. What precipitates agoraphobia? Lancet 1990 Jun 2; 335(8701):1314-5. Williams KE, Chambless DL. The relationship between therapist characteristics and outcome of in vivo exposure treatment for agoraphobia. Behav Therapy 1990 Winter;21(l):1 11-6. Williams SL. Guided mastery treatment of agoraphobia: beyond stimulus exposure. Prog Behav Modif 1990;26:89-121. Williams SL. Kinney PJ, Falbo J. Generalization of therapeutic changes in agoraphobia: the role of perceived self-efficacy. J Consult Clin Psychol 1989 Jun;57(3):436-42. Williams SL. Kleifield E. Transfer of behavioral change across phobias in multiply phobic clients. Behav Modif 1985 Jan;9(1):22-3l. Williams SL. Zane G. Guided mastery and stimulus exposure treatments for severe performance anxiety in agoraphobics. Behav Res Ther l989;27(3): 237—45. Winter D. Goumay K. Construction and constriction in agoraphobia. Br J Med Psychol 1987 Sep;60(Pt 3): 233-44. Wood AV. Hypnosis and audio tapes as a treatment for agoraphobia. Aust J Clin Hypnother Hypnosis 1986 Sep;7(2):100—4. , Woods SW. Chamey DS, Loke I. Goodman WK, Redmond DE Jr. Heninger GR. Carbon dioxide sensitivity in panic anxiety. Ventilatory and anxiogenic response to carbon dioxide in healthy subjects and patients with panic anxiety before and after alprazolam treatment. Arch Gen Psychiatry 1986 Sep;43(9):900-9. Woods SW, Chamey DS. McPherson CA. Gradman AH, Heninger GR. Situational panic attacks. Behavioral, physiologic, and biochemical characterization. Arch Gen Psychiatry 1987 Apr; 44(4):365-75. Yager EK. Treating agoraphobia with hypnosis. subliminal therapy and paradoxical intention. Med Hypnoanal I 1988 Dec;3(4):156-60. 65 Zarate R. Craske MG. Barlow DH. Situational exposure treatment versus panic control treatment for agoraphobia. A case study. J Behav Ther Exp Psychiatry 1990 Sep;21(3):211-24. Zgourides GD. Warren R. Englert ME. Further evidence of construct validity for the Agoraphobic Cognitions Questionnaire and the Body Sensations Questionnaire. Psychol Rep 1989 Apr;64(2):590. Zoldak W. Agoraphobia. fear of the marketplace. Emot First Aid J Crisis Interv 1986 Summer; 3(2):15-8. 66 REVIEWS Abstracts from Panic and Anxiety: a Decade of Progress. An international conference. June 19-22, 1990, Geneva, Switzerland. J Psychiatr Res 1990; 24 Suppl 121-103. Bittikofer F. Kane CA. Panic disorder. West J Med l987;146(3):353—4. Chambless DI... Update on panic disorder and agoraphobia. Curr Opin Psychiatry 1990;3(6):790-4. Crowe RR. Noyes R Jr. Panic disorder and agoraphobia. Dis Mon 1986 Jul;32(7):389—444. Dilsaver SC. Panic disorder. Am Fam Physician 1989 Jun;39(6):167-72. Fyer AJ. Agoraphobia. Mod Probl Pharmacopsychiatry 1987 2291-126. Hasan MK, Mooney RP. Panic disorder: a review. Compr Ther 1986 Aug;12(8):3-7. Heninger GR. Recent research on the neurobiology of panic. Curr Opin Psychiatry 1989;2(1):112-6. Katon W. Panic disorder: epidemiology. diagnosis, and treatment in primary care. J Clin Psychiatry 1986 Oct;47 Suppl:21-30. Klerman GL. Conclusions. Panic disorder: Strategies for long-term treatment. J Clin Psychiatry 1991; 52(2 Suppl):33. Lum LC. Hyperventilation syndromes in medicine and psychiatry: a review. J R Soc Med 1987 Apr; 80(4):229-31. Mathis IL. Panic disorder with agoraphobia. N C Med J 1988 Oct;49(10):521-2. O’Boyle M. Panic disorder: diagnosis and treatment. Tex Med 1989 Aug;85(8):46-9. Panic disorder. Proceedings of a symposium. Gothenburg. Sweden, September 18-19. 1986. Acta Psychiatr Scand Suppl 1987;335:1-98. Panic disorder: diathesis and treatment issues. 143rd annual meeting of the American Psychiatric Association. New York. N.Y.. May 12-17. 1990. Proceedings. J Clin Psychiatry 1990 Dec;51 Suppl A:3-47. Parker G, Curtis J. Panic disorder. Psychiatr Dev 1987 Autumn;5(3):265-77. Raj A, Sheehan DV. Panic anxiety: diagnosis. etiology. and treatment. Compr Ther 1986 Oct; 12(10):7-15. Rosenbaum JF. Panic disorder: Diathesis and treatment issues. J Clin Psychiatry 1990;51(12 Suppl A):3-4. Roth M. Argyle N. Anxiety, panic and phobic disorders: an overview. J Psychiatr Res 1988;22 Suppl 1:33—54. Sargent M. Panic disorder. Hosp Community Psychiatry 1990 Jun;41(6):621-3. Uhde TW. Maser JD. NIMH report. Current perspectives on panic disorder and agoraphobia. Hosp Community Psychiatry 1985 Nov;36(ll): 1153-4. BOOKS AND BOOK CHAPTERS Achte K. Tarnminen T, Laaksonen R. editors. Many faces of panic disorder. Proceedings of the WPA Symposium on the Psychopathology of Panic Disorder; 1988 Aug 26-27; Espoo. Finland. Helsinki: Foundation of Psychiatric Research in Finland; 1989. 158 p. (Psychiatria Fennica supplementum; 1989). Albu M, Zellner A. Ackenheil M, Braune S. Engel RR. Do anxiety patients differ in autonomic base levels and stress response from normal controls? In: Hand 1. Wittchen HU. editors. Panic and phobias 2: treatments and variables affecting course and outcome. Berlin: Springer-Verlag; 1988. p. 171-9. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed. rev. Washington: The Association; 1987. 300.21 Panic disorder .with agoraphobia, 300.01 Panic disorder without agoraphobia; p. 235-9. American Academy of Clinical Psychiatrists. Update on anxiety and panic disorders. Annual meeting of the American Academy of Clinical Psychiatrists; 1985 Oct 9; San Francisco. [Memphis (TN): Physicians Postgraduate Press; c1986]. 39 p. (Journal of clinical psychiatry; vol. 47. no. 6, suppl.). Andrews G, Moran C. Exposure treatment of agoraphobia with panic attacks: are drugs essential? In: Hand I. Wittchen HU. editors. Panic and phobias 2: treatments and variables affecting course and outcome. Berlin: Springer-Verlag; 1988. p. 89-99. Anton RF. Prostaglandins - relationship to the central- nervous-system and the platelet in panic disorder. In: Ballenger JC. editor. Neurobiology of panic disorder. New York: Wiley-Liss; 1990. p. 349-64. Baker R. Introduction: where does "panic disorder" come from? In: Baker R. editor. Panic disorder: theory, research, and therapy. New York: Wiley; 01989. p. 1-12. Baker R. Personal accounts of panic. In: Baker R, editor. Panic disorder: theory. research and therapy. New York: Wiley; 1989. p. 67-88. Baker R. Synthesis. In: Baker R, editor. Panic disorder: theory, research and therapy. New York: Wiley; 1989. p. 325-44. Baker R, editor. Panic disorder: theory, research, and therapy. New York: Wiley; c1989. 350 p. Ballenger JC. Treatment of panic disorder and agoraphobia. In: Coryell W, Winokur G, editors. 67 The clinical management of anxiety disorders. New York: Oxford University Press; 1991. p. 41~62. Ballenger JC, Burrows G. Dupont R, Lesser 1M, Noyes R, Peckrrold J. Ritkin A, Swinson R. Aprazolam in panic disorder and agoraphobia. Results from a multicenter trial. 1. Efficacy of short-term treatment. In: Ballenger JC. editor. Clinical aspects of panic disorder. New York: Wiley-Liss; 1990. p. 219-38. Ballenger JC. editor. Clinical aspects of panic disorder. New York: Wiley-Liss; c1990. 328 p. (Frontiers of clinical neuroscience; vol. 9). Ballenger JC, editor. Neurobiology of panic disorder. New York: Wiley-Liss; 01990. 391 p. (Frontiers of clinical neuroscience; vol. 8). Barlow DH. A psychological model of panic. In: Shaw BF. Segal ZV. Vallis TM, Cashman FE, editors. Anxiety disorders: psychological and biological perspectives. New York: Plenum; 1986. p. 93-114. Barlow DH. Anxiety and its disorders: the nature and treatment of anxiety and panic. New York: Guilford Press; 01988. 698 p. Barlow DH. Current models of panic disorder and a view from emotion theory. In: Frances A], Hales RE. editors. American Psychiatric Press review of psychiatry. Vol. 7. Washington: American Psychiatric Press; 1988. p. 10-28. Barlow DH. Panic disorder - foreword. In: Frances A]. Hales RE, editors. American Psychiatric Press review of psychiatry. Vol. 7. Washington: American Psychiatric Press; 1988. p. 5-9. Barlow DH, Cemy JA. Psychological treatment of panic. New York: Guilford Press; c1988. 227 p. Barlow DH, Craske MG. The phenomenology of panic. In: Rachman S, Maser JD, editors. Panic: psychological perspectives. Hillsdale (NJ): Lawrence Erlbaum Associates; 1988. p. 11-36. Barreto E. Amado H. Identifying panic disorders. In: Munoz RA, editor. Treating anxiety disorders. San Francisco: Iossey-Bass. Inc.; 1986. p. 31-44. (New directions for mental health services; no. 32). Beck AT. Cognitive approaches to panic disorder: theory and therapy. In: Rachman S. Maser ID. editors. Panic: psychological perspectives. Hillsdale (NJ): Lawrence Erlbaum Associates; 1988. p. 91-109. Beck AT, Emery G. Anxiety disorders and phobias: a cognitive perspective. New York: Basic Books; 01985. 343 p. 68 Beitrnan BD. Mukerji V. Flaker G. Trombka LH. Basha IM. Panic disorder in cardiology patients with atypical chest pain. In: Ballenger JC. editor. Clinical aspects of panic disorder. New York: Wiley-Liss; 1990. p. 111-40. Bradley S]. Panic disorder in children and adolescents - a review with examples. In: Feinstein SC. Esman AH. Looney JG. et al., editors. Adolescent psychiatry. Vol. 17, Developmental and clinical studies. Chicago: University of Chicago Press; 1990. p. 433-50. Brown JT. Panic attacks. In: Walker 11, Brown IT. Gallis HA, editors. The complicated medical patient: new approaches to psychomedical syndromes. New York: Human Sciences Press; 1987. p. 174-86. Buller R. Maier W, Benkert 0. Factors relevant to lactate response in panic disorder. In: Hand 1. Wittchen HU. editors. Panic and phobias 2: . treatments and variables affecting course and outcome. Berlin: Springer-Verlag; 1988. p. 167-70. Cassano GB. Deltito JA. Standard therapies for panic disorder. In: Lader MH. Davies HC, editors. Drug treatment of neurotic disorders: focus on alprazolam. Proceedings of an international symposium; 1984 Nov 14-15; Vienna. Austria. New York: Churchill Livingstone; 1986. p. 166-72. Cassano GB. Petracca A. Perugi G. Nisita C. Musetti L. Mengali F. McNair DM. Comparative evaluation of clomipramine and irnipramine in panic disorder: preliminary report of a naturalistic treatment trial. In: Racagni G. Smeraldi E. editors. Anxious depression: assessment and treatment. New York: Raven Press; 1987. p. 181-8. Charnbless DL. Cognitive mechanisms in panic disorder. In: Rachman S. Maser ID. editors. Panic: psychological perspectives. Hillsdale (NJ): Lawrence Erlbaurn Associates; 1988. p. 205-17. Charnbless DL. Gracely EJ. Prediction of outcome following in vivo exposure treatmewnt of agoraphobia. In: Hand 1. Wittchen HU. editors. Panic and phobias 2: treatments and variables affecting course and outcome. Berlin: Springer- Verlag; 1988. p. 209-20. Chamey DS. Woods SW. Krystal JH. Nagy LM. HeningerGR. Hypotheses relating serotonergic dysfunction to the etiology and treatment of panic and generalized anxiety disorders. In: Coccaro EF. Murphy DL. editors. Serotonin in major psychiatric disorders. Washington: American Psychiatric Press; 1990. p. 127-52. Chamey DS, Woods SW. Price LH. Goodman WK. Glazer WM. Heninger GR. Noradrenergic dysregulation in panic disorder. In: Ballenger JC. editor. Neurobiology of panic disorder. New York: Wiley-Liss; 1990. p. 91-106. Clark DM. A cognitive model of panic attacks. In: Rachman S, Maser JD, editors. Panic: psychological perspectives. Hillsdale (NJ): Lawrence Erlbaum Associates; 1988. p. 71-89. Clark DB. Taylor CB, Hayward C. Naturalistic assessment of the physiology of panic. In: Ballenger JC. editor. Clinical aspects of panic disorder. New York: Wiley-Liss; 1990. p. 83-98. Cowley DS. Roy-Byrne PP. Panic disorder and hyperventilation syndrome: implications of recent research. In: Roy-Byme PP. editor. Anxiety: new findings for the clinician. Washington: American Psychiatric Press; 1989. p. 19—42. Craske MC. Cognitive-behavioral treatment of panic. In: Frances A]. Hales RE, editors. American Psyciatric Press review of psychiatry. Vol. 7. Washington: American Psychiatric Press; 1988. p. 121-37. Crowe RR. Molecular genetics and panic disorder. New approaches to an old problem. In: Ballenger JC. editor. Neurobiology of panic disorder. New York: Wiley-Liss; 1990. p. 59-70. Crowe RR, Noyes R Jr. Persico T. Wilson AF. Elston RC. Genetic studies of panic disorder and related conditions. In: Dunner DL. Gershon ES. Barrett JE, editors. Relatives at risk for mental disorder. New York: Raven Press; 1988. p. 73-85. Crowe RR. Noyes R. Panic disorder and agoraphobia. Chicago: Year Book Medical Publishers; c1986. (Disease-a-month; vol. 32. no. 7). Dager SR. Roth WT. Panic disorder and cardiac fears: is there reason to worry? In: Roy-Byme PP. editor. Anxiety: new findings for the clinician. Washington: American Psychiatric Press; 1989. p. 99-120. Dencker SI. Holmberg G, editors. Panic disorder: proceedings of a symposium; 1986 Sep 18-19; Gothenburg. Sweden. Copenhagen: Munksgaard; 1987. 98 p. (Acta psychiatrica Scandinavica; vol. 76. Suppl. no. 335). Durham RC. Cognitive therapy of panic disorder. In: Baker R. editor. Panic disorder: theory, research and therapy. New York: Wiley; 1989. p. 261-80. Eaton WW. Dryman A. Weissman MM. Panic and phobia: the diagnosis of panic disorder and phobic disorder. In: Robins LN. Regier DA, editors. Psychiatric disorders in America: the Epidemiologic Catchment Area study. New York: The Free Press; 1991. p. 155-79. Ehlers A, Margraf J. The psychophysiological model of panic attacks. In: Emmelkamp PMG. Everaerd WTAM. Kraaimaat FW, van Son MIM. editors. Fresh perspectives on anxiety disorders. Berwyn (PA): Swets North America; 1989. p. 1-29. Emmellkarnp PMG. Marital quality and treatment outcome in anxiety disorders. In: Hand I, Wittchen HU. editors. Panic and phobias 2: treatments and variables affecting course and outcome. Berlin: Springer-Verlag; 1988. p. 233-9. Fiegenbaum W. Long-term efficacy of ungraded versus graded massed exposure in agoraphobia. In: Hand I. Klerman HU. editors. Panic and phobias 2: treatments and variables affecting course and outcome. Berlin: Spinger-Verlag; 1988. p. 838. Fischer M. Hand 1. Angenendt J. Buttner-Westphal H. Failures in exposure treatment of agoraphobia: evaluation and prediction. In: Hand I. Wittchen HU. editors. Panic and phobias 2: treatments and variables affecting course and outcome. Berlin: Springer-Verlag; 1988. p. 195-208. Foa EB. What cognitions differentiate panic disorder from other anxiety disorders? In: Hand I. Wittchen HU. editors. Panic and phobias 2: treatments and variables affecting course and outcome. Berlin: Springer-Verlag; 1988. p. 159-66. Fontaine R. The role of the primary care physician in the treatment of panic disorder. In: Walker JR, Norton GR, Ross CA. editors. Panic disorder and agoraphobia: a comprehensive guide for the practitioner. Pacific Grove (CA): Brooks/Cole Pub. Co.; c1991. p. 352-67. Freedman RR. Ambulatory monitoring findings on panic. In: Baker R, editor. Panic disorder: theory. research and therapy. New York: Wiley; 1989. . p. 51-66. Fyer AJ. Effects of discontinuation of antipanic medication. In: Hand 1. Wittchen HU, editors. Panic and phobias 2: treatments and variables affecting course and outcome. Berlin: Springer- Verlag; 1988. p. 47-53. Fyer AJ, Sandberg D. Pharmacologic treatment of panic disorder. In: Frances A], Hales RE. editors. American Psychiatric Press review of psychiatry. Vol. 7. Washington: American Psychiatric Press; 1988. p. 88-120. 69 Fyer AJ, Sandberg D. Klein DF. The pharmacologic treatment of panic disorder and agoraphobia. In: Walker JR. Norton GR, Ross CA. editors. Panic disorder and agoraphobia: a comprehensive guide for the practitioner. Pacific Grove (CA): Brooks/Cole Pub. Co.; c1991. p. 211-51. Gentil V. The aversive system. 5-HT and panic attacks - commentary. In: Simon P, Soubrie P, Wildlocher D, editors. Selected models of anxiety. depression and psychosis. Vol. 1, Animal models of psychiatric disorders. Basel: Karger; 1988. p. 142-5. ' Gold PW, Pigott TA, Kling MA. Brandt HA, Kalogeras K, Demitrack MA, Geracioti TD. Hypothalarnic pituitary-adrenal axis in panic disorder. In: Ballenger JC. editor. Neurobiology of panic disorder. New York: Wiley-Liss; 1990. p. 313—20. Goodwin DW. Anxiety. New York: Oxford Univ. Press: 1986. Chapter 12. Panic disorder; p. 112-22. German JM. Panic disorders. In: Klein DF. editor. Anxiety. New York: Karger; 1987. p. 36-90. (Modem problems of pharmacopsychiatry; vol. 22). German JM. Papp L, Klein DF. Biological models of panic disorder. In: Burrows GD, Roth M, Noyes R, editors. Neurobiology of anxiety. Amsterdam: Elsevier; 1990. p. 59-78. Gorman JM. Papp LA. Respiratory physiology of panic. In: Ballenger JC. editor. Neurobiology of panic. New York: Wiley-Liss; 1990. p. 187-204. Gournay K. editor. Agoraphobia: current perspectives on theory and treatment. New York: Routledge; 1989. 243 p. Hallarn RS. Anxiety: psychological perspectives on panic and agoraphobia. Orlando: Academic Press; 1985. 210 p. Hallarn R. Classification and research into panic. In: Baker R. editor. Panic disorder: theory, research and therapy. New York: Wiley; 1989. p. 93-105. Hand I. Angenendt J, Fischer M. Wilke C. Exposure in-vivo with panic management for agoraphobia: treatment rationale and longterm outcome. In: Hand I, Wittchen HU, editors. Panic and phobias: empirical evidence of theoretical models and longterm effects of behavioral treatments. Berlin: Springer-Verlag; 1986. p. 104-27. Hand 1. Wittchen HU. editors. Panic and phobias: empirical evidence of theoretical models and longterrn effects of behavioral treatments. 15th congress of the European Association of Behaviour Therapy; 1985; Munich, Germany. Berlin: Springer- Verlag; c1986. 130 p. 70 Hand I. Wittchen HU, editors. Panic and phobias 2: treatments and variables affecting course and outcome. Berlin: Springer-Verlag; 1988. 275 p. Hayward C. Clark DB. Taylor CB. Panic disorder. anxiety. and cardiovascular risk. In: Ballenger JC, editor. Clinical aspects of panic disorder. New York: Wiley-Liss; 1990. p. 99-110. Hecker IE, Thorpe GL. Agoraphobia and panic: a guide to psychological treatment Boston: Allyn and Bacon; 1991. Heninger GR. A biologic perspective on comorbidity of major depressive disorder and panic disorder. In: Maser JD, Cloninger CR. editors. Comorbidity of mood and anxiety disorders. Washington: American Psychiatric Press; 1990. p. 381-401. Hoehn-Saric R. McLeod RD. Panic and generalized anxiety disorders. In: Last CG, Hersen M. editors. Handbook of anxiety disorders. New York: Pergamon Press; 1988. p. 109-26. Hoffmann-La Roche Limited. Panic disorder: relative merits of pharmacotherapy and psychotherapy; summary proceedings of the satellite symposium. l4lst American Psychiatric Association Annual Meeting; 1988 May 8; Montreal. Mississauga (ONT): MES Medical Education Services; c1988. 20 p. Hollander E. Levin AP, Liebowitz MR. Biological tests in the differential diagnosis of anxiety disorders. In: Ballenger JC, editor. Clinical aspects of panic disorder. New York: Wiley-Liss; 1990. p. 31-46. Hsiao JK. Potter WZ. Mechanisms of action of antipanic drugs. In: Ballenger JC, editor. Clinical aspects of panic disorder. New York: Wiley-Liss; 1990. p. 297— . Jacob RG. Lilienfeld SO. Panic disorder: diagnosis. medical assessment, and psychological assessment. In: Walker JR, Norton GR. Ross CA, editors. Panic disorder and agoraphobia: a comprehensive guide for the practitioner. Pacific Grove (CA): Brooks/Cole Pub. Co.; 01991. p. 61-102. Jacob RG, Turner SM. Panic disorder — diagnosis and assessment. In: Frances AJ. Hales RE. editors. American Psychiatric Press review of psychiatry. Vol.7. Washington: American Psychiatric Press; 1988. p. 67-87. Kagan J, Reznick JS. Snidman N, Johnson MO, Gibbons J, Gersten M. Biederman J, Rosenbaum JF. Origins of panic disorder. In: Ballenger JC, editor. Neurobiology of panic disorder. New York: Wiley- Liss; 1990. p. 71-90. Kaplan HS. Sexual aversion. sexual phobias, and panic disorder. New York: Brunner/Mazel; c1987. 158 p. Katon W. Panic disorder in the medical setting. Washington: American Psychiatric Press; c1990. 147 p. Katon W. Patients with unexplained cardiac symptoms: relationship to panic disorder. In: Roy-Byme PP, editor. Anxiety: new findings for the clinician. Washington: American Psychiatric Press; 1989. p. 1-18. Katschnig H, Amering M. Panic attacks and panic disorders in cross-cmniral—perspective. In: Ballenger JC, editor. Clinical aspects of panic disorder. New York: WIley-Liss; 1990. p. 67-82. Kellner C, Roybyme PP. Computed-tomography and magnetic-resonance—imaging in panic disorder. In: Ballenger JC, editor. Neurobiology of panic disorder. New York: Wiley-Liss; 1990. p. 271-80. King R. Margraf J, Ehlers A. Maddock R. Panic disorder: overlap with symptoms of somatization disorder. In: Hand I. Wittchen HU, editors. Panic and phobias: empirical evidence of theoretical models and longterm effects of bahavioral treatments. Berlin: Springer-Verlag; 1986. p. 72-7. Klein DF. Klein HM. The definition and psychopharmacology of spontaneous panic and phobia. In: Tyrer P, editor. Psychopharmacology of anxiety. New York: Oxford Univ. Press; 1989. p. 135-62. Klein DF, Klein HM. The nosology. genetics. and theory of spontaneous panic and phobia. In: Tyrer P. editor. Psychopharmacology of anxiety. New York: Oxford Univ. Press; 1989. p. 163-95. Klerman GL. Diagnosis of panic states: a North American view. In: Lader MH, Davies HC. editors. Drug treatment of neurotic disorders: focus on alprazolam. Proceedings of an international symposium; 1984 Nov 14-15; Vienna, Austria. New York: Churchill Livingstone; 1986. p. 151-9. Klerman GL. History and development of modern concepts of anxiety and panic. In: Ballenger JC, editor. Clinical aspects of panic disorder. New York: Wiley-Liss; 1990. p. 3-12. Klosko JS, Barlow DH, Tassinari RB, Cemy JA. Comparison of alprazolam and cognitive behavior therapy in the treatment of panic disorder: a preliminary report. In: Hand 1, Wittchen HU, editors. Panic and phobias 2: treatments and variables affecting course and outcome. Berlin: Springer-Verlag; 1988. p. 54-65. Knapp S. VandeCreek L. Diagnosis and treatment selection for anxiety disorders. Sarasota (FL): Professional Resource Exchange. Inc.; 1989. Panic attacks and agoraphobia; p. 24-35. Lader M. The biology of panic disorder: a long—term view and critique. In: Walker JR, Norton GR, Ross CA, editors. Panic disorder and agoraphobia: a comprehensive guide for the practitioner. Pacific Grove (CA): Brooks/Cole Pub. Co; c1991. p. 150-74. Lader MH. Davies HC, editors. Drug treatment of neurotic disorders: focus on alprazolam: proceedings of an international symposium; 1984 Nov 14-15; Vienna, Austria. Edinburgh: Churchill Livingstone; 1986. 186 p. Lang PJ. Fear, anxiety, and panic: context, cognition, and visceral arousal. In: Rachman S. Maser JD, editors. Panic: psychological perspectives. Hillsdale (NJ): Lawrence Erlbaum Associates; 1988. p. 21936. Leckrnan JF, Clubb MM, Pauls DL. Comorbidity of panic disorder and major depression - a review of epidemiologic and genetic data. In: Ballenger JC, editor. Clinical aspects of panic disorder. New York: Wiley-Liss; 1990. p. 141-50. Lepola U. Panic disorder: a clinical, neurochemical, neurophysiological. and neuroradiological study. Kuopio: University of Kuopio, Dept. of Neurology; 1990. 163 p. (Neurologian klinikan julkaisusarja; no. 19). Lesser IM. Panic disorder and depression - cooccurrence and treatment. In: Ballenger JC, editor. Clinical aspects of panic disorder. New York: Wiley-Liss; 1990. p. 181-94. Ley R. Panic disorder: a hyperventilation interpretation. In: Michelson L, Ascher IM. editors. Anxiety and steess disorders: cognitive-behavioral assessment and treatment. New York: Guilford Press; 1987. p. 191-212. Liebowitz MR, Fyer AJ, Gonnan IM. Campeas R. Levin A, Davies SR, Klein DF. Alprazolam in the treatment of panic disorders. In: Lader MH. Davies HC, editors. Drug treatment of neurotic disorders: focus on alprazolam. Proceedings of an international symposium; 1984 Nov 14-15; Vienna, Austria. New York: Churchill Livingstone; 1986. p. 173—7. Lydiard RB, Ballenger JC, Laraia MT, Fossey M, Howell EF, Peterson G, Hucek A, Lack CR. Effects of chronic alprazolam and imipramine treatment of catecholamine function in patients with agoraphobia with panic attacks or panic disorder. In: Ballenger 71 JC. editor. Clinical aspects of panic disorder. New York: Wiley-Liss; 1990. p. 239—50. Maier W. Buller R. Hallrnayer J. Comorbidity of panic disorder and major depression: results from a family study. In: Hand 1, Wittchen HU. editors. Panic and phobias 2: treatments and variables affecting course and outcome. Berlin: Springer-Verlag; 1988. p. 181-5. Malcolm R, Ballenger JC, Brady K, Hodges R. Benzodiazepine abuse. In: Ballenger JC, editor. Clinical aspects of panic disorder. New York: Wiley-Liss; 1990. p. 273-80. Margraf J, Ehlers A. Biological models of panic disorder and agoraphobia - theory and evidence. In: Burrows GD. Roth M, Noyes R, editors. Neurobiology of anxiety. Amsterdam: Elsevier; 1990. p. 79-140. Margraf J, Ehlers A. Etiological models of panic - medical and biological aspects. In: Baker R, editor. Panic disorder: theory, research and therapy. New York: Wiley; 1989. p. 145-203. Margraf J, Ehlers A. Etiological models of panic - psychophysiological and cognitive aspects. In: Baker R, editor. Panic disorder: theory, research and therapy. New York: Wiley; 1989. p. 205-31. Margraf J, Ehlers A, Roth WT. Panic attacks: theoretical models and empirical evidence. In: Hand I, Wittchen HU, editors. Panic and phobias: empirical evidence of theoretical models and longterm effcts of behavioral treatments. Berlin: Springer-Verlag; 1986. p. 31—43. Marks I. Agoraphobia and panic disorder. In: Baker R, editor. Panic disorder: theory, research and therapy. New York: Wiley; 1989. p. 107-15. Marks IM. Diagnosis of panic states: a European view. In: Lader MH, Davies HC, editors. Drug treatment of neurotic disorders: focus on alprazolam. Proceedings of an international symposium; 1984 Nov 14—15; Vienna, Austria. New York: Churchill Livingstone; 1986. p. 160-5. Marks IM. Fears, phobias, and rituals: panic, anxiety, and their disorders. New York: Oxford University Press; 1987. 682 p. Marks 1, O’Sullivan G. Anti-anxiety drug and psychological treatment effects in agoraphobia/panic and obsessive-compulsive disorders. In: Tyrer P, editor. Psychopharmacology of anxiety. New York: Oxford Univ. Press; 1989. p. 196-242. 72 Marshall WL. An appraisal of expectancies. safety signals. and the treatment of panic disorder patients. In: Rachman S. Maser JD. editors. Panic: psychological perspectives. Hillsdale (NJ): Lawrence Erlbaum Associates; 1988. p. 305-20. Mathew R]. Wilson WH. Cerebral blood-flow in anxiety and panic. In: Ballenger JC. editor. Neurobiology of panic disorder. New York: Wiley- Liss; 1990. p. 281—312. Mathews A. Cognitive factors in the treatment of anxiety states. In: Hand I. Wittchen HU. editors. Panic and phobias 2: treatments and variables affecting course and outcome. Berlin: Springer- Verlag; 1988. p. 75-82. Mavissakalian M. Agoraphobia. In: Beitrnan BD, Klerman GI... editors. Integrating pharmacotherapy and psychotherapy. Washington: American Psychiatric Press. Inc.; 1991. p. 165-81. Mavissakalian M. Differential efficacy between tricyclic antidepressants and behavior therapy of panic disorder. In: Ballenger JC. editor. Clinical aspects of panic disorder. New York: Wiley-Liss; 1990. p. 195-210. Mavissakalian M. Relationship of dose plasma- concentrations of irniprarnine to the treatment of panic disorder with agoraphobia. In: Ballenger JC. editor. Clinical aspects of panic disorder. New York: Wiley-Liss; 1990. p. 211-8. Mavissakalian M. The mutually potentiating effects of irniprarnine and exposure in agoraphobia. In: Hand 1. Wittchen HU. editors. Panic and phobias 2: treatments and variables affecting course and outcome. Berlin: Springer-Verlga; 1988. p. 36-43. McFadyen M. The cognitive invalidation approach to panic. In: Baker R. editor. Panic disorder: theory, research and therapy. New York: Wiley; 1989. p. 281-99. McGlynn TJ. Metcalf HL, editors. Diagnosis and treatment of anxiety disorders: a physician's handbook. [Washington]: American Psychiatric Press; 1989. Panic disorder with or without agoraphobia; p. 67-76. McLean JN. Knights SA. Phobics and other panic victims: a practical guide for those who help them. New York: Continuum; 1989. 179 p. Mellman TA. Uhde TW. Sleep in panic and generalized anxiety disorders. In: Ballenger JC. editor. Neurobiology of panic disorder. New York: Wiley- Liss; 1990. p. 365- . Michelson L. Cognitive. behavioral. and psychophysiological treatments and correlates of panic. In: Rachman S, Maser JD, editors. Panic: psychological perspectives. Hillsdale (NJ): Lawrence Erlbaum Associates; 1988. p. 137-65. Michelson L. Cognitive—behavioral assessment and treatment of agoraphobia. In: Michelson L. Ascher LM. editors. Anxiety and stress disorders: cognitive—behavioral assessment and treatment. New York: The Guilford Press; 1987. p. 213-79. Nesse RM. Cameron 0G, Green MA, Kuttesch DA. Panic disorder and agoraphobia. In: Howells JG. editor. Modern perspectives in the psychiatry of neuroses. New York: Mazel; 1989. p. 130-52. (Modern perspectives in psychiatry; vol. 12). Norman TR. Burrows GD, Judd FK. Towards a biochemistry of panic disorders - a critique of platelet studies. In: Burrows GD. Roth M, Noyes R, editors. Neurobiology of anxiety. Amsterdam: Elsevier; 1990. p. 245-68. Norton GR. Walker JR. Ross CA. Panic disorder and agoraphobia: an introduction. In: Walker JR, Norton GR. Ross CA. editors. Panic disorder and agoraphobia: a comprehensive guide for the practitioner. Pacific Grove (CA): Brooks/Cole Pub. Co.; c1991. p. 3-15. Noyes R, Garvey MJ. Cook BL. Benzodiazepines other than alprazolam in the treatment of panic disorder. In: Ballenger JC. editor. Clinical aspects of panic disorder. New York: Wiley—Liss; 1990. p. 251-8. Nutt DJ. Basic mechanisms of benzodiazepine tolerance. dependence, and withdrawal. In: Ballenger JC. editor. Clinical spects of panic disorder. New York: Wiley-Liss; 1990. p. 281-96. Ost LG. Panic disorder, agoraphobia. and social phobia. In: Turpin G. editor. Handbook of clinical psychophysiology. Chichester (Sussex. United Kingdom): Wiley; 1989. p. 309-28. Pauls DL, DiBenedetto AM. The familial relationship between panic disorder and major depressive disorder. In: Racagni G. Smeraldi E. editors. Anxious depression: assessment and treatment. New York: Raven Press; 1987. p. 73-80. Pecknold JC. Serotonin abnormalities in panic disorder. In: Ballenger JC. editor. Neurobiology of panic disorder. New York: Wiley-Liss; 1990. p. 121-42. Peter H. Hand I. Patterns of patient-spouse interaction in agoraphobics: assessment by Camberwell Family Interview (CPI) and impact on outcome of self- exposure treatment. In: Hand I. Wittchen HU. editors. Panic and phobias 2: treatments anf variables affecting course and outcome. Berlin: SPringer—Verlag; 1988. p. 240-51. Pohl R. Yeragani V. Balon R, Ortiz A, Aleem A. Isoproterenol-induced panic - a beta-adrenergic model of panic anxiety. In: Ballenger JC. editor. Neurobiology of panic disorder. New York: Wiley- Liss; 1990. p. 107-20. Rachman S. Parties and their consequences: a review and prospect. In: Rachman S. Maser JD. editors. Panic: psychological perspectives. Hillsdale (NJ): Lawrence Erlbaum Associates; 1988. p. 259-303. Rachman S. Maser JD. editors. Panic: psychological perspectives. Hillsdale (NJ): Lawrence Erlbaum Associates; 1988. 373 p. Rachman S, Maser JD. Panic: psychological contributions. In: Rachman S, Maser JD, editors. Panic: psychological perspectives. Hillsdale (NJ): Lawrence Erlbaurn Associates; 1988. p. 1-10. Rainey JM. Manov G. Aleem A, Toth A. Relationships between posttraumatic-stress—disorder and panic disorder - concurrent psychiatric-illness. effects of lactate infusions. and erythrocyte lactate production. In: Ballenger JC. editor. Clinical aspects of panic disorder. New York: Wiley-Liss; 1990. p. 47-56. Rapee RM, Barlow DH. Psychological treatment of unexpected panic attacks: cognitive/behavioural components. In: Baker R. editor. Panic disorder: theory. research and therapy. New York: Wiley; 1989. p. 23959. Rapee RM. Barlow DH. The cognitive-behavioral treatment of panic attacks and agoraphobic avoidance. In: Walker JR. Norton GR. Ross CA. editors. Panic disorder and agoraphobia: a comprehensive guide for the practitioner. Pacific Grove (CA): Brooks/Cole Pub. Co.; c1991. p. 252-305. Raskin A. Role of depression in the antipanic effects of antidepressant drugs. In: Ballenger JC. editor. Clinical aspects of panic disorder. New York: Wiley-Liss; 1990. p. 169-80. Reiamn EM. PET. panic disorder. and normal anticipatory anxiety. In: Ballenger JC. editor. Neurobiology of panic disorder. New York: Wiley- Liss; 1990. p. 245—70. Reichler RJ. Sylvester CE. Hyde TS. Biological studies on offspring of panic disorder probands. In: Durmer DL. Gershon ES. Barrett JE. editors. Relatives at risk for mental disorder. New York: Raven Press; 1988. p. 103-25. Reiman EM. Contributions to the development and treatment of panic disorder: toward a piece of mind and brain. In: Beitman BD. Klerrnan GL. editors. Integrating pharmacotherapy and psychotherapy. 73 Washington: American Psychiatric Press. Inc.; 1991. p. 423-34. Reiman EM. Positron emission tomography in the study of panic disorder and anticipatory anxiety. In: Burrows GD, Roth M. Noyes R. editors. Neurobiology of anxiety. Amsterdam: Elsevier; 1990. p. 289-306. Rosenbaum JF. Tesar GE. Clonazepam and other anticonvulsants. In: Ballenger JC. editor. Clinical aspects of panic disorder. New York: Wiley-Liss; 1990. p. 259-72. Roy-Byme P. editor. Anxiety: new findings for the clinician. Washington: American Psychiatric Press; c1989. 204 p. (Clinical practice; no. 5). Salkovskis PM. Phenomenology. assessment. and the cognitive model of panic. In: Rachman S, Maser JD, editors. Panic: psychological perspectives. Hillsdale (NJ): Lawrence Erlbaum Associates; 1988. p. 111-36. Sandberg DP. Liebowitx MR. Potential mechanisms for sodium lactates induction of panic. In: Ballenger JC. editor. Neurobiology of panic disorder. New York: Wiley-Liss; 1990. p. 155-72. Schatzberg AF. Herrygers EJ. Rege GC. editors. Anxiety disorders. panic attacks. and phobias: proceedings of the Key Biscayne Research Conference on Anxiety Disorders, Panic Attacks, and Phobias; 1982 Dec 9-11; Key Biscayne, FL. New York: Pergarnon Press; 1988. 114 p. (Journal of psychiatric research; vol. 22. suppl. 1). Scrignar CB. From panic to peace of mind: overcoming panic and agoraphobia. New Orleans (LA): Bruno Press; 1991. Seligrnan MEP. Competing theories of panic. In: Rachman S. Maser JD. editors. Panic: psychological perspectives. Hillsdale (NJ): Lawrence Erlbaum Associates; 1988. p. 321-9. Shear MK. Cognitive and biological models of panic: toward an integration. In: Rachman S. Maser JD. editors. Panic: psychological perspectives. Hillsdale (NJ): Lawrence Erlbaurn Associates; 1988. p. 51-70. Shear MK. Panic disorder. In: Beitman BD. Klerman GL. editors. Integrating pharmacotherapy and psychotherapy. Washington: American Psychiatric Press. Inc.; 1991. p. 143-64. 74 Shear MK. The psychodynamic approach in the treatment of panic disorder. In: Walker JR. Norton . GE. Ross CA. editors. Panic disorder and agoraphobia: a comprehensive guide for the practitioner. Pacific Grove (CA): Brooks/Cole Pub. Co.; 01991. p. 335-51. Shear MK. Ball GG. Josephson S. Gitlin. Cognitive- behavioral treatment of panic. In: Hand I, Wittchen HU, editors. Panic and phobias 2: treatments and variables affecting course and outcome. Berlin: Springer-Verlag; 1988. p. 66-74. Shear MK, Barlow D. Panic disorder - afterword. In: Frances AJ, Hales RE, editors. American Psychiatric Press review of psychiatry. Vol. 7. Washington: American Psychiatric Press; 1988. p. 138-46. Shear MK, Fyer MR. Biological and psychopathologic findings in panic disorder. In: Frances A]. Hales RE. editors. American Psychiatric Press review of psychiatry. Washington: American Psychiatric Press; 1988. p. 29-53. Sheehan DV, Raj BA. Panic disorder. In: Thase ME. Edelstein BA. Hersen M, editors. Handbook of outpatient treatment of adults: nonpsychotic mental disorders. New York: Plenum; 1990. p. 177-208. Sheehan DV. Raj BA. Treatment of the difficult case with panic disorder. In: Walker JR. Norton GR. Ross CA, editors. Panic disorder and agoraphobia: a comprehensive guide for the practitioner. Pacific Grove (CA): Brooks/Cole Pub. Co.; c1991. p. 368-97. Stein MB. Uhde TW. Panic disorder and major depression - lifetime relationship and biological markers. In: Ballenger JC, editor. Clinical aspects of panic disorder. New York: Wiley-Liss; 1990. p. 151-68. Stern EM. editor. Psychotherapy and the terrorized patient. New York: Haworth Press; c1985. 116 p. (The psychotherapy patient; vol. 1. no. 4). Swinson RP, Kuch K. Clinical-features of panic and related disorders. In: Ballenger JC. editor. Clinical aspects of panic disorder. New York: Wiley-Liss; 1990. p. 13-30. Swinson RP, Kuch K, Antony MM. Combining pharmacotherapy and behavioral therapy for panic disorder and agoraphobia. In: Walker JR. Norton GR, Ross CA, editors. Panic disorder and agoraphobia: a comprehensive guide for the practitioner. Pacific Grove (CA): Brooks/Cole Pub. Co.; c1991. p. 306-34. Sylvester CE. Hyde TS. Reichler RJ. Clinical psychopathology among children of adults with panic disorder. In: Dunner DL. Gershon ES. Barrett JE. editors. Relatives at risk for mental disorder. New York: Raven Press; 1988. p. 87-102. Taylor CB. Amow B. The nature and treatment of anxiety disorders. New York: The Free Press; 1988. Chapter 7. Panic disorder (uncomplicated); p. 137-82. Taylor CB, Amow B. The nature and treatment of anxiety disorders. New York: The Free Press; 1988. Chapter 8. Agoraphobia (Panic disorder with agoraphobia); p. 183-229. Teasdale J. Cognitive models and treatments for panic: a critical evaluation. In: Rachman S, Maser JD. editors. Panic: psychological perspectives. Hillsdale (NJ): Lawrence Erlbaum Associates; 1988. p. 189-203. Telch MI. Combined pharmacological and psychological treatments for panic sufferers. In: Rachman S, Maser JD, editors. Panic: psychological perspectives. Hillsdale (NJ): Lawrence Erlbaum Associates; 1988. p. 167-87. Thorpe GL. Hecker IE. Psychosocial aspects of panic disorder. In: Walker JR. Norton GR, Ross CA, editors. Panic disorder and agoraphobia: a comprehensive guide for the practitioner. Pacific Grove (CA): Brooks/Cole Pub. Co.; 01991. p. 175-207. Thyer BA. Treating anxiety disorders: a guide for human service professionals. Newbury Park (CA): Sage Publications; 1987. Chapter 4, Agoraphobia and panic disorder: diagnosis, etiology, and assessment; p. 61-75. Thyer BA. Treating anxiety disorders: a guide for human service professionals. Newbury Park (CA): Sage Publications; 1987. Chapter 5. Agoraphobia and panic disorder: treatment strategies; p. 76—91. Torgerson S. Twin studies in panic disorder. In: Ballenger JC, editor. Neurobiology of panic disorder. New York: Wiley-Liss; 1990. p. 51-8. Turner SM, Beidel DC, Jacob RG. Assessment of panic. In: Rachman S. Maser JD. editors. Panic: psychological perspectives. Hillsdale (NJ): Lawrence Erlbaum Associates; 1988. p. 37-50. Tyrer P. Classification of neurosis. Chichester (Sussex, United Kingdom): Wiley; 1989. Panic and generalized anxiety disorder, p. 17—41. Uhde TW. Caffeine provocation of panic - a focus on biological mechanisms. In: Ballenger JC, editor. Neurobiology of panic disorder. New York: Wiley- Liss; 1990. p. 219—44. Uhde TW, Roy-Byme PP, Vittone BI, Boulenger JP, Post RM. Phenomenology and neurobiology of panic disorder. In: 'Ihma AH, Maser J, editors. Anxiety and the anxiety disorders. Hillsdale (NJ): Lawrence Erlbaum Associates; 1985. p. 557-76. Uhde TW, Stein MB. Biology and pharmacological treatment of panic disorder. In: Hand 1, Wittchen HU. editors. Panic and phobias 2: treatments and variables affecting course and outcome. Berlin: Springer-Verlag; 1988. p. 18-35. Uhde TW. Tancer ME. Chemical models of panic: a review and critique. In: Tyrer P, editor. Psychopharmacology of anxiety. New York: Oxford University Press; 1989. p. 109-31. van den Hout MA. Panic, perception, and pC02. In: Hand 1, Wittchen HU. editors. Panic and phobias 2: treatments and variables affecting course and outcome. Berlin: Springer-Verlag; 1988. p. 117-28. van den Hout MA. The explanation of experimental panic. In: Rachman S, Maser JD. editors. Panic: psychological perspectives. Hillsdale (NJ): Lawrence Erlbaum Associates; 1988. p. 237-57. van der Molen GM, Merckelbach H, Jansen A. van den Hout MA. Panic, phobia and hypocapnia: an interwoven triad. In: Emmelkamp PMG, Everaerd WTAM, Kraaimaat FW, van Son MJM. editors. Fresh perspectives on anxiety disorders. Berwyn (PA): Swets North America; 1989. p. 45-58. Vanggaard T. Panic: the course of a psychoanalysis. Vanggaard J, translator. New York: W.W. Norton; c1989. 144 p. Translation of: Angst. Von Korff M, Eaton WW. Epidemiologic findings on panic. In: Baker R. editor. Panic disorder: theory, research and therapy. New York: Wiley; 1989. p. 35-50. Walker L, Ashcroft G. Pharmacological approaches to the treatment of panic. In: Baker R, editor. Panic disorder: theory, research and therapy. New York: WIley; 1989. p. 301-14. Walker JR, Norton GR, Ross CA, editors. Panic disorder and agoraphobia: a comprehensive guide for the practitioner. Pacific Grove (CA): Brooks/Cole Pub. Co.; 01991. 575 p. Waring H. The nature of panic attack symptoms. In: Baker R, editor. Panic disorder: theory, research and therapy. New York: Wiley; 1989. p. 17-34. Weeks C. The key to resisting relapse in panic. In: Baker R, editor. Panic disorder: theory, research and therapy. New York: Wiley; 1989. p. 315-23. 75 Weissman MM. Epidemiology of panic disorder and agoraphobia. In: Ballenger JC, editor. Clinical aspects of panic disorder. New York: Wiley-Liss; 1990. p. 57-66. Weissman MM. The epidemiology of panic disorder and agoraphobia. In: Frances A], Hales RE, editors. American Psychiatric Press review of psychiatry. Vol. 7. Washington: American Psychiatric Press; 1988. p. 54-66. Westphal CFO. Agbraphobie with commentary: the beginnings of agoraphobia. Schurnacher MT, translator. Lanham (MD): University Press of America; c1988. 99 p. Wittchen HU. Epidemiology of panic attacks and panic disorders. In: Hand I, Wittchen HU. editors. Panic and phobias: empirical evidence of theoretical models and longterrn effects of behavioral treatments. Berlin: Springer-Verlag; 1986. p. 18-28. Wittchen HU. Essau CA. The epidemiology of panic attacks, panic disorder, and agoraphobia. In: Walker JR, Norton GR, Ross CA, editors. Panic disorder and agoraphobia: a comprehensive guide for the practitioner. Pacific Grove (CA): Brooks/Cole Pub. Co.; c1991. p. 103-49. Woods SW, Chamey DS. Biologic responses to panic anxiety elicited by nonpharmacologic means. In: Ballenger JC, editor. Neurobiology of panic disorder. New York: Wiley-Liss; 1990. p. 205-18. Zal HM. Panic disorder: the great pretender. New York: Plenum Press; c1990. 232 p. Zane MD. A contextual approach to panic. In: Baker R, editor. Panic disorder: theory, research and therapy. New York: Wiley; 1989. p. 117-40. Zitrin CM. New perspectives on the treatment of panic and phobic disorders. In: Shaw BF, Segal ZV, Vallis TM, Cashman FE. editors. Anxiety disorders: psychological and biological perspectives. New York: Plenum; 1986. p. 179-202. 76 AUDIOVISUALS Anxiety disorders: generalized anxiety. agoraphobia, and obsessive compulsive anxiety [videorecording]. [Chapel Hill (NC)]: University of North Carolina at Chapel Hill. School of Medicine. Medical Sciences Teaching Laboratories; c1988. 2 Videocassettes (77 min.): sound, color; 3/4 in. + 1 guide. (Simulated psychiatric profiles; 3). Panic [videorecording]. Dartmouth Hitchcock Medical Center. producer. [Princeton (NJ)]: Films for the Humanities and Sciences; c1990. 1 videocassette (26 min.): sound. color; 1/2 in. Panic disorder. the nameless fear [videorecording]. Fogelson DL. Secaucus (NJ): Network for Continuing Medical Education; 1986. 1 videocassette (18 min.): sound. color. 3/4 in. + 1 booklet. (NCME telecourse; no. 492). Panic/Panic disorders [slide]. Jones BA. Mavissakalian M. [Columbus (OI-I): Ohio Medical Education Network; 1989]. 18 slides: color + 1 sound cassette (60 min.: 1 7/8 ips) + 1 guide. (OMEN; no. 14). Phobias and panic disorders [videorecording]. Uhde T. National Institutes of Health. Office of Clinical Reports and Inquiries. [Los Angeles]: Hospital Satellite Network; c1985. [1 videocassette (58 min.): sound. color; 3/4 in]. National Library of Medicine Reference Bibliography Series Inn-s m CURRENT [BERLHOGIRAIPIHUHES AIDS IIN WEDIICIINTE mm /" ”' Care and Use 1 of Laboratory 'y Animals pl. W 9“ ”’e ;@a oswy $59 per year (12 Monthly issues) W Individual i550” $5 Per COPY $52 per year (Approx. 20 Titles/yr.) List ID: AID9l Individual issues 83 per copy List ID: CBM91 Previously published quarterly. ._ Each issue consists of about 700- A continuation of the Library's 900 W! references ”30‘1"“! Literature Search Series. which articles. books. and audiovisuals on ended in 1987. Topics will continue AIDS. to be chosen for their current popular interest in distinct subject areas of biomedicine (excluding AIDS). ‘Subscribers receive all issues for a given calendar year without regard to the date of order. Superintendent of Documents Subscriptions Order Form 3:" I'm 6999 Charge your order. . . . _ It’s easy! Cl YES, please send me the subscnptton(s) indicated above. To fax your orders and inquiries—(202 The total cost of my order is $___. Prices include regular domestic postage and handling and are subject to change. lntemational customers please add 25%. Please Choose Method of Payment: (Company or personal name) (Please type or prim) E] Check payable to the Superintendent of Documents [:1 GPO Deposit Account CECEEED {1 (Additional address/attention line) D VISA or MasterCard Account (Streetaddress) IllllLJlllIlHllllllJ I (City. 513th ZIP C046) (Credit card expiration date) Thank you for your order. ( ) (Daytime phone including area code) (Signature) 2/91 Mail To: Superintendent of Documents, Government Printing Office, Washington, DC 20402-9371 I 9 GRATEFUL MED® Software For Macintosh & IBM Please send me Please send me copies of GRATEFU L copies of GRATEFU L MED for the MED for IBM and Macintosh. compatibles. Order No. PB89- Order N o. PB86- 196083/GBB at $29.95 15848?JGBB at $29.95 each. each. Total Mac versions + Total IBM versions + Handling $3.00 + Billing Fee* = Total * Add $7.50 Billing Fee if using a Purchase Order. Please attach this form to any purchase order you use. P.O. #: Send to: Enclosed is check / money order payable to NTIS for US. Department of Commerce $ . . . . . Charge to (check one): §2agéogzltT§3211§31 Information Servxce American Express D VISA E] MasterCard E] Springfield, VA 22161 Card Number Exp. Signature (required to validate order): Telephone: (703) 4874650 For ordering by FAX: (703) 321—8547 (only for orders using credit card or purchase order) Please complete the following. Last Name: First Initial: Title: Company / Organization: Address: City / State / Zip: Phone Number: ( ) In addition to your order you will receive free yearly upgrades of the software and information on obtaining a user code required to access the National Library of Medicine's data/Hes.